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RING Finger protein 17 (Rnf17) of Myc/Max/Mxd Network: Expression 
and Function during Mouse Reproduction and Development 
By Ayat Majed Sultan Bakheet 
The preimplantation mammalian embryo is sensitive to the environment in which 
they develop and grow, either in vivo or in vitro.  Disturbance to embryo 
environmental conditions can affect embryo growth.   Changes in gene expression is 
one of the embryo responses to such conditions that may influence developmental 
potential and phenotype during later gestation.  The signalling network 
Myc/Max/Mxd function as a molecular switch that regulates cell growth, proliferation 
and differentiation by controlling a common set of genes.  RING finger protein 
17(Rnf17) enhance Myc activity by sequestering all four members of Mxd family and 
creating a "Mxd-null phenotype".   The MXD family functions as MYC repressor 
proteins.  Two isoforms were described for Rnf17, long (Rnf17L) and short 
(Rnf17S).  Rnf17 is expressed in adult mouse testis and in the mouse 
preimplantation embryo.   The Rnf17 proteins contain RING finger domain and 
varying copies of the Tudor repeat domain (Tdrd).  The aim of my thesis was to 
study the potential for Rnf17 regulating the Myc/Max/Mxd network during 
preimplantation development on the phenotype of the blastocyst and foetal testes.  
First, F9 murine carcinoma cells were used to question whether Rnf17 can modulate 
Myc responses.   Functional assays were developed for Rnf17 over-expression by 
expression plasmids or Rnf17 knockdown by RNAi construct.   The specificity of 
Rnf17 E3 ligase was investigated by co-transfection of Flagg-tagged constructs for 
RNF17 and MXD1 in F9 cells.  Second, expression of Rnf17 mRNA and subcellular 
localisation of RNF17 protein were examined in mouse preimplantation embryo and 
in E17.5 foetal testes under normal condition and in response to maternal protein 
diets (LPD; 9% casein, HPD; 30% casein and control NPD; 18% casein).  Finally 
Rnf17 knockdown was performed in mouse embryo by siRNA microinjection to point 
out the role of Rnf17 in embryo development.   
RNF17 was able to degrade MXD1 by ubiquitinylation pathway in co-transfected 
Cos-1 cells.   Rnf17-SV40 expression construct significantly induced Luciferase 
activity of c-Myc reporter construct (P≤0.05) when over-expressed in F9 cells, and 
knockdown of Rnf17 using Rnf17-RNAi construct significantly reduced Luciferase 
activity of Rnf17-sensor construct (P≤0.05).  Rnf17 mRNA is expressed through 
preimplantation development, in E17.5 foetal testes and in F9 cells.   Members of 
Myc/Max/Mxd are expressed in mouse preimplantation embryo.  The expression 
pattern of RNF17 in F9 cells and mouse embryos was predominantly nuclear and 
also presented in the cytoplasm.   RNF17 was only expressed in the nuclei of Sertoli 
cells with faint signal in prospermatogonia in E17.5 foetal testes.  Knockdown of 
Rnf17 in microinjected embryos using Rnf17_siRNA reduced expression of Rnf17S, 
delayed blastocyst formation, and reduced RNF17 protein signal.  Maternal diet 4 
 
differentially regulate expression of Rnf17 and c-Myc in mouse blastocyst and E17.5 
testes.   
In conclusion, over-expression of Rnf17 can amplify Myc response in F9 cells.  MXD 
is a target protein for Rnf17 E3 ligase.  Knockdown of Rnf17 in mouse embryo 
delayed blastocyst development.   This study implicates that Rnf17 involved in 
regulating Myc/Max/Mxd signalling network and indicates a role for Rnf17 in 
blastocyst proliferation and growth.  Changes in Rnf17 expression have the capacity 
to modulate early embryonic development and may contribute to phenotypic 
changes occurring later in life.   
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1.  General Introduction 
The preimplantation period is a critical stage that needs optimum conditions 
to maintain high rates of proliferation, growth and differentiation.  
Compromised environmental conditions during embryo development may 
influence foetal growth and have adverse consequences on the future health 
of the offspring.    
The Developmental Origins of Health and Disease (DOHaD) hypothesis, also 
known as the Barker hypothesis, has described the relationship between 
disturbance in environmental conditions in foetal life and long-term 
developmental and physiological changes in tissues or organ systems which 
may increase disease risk in adulthood.  Maternal diets, either under nutrition 
or over nutrition, and Assisted Reproduction Technology (ART) have been 
reported to alter the environment of embryo growth and may lead to 
phenotypic and epigenetic changes. 
This literature review will address the effects of maternal diets and culture 
conditions on gene expression at the preimplantation embryo stage as well 
as on embryo growth and phenotype that can influence future health.  The 
mechanism of the signalling network- Myc/Max/Mxd will be outlined, which is 
associated with cell proliferation and differentiation and regulates gene 
expression.  Finally, we will focus on the structure and function of the RING 
finger protein 17 (Rnf17).  Rnf17 has been found to interact with Mxd, a 
member of the Myc/Max/Mxd network, and regulates its activity. 
1.1 Environmental conditions and DOHaD hypothesis 
The observations made by Professor David Barker and colleagues in the late 
1980s identified the association between low birth weight in humans and the 
risk of cardiovascular disease (Barker & Osmond, 1986; Barker et al, 2000).  
On the basis of these observations, the effects of in utero developmental 
conditions on embryo growth and later adult health were explained by the 28 
 
DOHaD hypothesis.  The hypothesis is based on human and animal studies 
and suggests a relationship between early growth, nutrition and long-term 
risk of age-related diseases, such as chronic heart disease.  Later studies 
have adapted the DOHaD hypothesis to investigate conditions related to 
preimplantation growth such as in vitro culture and also to study the 
mechanisms underlying the physiological and phenotypic changes to the 
foetus and adult later life (Langley-Evans, 2006). 
1.1.1 Effect of maternal diets on embryo growth and adult 
health 
Restricted maternal diet during periconception, preimplantation or gestation 
periods were reported to influence early embryo growth and long-term health 
and adult-onset diseases.  For example, mothers fed a LPD of 9% protein 
content, but isocaloric with NPD exclusively during the mouse 
preimplantation stage produced offspring with increased weight at birth and 
throughout postnatal life (Watkins et al, 2008a).  LPD offspring displayed 
raised SBP with reduced female heart size.  LPD females offspring showed 
anxiety-related behaviour (rearing and jumping) in open field analysis.  
Female mice exposed to LPD of 9% isocaloric during one ovulatory cycle, 
and prior to natural mating, showed sensitivity of oocyte maturation to 
maternal diet, and their offspring were identified to be abnormal, with anxiety-
related behaviour in open field activities (Watkins et al, 2008b).  The study 
displayed elevated SBP in male offspring at all assay times, and in both 
sexes at 21 weeks, whereas female offspring exhibited smaller kidneys but 
increased nephron numbers at 28 weeks. 
In a study by Kwong et al (2000), female rats were fed standard chow diet at 
pre-conception followed by normal protein diets (NPD) (18% casein) or LPD 
(9% casein) in the plug-positive to preimplantation period (0-4.25 day) and 
then the diet was switched to NPD for the reminder of gestation.  
Preimplantation maternal LPD did not affect the gestational length, litter size 29 
 
or the sex ratio.  Maternal LPD significantly caused reduction in the birth 
weight of female offspring up to 7 weeks after which an overcompensation to 
heavier weight gain than the control female offspring, and remained 
equivalent to the control NPD up to weeks 11-12.  The male offspring 
displayed induced SBP at age 4 and 11 weeks with a disproportionate size of 
liver and kidney in relation to body weight at age 12 weeks. 
Different species have shown that restricted maternal diets during 
preimplantation time may affect the cell numbers and differentiation in the 
blastocyst either at early or late stages.  Kwong et al (2000) showed that no 
differences were seen in the cell lineage number at day 3 in morula or at day 
4 in blastocysts of rats fed LPD or control NPD.  However, a significant 
reduction in inner cell mass (ICM) was seen in early blastocysts at day 4 and 
at day 4.25 in expanded blastocysts with a smaller reduction within the 
trophectoderm (TE).  The study revealed the effect of restricted maternal 
LPD (6% casein) to slow the rate of proliferation by reducing cell number 
when mitotic index was measured.  However, no differences in implantation 
rate, in the size of the deciduum or enclosed visceral yolk-sac were 
observed. 
Female mice were exposed at the periconception period to diets supplied 
with 7% total fat, 4.7% crude fibre, and between 15.5 and 16.5 MJ/kg of 
digestible energy, with a protein concentration of 21.7% for the high- protein 
diet (HPD), 12.7% for the medium-protein diet (MPD; control), and 8.4% for 
the low-protein diet (LPD).  The study showed reduced ICM with significant 
reduction in the proportion of ICM:TE cells of females derived from HPD: 
27.7%  and LPD: 24.4% compared to MPD: 42.9% (Mitchell et al, 2009). 
Not only do maternal LPD or HPD affect blastocyst development, but also 
maternal diet-induced obesity affects embryo development and growth.  The 
development of the zygotes into blastocysts from female mice fed an 
obesogenic diet (10% simple sugars, 20% animal lard, 28% polysaccharide, 30 
 
23% protein [w/w], supplemented with sweetened condensed milk and 
micronutrient mineral mix) failed in comparison with controls (Igosheva et al, 
2010).  The study also showed that the maternal diet-induced obesity led to a 
dramatic increase in inner mitochondrial membrane potential in oocytes 
(147%) and zygotes (74%) compared with those of lean females.  Abnormal 
localisation of mitochondria was detected in the eggs of the obese females, 
which may have contributed to the failure of blastocyst development and the 
preimplantation embryo.   
1.1.2 Effects of culture conditions on embryo growth and 
adult health 
Several studies have considered the sensitivity of the embryo to its culture 
environment, particularly in vitro culture (IVC) or in vitro fertilisation (IVF), and 
the possible short- and long-term consequences.   
A prospective follow-up study (Wisborg et al, 2010) showed a significantly 
increased risk of preterm delivery and considerable preterm delivery in 
women who conceived after IVF or intra-cytoplasmic injection (ICSI) 
compared with fertile women has been observed.  No significant differences 
in the risk of preterm delivery and considerable preterm delivery were 
observed between fertile women, women who became pregnant after non-
IVF assisted reproductive treatment or subfertile women.  Compared with 
spontaneously delivered infants of infertile women, IVF/ICSI children were of 
the highest risk for low birth weight.  Wisborg (2010) also showed that infants 
born after IVF or ICSI and after non-IVF treatment had a high risk of 
admission to a neonatal intensive care unit.   
Low birth weight after ART conception is associated to increased rates of 
cardiovascular and metabolic diseases, e.g. Diabetes-2 in adulthood.  Major 
birth defects were diagnosed by one year of age in infants born with the use 
of assisted conception by IVF/ICSI (Hansen et al, 2002).  Infants conceived 
after IVF/ICSI had low birth weight, preterm birth and twice as high a risk of a 31 
 
major birth defect as naturally conceived infants.  About two thirds of the 
major defects were diagnosed during the first week of life and > 90% were 
diagnosed by six months of age.  IVF children had a significantly greater 
prevalence of cardiovascular, urogenital, central nervous system and other 
defects, whereas ICSI recorded high rates for both the renal and the 
musculoskeletal defects, chromosomal and metabolic abnormalities.  Overall, 
the study revealed that 1.6% of IVF and 2.0% of ICSI infants were 
significantly more likely to have multiple major defects than naturally 
conceived infants (0.5%) (Hansen et al, 2002). 
Ceelen et al (2008) considered the postnatal growth and development in 
children from 8 to 18 years old born to subfertile parents who were either 
treated with IVF or conceived spontaneously (control).  This study showed 
that children born after IVF were of lower birth weight and gestational age 
compared to the control.  IVF-children displayed higher systolic and diastolic 
blood pressure, which may result in an increase the risk of developing 
cardiovascular disease independent of birth weight.  The level of fasting 
glucose was higher in children born after IVF compared to those conceived 
spontaneously, but no significant differences were measured in fasting insulin 
concentration and insulin resistance. 
ART media could be detrimental to development of the preimplantation 
embryo.  In the Lane and Gardner (2003) study, a significant decrease was 
observed in total cell numbers of mouse blastocysts cultured in media of 37.5 
µM ammonium.  Increasing ammonium level to 150 or 300 µM significantly 
reduced total cell numbers, number of ICM cells, and the percentage of ICM 
cells.  Embryos cultured in 300 µM ammonium increased the apoptotic cell 
index and significantly decreased percentage of implantation and foetal 
development.  However, embryos that managed to implant were significantly 
delayed in their development by 1.5 days at day 15 of pregnancy.  
Blastocysts cultured in media with 300 µM ammonium concentration 32 
 
increased the level of the expression of the imprinted gene H19 compared to 
the control blastocysts cultured in media without ammonium. 
Using Microarray assay (Rinauda et al, 2006), the gene expression profile of 
mouse embryos cultured in the presence of 5% O2, as the physiological 
condition for tissue growth more closely approximated to in vivo embryos, 
compared to those developed in 20% O2.  Genes involved in cell growth were 
mis-regulated when cultured at 20% O2 in media with or without the addition 
of amino acids (KSOM/AA or Whitten’s, respectively).  Embryos cultured in 
Whitten’s showed a down regulation of genes involved in gastrulation which 
could compromise the developmental competence of the blastocysts.  
Rinauda’s study showed increased cell numbers (ICM/TE) of the blastocysts 
cultured at 5% O2 in KSOM/AA or Whitten’s media.  Blastocysts cultured in 
KSOM/AA were of 55% highest ICM cell number and percentage than those 
cultured in the Whitten’s.  Embryos cultured at 20% O2 in both media had 
reduced birth weight. 
Watkins et al (2007) reported that in vitro cultured mouse embryos had 
reduced blastocyst cell number compared to in vivo developed blastocysts at 
96 hour post-human chorionic gonadotropin (hCG).  Extended culture of the 
in vitro group for a further 20 hours showed a comparable cell number to 
those within in vivo embryos at 96-hours post-hCG.  At 21 weeks, offspring 
derived from in vitro culture in T6 medium supplemented with protein source 
(BSA) and transferred to recipient (IVC-ET) displayed the highest mean SBP 
that was significantly higher than those derived from in vivo.  Significant 
differences between female offspring derived from IVC-ET and IV-ET kidney 
and lung weights were observed at 27 weeks.   
1.1.3 Effects of environmental conditions on gene expression 
in preimplantation embryo development 
Gene expression is of major importance in early embryo development, in 
which expression of the imprinted genes contributes to normal gene 33 
 
expression.  Imprinted genes are expressed in a parent-of-origin-specific 
manner in which only one allele from the mother or father is expressed.  For 
example, genes associated with growth, such as insulin-like growth factor 2 
(Igf2), Igf2 receptor gene (Igf2R), and H19, are imprinted during 
gametogenesis or preimplantation periods.  Igf2 is activated in the paternal 
genome, but is turned off in the maternal genome.  Igf2 is regulated by the 
active maternal gene H19 that is turned off in the paternal genome.  Igf2R is 
imprinted in the same way as of the H19 (Wolpert et al, 1998).  Loss of 
imprinting of one or a cluster of these genes has been shown to contribute to 
epigenetic and phenotypic changes.   
Variations in foetal overgrowth have been investigated in sheep, human, 
mouse, and other species and are associated with altered expression of 
imprinted genes.  Sheep reported for the large offspring syndrome (LOS) in 
which a significant increase in body weight and organ enlargements are 
associated with body growth and birth problems.  LOS is related to the loss of 
imprinting and hypomethylation of a differentially methylated region (DMR) of 
the maternal Igf2R allele, which causes degradation of Igf2.  Young et al 
(2001) showed a reduction of Igf2R expression in some sheep embryo 
tissues following in vitro culture of fertilised embryos for five days in a 
medium (co-cultured granulosa cells) supplemented with serum.  Foetuses 
exhibiting LOS had a reduced expression of Igf2R by 30-60% relative to 
controls (medium without serum) with a reduction of IGF2R protein levels by 
61% in muscle, 81% in liver and 67% in circulating form.  Restriction analysis 
revealed a complete loss of methylation of IGF2R in DMR in 9 of 12 LOS 
individuals.  As reduced IGF2R impaired IGF2 levels in the circulation, 
radioimmunoassay showed reduced levels of IGF2 in 125-day tissue 
samples.   
In humans, studies revealed that ART manipulations are associated with 
epigenetic diseases, specifically Beckwith-Wiedemann syndrome (BWS) and 
Angelman syndrome (AS).  BWS is one of the most common overgrowth 34 
 
syndrome associated with genetic and epigenetic changes in an imprinting 
cluster including IGF2 and various maternally expressed genes on 
chromosome 11p15.  Loss of imprinting of paternal IGF2 is responsible for 
abnormal methylation and silencing in the DMR (normally unmethylated) from 
H19 activating and over-expressing the maternal IGF2 contributing to foetus 
overgrowth (Reik and Maher, 1997).  Maher et al (2003) assessed two cases 
out of six BWS children born after IVF/CSI had loss of methylation on the 
KvDMR1 maternal allele (maternally methylated gene in somatic tissues).  
DeBaun et al (2003) tested imprinting alteration in six out of seven BWS 
children born after IVF/ICSI.  Five of the six showed abnormal imprinting of 
maternal LIT1 indicated by hypomethylation of the LIT1 DMR, whereas only 
one BWS child exhibited abnormal imprinting of H19 indicated by 
hypermethylation of the H19 DMR. 
Doherty et al (2000) revealed that culture media can dramatically affect the 
expression of the imprinted H19.  Blastocysts cultured from 2-cell in Whitten’s 
medium or KSOM containing amino acids (KSOM+AA) expressed both 
alleles (maternal and paternal) of H19.  The normally silent paternal H19 
allele expressed in the blastocyst: 40% ± 6% of the total H19 expressed in 
the Whitten’s medium, compared to those cultured in KSOM+AA: 10% ﾱ 3% 
of the paternal H19.  Blastocysts cultured in Whitten’s medium showed loss 
of methylation status of DNA at the HhaI site 5 (CpG dinucleotide located 
upstream from the start of H19), but methylation was detected for embryos 
cultured in KSOM+AA medium which confirmed the selective effect  of the 
culture media on  H19. 
Giritharan et al, (2007) assessed the global pattern of gene expression in the 
mouse preimplantation period using Microarray technology.  The Affymetrix 
430 2.0 chip was used to compare mouse blastocysts produced by different 
fertilisation methods; in vitro fertilisation (IVF) or in vitro culture (IVC) 
compared to in vivo.  Differential gene expression in the IVF blastocysts were 
detected in comparing to IVC and in vivo blastocysts.  29 genes were 35 
 
changed by more than a 4-fold expression in the IVF embryos in relation to 
the in vivo and 3 genes in IVC. 
Maternal diet may cause a gender–specific programming of imprinting gene 
expression.  Maternal LPD reduced the level of H19 (30%) in rat male 
blastocyst exposed to maternal LPD (9% casein) without affecting the relative 
expression of β-actin, Igf2 and Igf2R, either in males or in females.  The 
examined blastocyst either remained on LPD until day 20 or switched back to 
the control diet (18% casein) after implantation on day 4.25.  On day 20, only 
the switched diet group showed a reduction in relative levels of H19 (9.4%) 
and Igf2 (10.9%) in male foetal liver.  Reduced levels of growth regulating 
genes (H19 and Igf2) have been suggested as affecting individual foetal 
growth in response to maternal LPD (Kwong et al, 2006). 
Maternal methyl-supplemented diets (folic acid, vitamin B12, betaine, and 
choline) provide substantially increased amounts of cofactors and methyl 
donors for methyl metabolism and Dnmt (DNA methyltransferase enzyme 
which catalyses the transfer of a methyl group to DNA) (Cooney et al, 2002).  
Such an example is the mutation of mouse agouti allele.  The mouse agouti 
allele (wild-type) Aw regulates the alternative production of black (eumelanin) 
and yellow (pheomelanin) pigment in individual hair follicles.  Insertion of 
intracisternal A particle (IAP) in the regulatory regions of the agouti locus 
controls the gene and yellow offspring are produced: viable yellow (Avy), IAP 
yellow (Aiapy), or hypervariable yellow (Ahvy).  The long terminal repeat (LTR) 
of the IAP expression is regulated by DNA methylation and causes hair 
follicle melanocytes to synthesise yellow instead of black pigment (Fig 1.1).  
DNA methylation as a result of maternal methyl diets are reported to change 
the LTR status and cause the epigenetic phenotype of Avy  that is also found 
to be maternally heritable (Wolff et al, 1998; Morgan et al, 1999). 
Although epigenetic factors may change the phenotypes of the individual and 
affect later health, it is considered to be heritable, and passes through the 36 
 
germ line in mammals.  Morgan et al (1999) described that the inheritance of 
Avy (as epigenetic changes) due to an epigenetic modification of the IAP at 
the agouti locus in mice may include DNA methylation.  Thus, silencing of the 
IAP is the result of the epigenetic modification rather than maternal 
environment effect.  The study also reported that yellow mice females (under 
standard conditions and diet) when mated with Avy/a males (“a” is the non-
agouti allele) were able to produce pseudoagouti offspring with more 
extensively methylated Avy allele in pseudoagouti than in yellow mice.   
A study by Waterland et al (2007) described that the Avy hypermethylation is 
diet-induced.  Avy/mice females of two generations (F1 and F2) were weaned 
onto methyl-supplemented diet and then mated with a/a males.  The effect of 
methyl diets was stable in the successive offspring (F1, F2 and third 
generation, F3) with fewer slightly mottled and more heavily mottled Avy/a 
offspring.  Waterland (2007) revealed that the acquired Avy is passed to the 
offspring through the female germ line because of a supplemented diet rather 
than transgenerational modification at the locus. 
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Fig 1.1: The mouse Avy locus.  The Avy mutation was caused by insertion 
of retro-transposition IAP ~ 100 kb upstream of the first coding exon (the 4.5 
kb IAP is not drawn to scale).  The agouti (A) and nonagouti (a) transcripts 
originate at exon 2 (arrow head labelled A, a).  The Avy transcript originates 
from a cryptic promoter within the IAP (arrowhead labelled Avy) (Waterland 
et al, 2007). 
 
Sinclair et al (2007) demonstrated that reductions in vitamin B12, folate and 
methionine, from maternal diet around the time of ovine conception leads to 
epigenetic modifications to the genome affecting the DNA methylation in the 
offspring, with long-term implications for adult health.  Using restriction 
landmark genome scanning (RLGS), these modifications were shown in 4% 
of 1,400 CpG islands in the liver of the sheep foetus for Methyl-deficient diet 
(MD) (reduced peripheral concentration of Vitamin B12, folate, and 
methionine), of which 53% of the alteration was specific to males.  Greater 
growth rates of ewe offspring for MD were observed than control offspring, 
and they became heavier by 22 months of age.  Female offspring were 
fatter than males with less tolerance to infused glucose, but no differences 
in body fatness between treatment groups were observed. However, MD 
males were 25% fatter than control males.  Females displayed greater 
resting heart rate than males, which displayed no differences in the treated 38 
 
groups, and were within the normal range for non-stressed sheep.  Blood 
pressure, systolic, diastolic and mean arterial pressure responses were 
increased only in MD male offspring.   
1.2 Tight junctions and signalling 
Whilst ART and in vitro culture aim to produce healthy and viable embryos, 
they may compromise embryo viability.  Trophectoderm tight junctions have 
been found to be compromised in preimplantation embryos by affecting gene 
expression and cell differentiation in human ART (Ghassemifar et al, 2003; 
Eckert et al, 2007).  The efficiency of para-cellular transport is regulated by 
the correct formation of intercellular junctions: zonular tight junction (TJ) and 
zonular adherens junction (AJ).  The junctions also function as mediators of 
intercellular signalling between epithelial cells, of which TJ interruption could 
affect cell proliferation and gene expression (Sheth et al, 2008; Eckert and 
Fleming, 2008).  Impaired junctions may be the result of reduced expression, 
or mislocalisation, of TJ proteins or disruption of gap junction communication 
or cellular energy status (Eckert and Fleming, 2008). 
Eckert et al, 2007 has linked the mechanisms of metabolism and junction 
membrane assembly in the early developed embryo, such that amino acid 
turnover could predict TE differentiation.  In this study, increased amino acid 
turnover during embryo developmental stages were related to an increased 
level of membrane assembly of junction components and protein synthesis, 
around the time of cavitation.  This resulted in normal blastocysts with 
functional integrity of TE.  In contrast, embryos failing to exhibit normal amino 
acid turnover could produce morphologically normal blastocysts but impaired 
TE differentiation.  Membrane assembly of occludin and ZO-1α+ showed a 
significant relationship with amino acid turnover (Eckert et al, 2007). 
Unbalanced embryo homeostasis is a state resulting from abnormal 
environmental conditions and may influence expression of various genes.  
For example, changing expression of metabolic and differentiation-related 39 
 
genes in early developmental stages has been shown to alter expression 
levels of genes involved in trophectoderm differentiation and intracellular 
junction formation (Fleming et al, 2004).  Thus, differentiation failure could be 
a consequence of junction assembly deficiency, as well as a cause of 
disturbed differentiation of the first epithelium during embryo development 
(Eckert and Fleming, 2008). 
1.3 Myc/Max/Mxd network 
Culture conditions or compromised maternal diets have been identified to 
affect preimplantation embryo growth, gene expression, signalling pathways 
and adult health.  The Myc/Max/Mxd network is known to be expressed 
during embryo development, and has been suggested to function as a 
molecular switch that regulates cell growth and differentiation by controlling a 
common set of genes (Hultquist et al, 2004). 
The Myc/Max/Mxd network (hereafter according to Mouse Genomic 
Informatics, the Mad1, Mxi1, Mad3 and Mad4 are referred to Mxd1, Mxd2, 
Mxd3 and Mxd4, respectively) comprises a group of transcription factors 
whose distinct interactions result in gene-specific transcriptional activation or 
repression (Grandori et al, 2000).  Members of this network contain the basic 
helix-loop-helix zipper (bHLHZip) domain which facilitates dimerisation of 
Max with members of the Mxd family (Mxd1, Mxd2, Mxd3 and Mxd4) or Myc 
family (c-Myc, N-Myc, L-Myc).  This domain is also required for DNA binding.  
The basic helix-loop-helix (bHLH) proteins act as transcriptional regulators 
and are involved with neurogenesis, myogenesis, cell proliferation, tissue 
differentiation, and other essential developmental processes (Morgenstern 
and Atchley, 1999). 
Max can dimerise with itself, but these so-called homodimers are 
transcriptionally silent and may even have a dominant negative function 
(Grandori et al, 2000).  Max can also forms heterodimers with Mnt and Mga 
proteins through the bHLHZip domain, but the activities of such complexes 40 
 
are not as well studied, and are believed to exhibit inhibitory activities.  Mxd 
proteins and Max complexes compete with Myc and Max complexes for 
binding to a specific-DNA-sequence (CACGTG), termed the E-box.  Mxd and 
Max repress transcription from such a sequence whereas Myc and Max 
promote transcription (Grandori et al, 2000). 
One mechanism by which the Myc-Max heterodimeric complex activates 
transcription is through the recruitment of a histone acetyltransferase (HAT) 
via TRRAP (Transformation/transcription domain-associated protein).  
Acetylation of surrounding histones and remodelling of the chromatin 
correlates with transcription and the ensuing phenotypic response of 
enhanced proliferation, cell cycle progression, growth, and, under certain 
conditions, apoptosis, although some studies suggest that the recruitment of 
Myc does not necessarily correlate with histone acetylation (Eberhardy et al, 
2000).  On the other hand, the heterodimers of Mxd-Max represses 
transcription by recruitment of a histone deacetylase activity (HDAC) via 
mSin3 co-repressor complex.  This causes deacetylation of histone tails and 
the restoration of a repressive chromatin structure that prevents the 
transcription of the associated genes.  In this way Mxd promotes growth 
arrest, and differentiation (Grandori et al, 2000) (Fig 1.2). 
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Fig 1.2: Myc and Mxd members of Myc/Max/Mxd network regulate 
the acetylation state of nucleosomal histone near E-box binding 
sites.  (A) Myc-Max heterodimer bound to an E-box sequence near the 
promoter of a target gene and recruit the TRRAP co-activator and the 
HAT, GCN5 resulting in acetylation of nucleosomal histones and 
expression of the target gene.  (B) During terminal differentiation, Myc is 
down regulated and release Max whereas Mxd is induced and 
heterodimer with Max.  Mxd-Max heterodimer occupy the target gene E-
box site and recruits the mSin3 co-repressor and HDACs leading to 
deacetylation and repression of target gene expression (modified from 
Eisenman, 2001). 42 
 
In addition to the well-studied genes operating the Myc/Max/Mxd pathway, 
as described above, there are other genes that have not been examined to 
the same levels of molecular detail.  These include Mga, Mnt, Mondo, Mlx, 
and some play an important role during early development.  For example, 
Mga is expressed in early mouse embryonic stages, at E9.5, E10 and 
E10.5, and its expression overlaps with members of T-box, suggesting a 
role of Mga in regulatory pathways controlling mesoderm induction (Hurlin 
et al, 1999).  Mga contains two domains, T-box and bHLHZip, which 
suggest a more complex transcriptional and biological activity of Mga than 
other members of bHLHZip and T-domain.  The T-domain acts as a master 
regulator directing the transcription genes essential for a variety of 
embryonic inductive events (Hurlin et al, 1999; Rikin and Evans, 2010).  
Mga suppression of Myc activation is less potent than that caused by Mxd 
proteins and Mnt (Hurlin et al, 1999). 
In zebrafish, Mga, is a T-box transcription factor required for 
embryogenesis, and regulates normal heart tube looping (Rikin and Evans, 
2010).  Blocking the function of Mga by injecting fertilized eggs of zebrafish 
with morpholinos generates phenotypes with increased cardiac oedema, 
with thin linear “heart-string”, similar to that caused by mutant tbox5, tbox20 
or gata4.  Morphant Mga shows up-regulation of c-myc, l-myc, mxd2 and 
mxd4 and 2-fold enhanced transcripts of tbox20, gata6 and gata4 (Rikin 
and Evans, 2010). 
Another bHLHZip Max-binding protein is Mnt, which co-expressed with Myc 
in a number of proliferating cell types.  The complex Mnt/Max is similar to 
Mxd acting as a transcriptional repressor.  Yeast two-hybrid screen 
revealed that Mnt also contains regions rich in proline residues that are 
similar to the activation domains of transcriptional factors, including Box I of 
the c-Myc activation domain.  Mnt is similar to Mxd, and contains the SID 
that interacts with mSin3 co-repressor proteins, mediated through paired 43 
 
amphipathic helix 2 (PAH2).  The deletion of SID converts Mnt from 
transcriptional repressor to transcriptional activator (Hurlin et al, 1997). 
In situ hybridization for mouse embryo showed that mnt is uniformly 
expressed at E9.5 and E10.5 and higher at later stages in neural structures.  
Expression of mnt at E10.5 appeared at the same time as c- and N-myc 
expression in proliferating cells, suggesting expression of mnt in both 
proliferating and differentiating cells.  Immunoprecipitated Max from MCF-7 
human breast carcinoma and HLF human neuroblastoma cell lines, using 
Mnt and Myc anti-sera, confirmed the presence of both Mnt/Max and 
Myc/Max hetero-complexes in proliferating cells (Hurlin et al, 1997). 
1.4 Rnf17: RING finger protein 
RING finger protein(Rnf17) is a germ cell specific gene that is expressed in 
the testis and required for male germ cell differentiation (Pan et al, 2005) 
and was identified by Yin et al 1999 and 2001, and originally termed Mmip-2 
(mad member interacting protein-2), following its isolation in a Y2H (yeast 
two hybrid) screen as a Mxd protein interactor.  Rnf17 encodes a protein 
containing both RING finger and Tudor domains and is reported as a 
component of a novel nuage, a French term for a cloud, which displays a 
perinuclear location in male germ cells (Pan et al, 2005).  Rnf17 is one of 
several novel spermatogonially expressed germ cell specific proteins and is 
involved in transcriptional or post-transcriptional regulation of gene 
expression (Wang et al, 2001).  Microarray data showed that Rnf17 is also 
expressed in early embryo development (Giritharan et al, 2007); however, 
Rnf17 function has not been studied in the early embryo.   
Hereafter, according to Mouse Genomic Informatics, the RING finger 
protein 17/Mmip2/Tdrd4 are referred to as Rnf17.  Also small letters Rnf17 
named mouse gene (mRNA) whereas capital letters RNF17 refers to the 
protein. 44 
 
1.4.1 Structure and function of Rnf17 
Pan et al (2005) identified two isoforms of mouse RNF17 that are longer 
than the ~300 residue protein previously reported as Mmip-2 (Yin et al, 
1999).  The short RNF17 (RNF17S) is 1130 amino acids (a.a) and the 
longer RNF17 (RNF17L) is 1640 a.a.  Northern blot analysis of a panel of 
adult mouse tissues showed that Rnf17 is exclusively expressed in the 
testis, including the two Rnf17 transcripts; Rnf17L (5.2 kb) and Rnf17S (3.5 
kb) (Pan et al, 2005).  The cDNA sequences of both Rnf17 were recorded in 
GenBank under the accession numbers: Rnf17L, AY864011; Rnf17S, 
AY854010 (Pan et al, 2005), and Mmip-2 is deposited with accession 
number: AF190166 (Yin et al, 1999). 
The mouse Rnf17 proteins consist of a RING finger domain of a zinc-
binding motif at the N-terminus with multiple Tudor domains at the C-
terminus.  Pan et al (2005) indicated 5 Tudor domains in the RNF17L and 3 
in the RNF17S.  However, AceView and UniProt annotated 4 Tudor 
domains in RNF17L and 2 in the RNF17S and they are named the maternal 
Tudor domain (Fig 1.3).  AceView revealed that the Rnf17 gene produces 
several proteins with no sequence overlap.  The gene is well expressed 
with 9 spliced mRNAs, and they putatively encode proteins in which they 
have been experimentally expressed and annotated in the genome 
database (a, b, c, d, e, f, g, h, i) and the 2 unspliced mRNA variants appear 
not to encode good proteins which are expressed but not annotated in 
genome database (j, k) (Fig 1.4).  Those encode good proteins containing 9 
isoforms and some contain maternal Tudor domains (a, b, d, e), a second 
peroximal domain (a, i), a coiled coil stretch (a, b, c, g), a Leucine zipper 
domain (a, b, e, d) and as many as 3 nuclear localisation domains (a, b, c, 
g).  However, the functional relevance of these domains is unclear at this 
point. 
Comparing the transcript sequences with the mouse genomic sequence 
demonstrated alternative splicing.  Rnf17 transcripts shared exons 1-25 45 
 
(Pan exon nomenclature) and differed in their 3' terminal sequences.  The 
short Rnf17 is AT rich in its last exon (exon 26) which contains a non-
canonical polyadenylation signal (AATAA) and an in-frame translational 
termination codon.  The long transcript of the Rnf17 lacks exon 26, but has 
12 additional exons with a canonical polyadenylation site of (AATAAA) (Fig 
1.5), which predicts alternative splicing.  Exon 26 is not annotated in the 
mouse (www.ensembl.org), but is within the rat genome sequence.  
Surprisingly, the human sequence lacks this exon, but carries the two 
flanking exons that are well conserved in the mouse sequence.   
It will be of significant interest to perform some evolutionary analysis to 
ascertain when this sequence was acquired by rodents, or lost by primates, 
and to examine Rnf17 genes within Laurasiatheria, a large group of placental 
mammals that includes shrews, hedgehogs, pangolins, bats, whales, most 
hoofed mammals and carnivorans, among others.  Interestingly whilst the 
human genome does not carry the exon to produce the 2x Tudor domain 
protein, a related protein is expressed by humans that appears to originate 
by some distinct, but ill-defined mechanism.  The last shared exon carried by 
both long and short murine transcripts is of 116bp and this size is conserved 
between mouse and human genes.  Within genomic DNA in the mouse this 
exon is followed by a 6040bp intron that carries the novel exon 26.  The 
6040bp intron can be divided into a 5’ intron of 2233bp, a 125bp exon (3’ 
terminal short transcript) and a 3’ intron of 3682bp.  The human genome has 
a significantly smaller intron of 2283bp followed by exon of 290 (287bp in 
mouse), 164, 120, 81 and 57 (60bp in mouse).  The novel rodent exon, if 
present in humans would reside with the 2283bp region.  It is not clear why 
this intron is truncated compared to the mouse.  In the rat, exon sizes for the 
5 exons preceding and following the 3’ terminal exon of the short transcript 
are absolutely conserved.  The intron carrying the short transcript terminal 
exon is of 3812bp compared to 6040bp in the mouse.  Other species that 
have an annotated Rnf17 gene are not at the level of completeness of 46 
 
knowledge to ascertain whether the 3’ terminal of the short murine transcript 
is a rodent peculiarity, or is found in other non-primates.  Canis familaris 
displays extensive exon size conservation both 5’ and 3’ of the short cassette 
exon, but has a relatively short intron of 1131bp for putatively carrying the 
exon that gives rise to the short transcript and protein.  Purely on size, one 
could argue that this would carry this exon.  No species, other than the 
mouse and the rat, has the short transcript encoding only two Tudor domains 
annotated.  However, as indicated above, the human genome does in fact 
express a related protein, with two Tudors, by another mechanism.  It is of 
interest that this protein lacks the N-terminal RING finger domain and is 
expressed from transcript 203 (www.ensembl.org).   
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Fig 1.3: Structure of RNF17 transcripts.  RNF17 contain a RING finger 
domain in the N-terminal and multiple Tudor domains in the C-terminal.  (A) 
Two transcripts for RNF17 described by Pan et al, (2005) contain 5 Tudor 
domains in the RNF17L and three Tudor domains in the RNF17S.  (B) 
Schematic diagram for RNF17 transcripts described by AceView shows four 
maternal Tudor domains are in the RNF17L (protein a) and two maternal 
Tudor domains in the RNF17S (protein b).  No maternal Tudor domain is in 
RNF17 transcript C (protein C) or Mmip2. 
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Fig 1.4: Alternative mRNAs aligned from 5’ to3’ on virtual genome as 
described in AceView.  Nine spliced Rnf17 mRNA encode good proteins (a, 
b, c, d, e, f, g, h, i) and two unspliced Rnf17 mRNA appear not to encode 
good proteins (j, K).  Underlined name/ending of transcript been supported by 
GenBank accession resulted from cDNA of testis, in vitro fertilised eggs, 
trophoblast stem cells, placenta, whole body, blastocyst, embryo and nine 
other tissues.  Names not underlined result from cDNA concatenation in the 
coding region and should be experimentally checked. 
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Fig 1.5: Schematic diagram of Rnf17 transcripts.  Both the short Rnf17 
(Rnf17s) and the long Rnf17 (Rnf17l) are shared exons 1 to 25.  Exon 26 is 
last in Rnf17s and is lost in Rnf17l which predict alternative splicing of about 
6040bp in the mouse and 2238bp in the human.  Rnf17l has 12 additional 
exons (modified from AceView; Pan et al, 2005). 
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1.4.2 Rnf17 and alternative splicing complexes 
Nuclear pre-mRNA splicing is the process of removing the primary transcript 
and joining the coding sequences to form mature mRNA that is transported to 
the cytoplasm for protein synthesis.  Splicing is catalysed through several 
steps, mediated by a large RNA-protein complex, termed the spliceosome.  
The conserved cell division cycle 5-like protein (CDC5L) is required for the 
second catalytic step of pre-mRNA splicing, a step that is essential for 
spliceosome assembly and catalysis (Ajuh et al, 2000). 
Human CDC5L interacts with human pleiotropic regulator 1 (PLRG1) and 
immuno-depletion of CDC5L from HeLa nuclear extract showed depletion of 
PRL1 (Ajuh et al, 2000).  The CDC5L/PLRG1 complex directly interacts in 
vivo with the heterogeneous nuclear ribonucleoprotein-M (hnRNP-M) and this 
interaction modulates both the 5' and the 3' alternative splicing process 
(Lleres et al, 2010).  Loss of the CDC5L/PLRG1 interaction domain on the 
hnRNP-M correlated with a loss of ability to modulate alternative splice site 
selection in E1A mini-gene assay.  Proteomic analysis of nuclear complexes 
of HeLa cells containing CDC5L antibody revealed an interaction between 
CDC5L (Q99459) and RNF17 (Swiss-PROT: Q9BXT8) (Lleres et al, 2010), 
suggesting some role for Rnf17 in the spliceosome complexes.   
Cdc5l and Plrg1 are highly expressed in the mouse blastocyst in response to 
maternal NPD and LPD compared to Rnf17 (Fig 1.6), although no differential 
regulation observed in response to maternal diets (Papenbrock et al, 
unpublished data). 
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Fig 1.6: Microarray data show expression of Cdc5l and Plrg1 comparing 
to Rnf17 in mouse blastocysts in response to maternal LPD.  Affymetrix 
1438820_at for Rnf17 is significantly increased in mouse blastocysts in 
response to maternal LPD.  No differential regulation was observed for Cdc5l 
and Plrg1 in mouse blastocysts; however, Affymetrix 1460429_at for Cdc5l 
showed 1.03 fold increases in response to maternal LPD (Papenbrock et al, 
unpublished data). 
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1.4.3 RING finger domain 
A RING finger is a type of zinc finger that can be identified within protein 
sequences containing a cysteine and histidine amino acid motif of consensus 
sequence C-X2-C-X[9-39]-C-X[1-3]-H-X[2-3]-C-X2-C-X[4-48]-C-X2-C.  The 
amino acid residues coordinate two zinc ions in a highly typical cross-brace 
structure and this domain may either bind DNA or be involved in protein-
protein interactions (Fig 1.7).  The RING domain in murine Rnf17 is at 
residues 30 to 75 of the full protein sequence and the sequence as shown in 
UniProt is:  
CTRCGRKVSVASGDHHKFPCGHAFCELCLLAPQEYTTSKCTDCE 
 
 
 
 
 
 
 
 
Fig 1.7: Schematic drawing of Zinc finger protein shows the cross-
brace structure between amino acid residues and the two zinc ions.  
The first cysteine that coordinates zinc is labelled as C1, and so on.  H1 
denotes the histidine ligand.  Xn refers to the number of amino acid residues 
in the spacer regions between the zinc ligands (modified from Deshaies and 
Joazeiro, 2009). 
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Many RING finger domains with their characteristic conserved pattern of His 
and Cys residues are observed to play a role in the tagging of proteins by 
ubiquitin that results in their degradation by the proteasome.  RING domain 
proteins exert E3 ubiquitin ligase activity (Pickart, 2001). 
The Ubiquitin system involves an ubiquitin-activating enzyme (E1), an 
ubiquitin-conjugating enzyme (E2) and ubiquitin-ligase (E3) and the system is 
particularly complex involving some 35 E2s and 250 E3s, although the 
genome only carries two E1s.  E1 activates ubiquitin (Ub) that binds to the 
active-site cysteine of the E1.  The activated Ub is transferred in a thioester 
linkage to the active-site cysteine of the E2 (E2~Ub).  The E2~Ub interacts 
with E3 ligase via a RING domain and the E3 ligase catalyses the transfer of 
Ub from the E2 to a targeted substrate, the latter being degraded by 
proteasome 26S (Fig 1.8). 
Van Wijk and colleagues, using the global Y2H screen described later, 
demonstrated that the human RNF17 RING domain was able to interact with 
the E2 protein, UBE2U.  Expression of the putative Rnf17 E3 ligase enzyme 
during early development could implicate its role in modifying the proteome 
independently of the transcriptome, i.e. post-translationally, through changes 
to the half-lives of key target proteins, and this observation provides further 
support for the notion that transcriptomics alone cannot provide answers to 
key development issues. 
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Fig 1.8: Schematic diagram shows the main steps of ubiquitin-
proteasome system (www.ebi.ac.uk). 
 
RING finger-containing proteins may modulate the Myc/Max/Mxd network 
by direct ubiquitinylation mediating degradation of target proteins.  For 
example, c-IAP (isoform of IAps protein that acts as an inhibitor of apoptosis 
in human adult tissues) has been shown to degrade Mxd1 by 
ubiquitinylation, and increases the level of two of Myc-responsive genes 
(ornithine decarboxylase-1 and Cyclin D2) and promotes cell proliferation 
and transformation (Xu et al, 2007). 
Serum induction in cultured cells induced Mxd1 degradation by 
phosphorylation of Mxd1 at Ser 145 by RSK and S6K or PI3K/Akt pathways 
through ubiquitinylation (Zhu et al, 2008; Chou et al, 2009). 
Taken together, questions that we could ask are: 
  Whether Rnf17 as an E3 ubiquitin-ligase has a role in the degradation of 
the members of Mxd family? 55 
 
  Does increased E3 ligase activity of Rnf17 promote cell proliferation by 
increasing c-Myc and enhancing c-Myc target genes? 
1.4.4 Tudor domain 
Tudor domains are small modules of amino acids mediating protein-protein 
interactions that are necessary for the assembly and regulation of germ 
granules.  The Tudor domain is implicated in chromatin remodelling, RNA 
splicing and transport of mitochondrial RNA from mitochondria to polar 
granules (Thomas and Lasko, 2005; Chen et al, 2009; Arkov and Ramos, 
2010).  The founding member of this family is a germ cell specific protein 
Tudor with multiple Tudor domains form Drosophila.  Related proteins in 
other organisms, including zebrafish and mouse are termed Tdrd (Tudor 
related domain) and have roles in germ cells (Pan et al, 2005; Chen et al, 
2009).  Microarray analysis, for the expression pattern of mammalian genes 
encoding Tudor domain proteins revealed a group whose expression is 
highly enriched in germ cells, such as Tdrd1, Tdrkh/Tdrd2, RNF17/Tdrd4, 
Tdrd5, Tdrd6, Tdrd7, Stk31/Tdrd8, Tdrd9, Tdrd10, Akap1 (Chen et al, 2009). 
Tudor domain-containing proteins are localized together with PIWI proteins in 
cytoplasmic electron-dense structures known as chromatoid bodies (CB), 
intermitochondrial cement (IMC) or nuage.  Interaction between Tudor 
domain-containing proteins and PIWI proteins, relatives of the Ago proteins 
that participate in RNA interference via the RISC, is mediated by symmetrical 
dimethyl arginine (sDMA).  These modifications are brought about by a 
protein arginine N-methyltransferase such as Prmt5 and is pivotal to protein-
protein interactions and to perform biological activities (Arkov and Ramos, 
2010).  Sites (RG/RA) and types (mono- or di-methyl, asymmetrical or 
symmetrical) of arginine methylation on PIWI proteins have been determined 
and identified to interact with Tudor domain aromatic cages via sDMA (Chen 
et al, 2009; Vagin et al, 2009).  Double mutation of the TDRKH Tudor domain 
residues including D390, which is conserved across the TDRD family of 56 
 
Tudor domains and F391, a component of the aromatic cage, completely 
abolished the binding of TDRKH to MIWI (Chen et al, 2009). 
PIWI proteins are also associated with Piwi-interacting RNAs (piRNAs) and 
function in piRNA-mediated posttranscriptional silencing.  PIWI proteins 
contain arginine-glycine and arginine-alanine (RG/RA)-rich clusters at their 
N-termini.  Immunoprecipitates of endogenous MIWI and MILI from lysates of 
adult testes followed by mass spectrometry, revealed that Tudor domain 
proteins and proteins involved in piRNA pathways are associated with MIWI 
or MILI or with both complexes (Chen et al, 2009; Vagin et al, 2009).  Chen 
(2009) determined the methylated sites of RG/RA-rich of MIWI and MILI and 
identified that 2 different arginines could be dimethylated simultaneously on a 
single peptide, suggesting a role of PIWI to recruit proteins with methyl 
arginine recognition models at the same time, such as Tudor domains and 
piRNA.  By scanning the lower mass range of several DMA peptides' MS/MS 
fragments, Chen (2009) identified that the modifications on PIWI proteins 
(RG/RA) are symmetrically dimethylated (sDMA).   
Both TDRD and their interaction partner MIWI, MILI or MIWI2 (mouse PIWI 
proteins) are localised in the cytoplasm in CB or nuage.  Mutant TDRD 
proteins or PIWI proteins revealed disorganisation of CB or nuage and co-
localisation of their components.  For example, TDRD1 localised in MILI-
containing nuage loses its localisation in Mili-deficient prospermatogonia and 
dispersed in the cytoplasm, whereas in Tdrd1 mutant MILI is still localised in 
nuage.  In contrast, MIWI2 that co-Immunoprecipitated with MILI and TDRD1 
is not required for correct TDRD1 co-localisation.  However, in Tdrd1 mutant 
MIWI is lost from nuage and is diffuse in the cytoplasm (Vagin et al, 2009). 
Endogenous MIWI and MILI complexes were recovered from mouse testis 
(3-6 months-old) using MIWI N2 or N3 and MILI N1 or N2 antibodies for 
Multidimensional Protein Identification Technology (MudPIT) analysis.  
MudPIT was followed by Immunoprecipitation for MIWI or MILI complexes 57 
 
and showed that RNF17 interacts with MIWI but not MILI proteins (1.5-1.8%) 
(Vagin et al, 2009).  The significance of this observation in early development 
is not clear as Microarray analysis revealed very low expression of MIWI and 
MIWI2, however MILI was highly expressed.  In the same study (Vagin et al, 
2009), proteomic analysis of 3xFlag-HA MILI, MIWI by MudPIT revealed a 
complex of proteins that interact with MILI and MIW including Tudor domain-
containing proteins.  The interaction showed that MIWI is associated with the 
greatest number of Tudor family proteins including RNF17 with a lesser 
degree of interaction (12 peptides, 8.7% coverage).  Interactions identified by 
mass spectrometry were also confirmed by Western blotting. 
In another study in zebrafish, Tdrd1 and the Piwi proteins, Zili and Ziwi, are 
localised in nuage-like structures in the cytoplasm in early stages of both 
oocyte and sperm development.  Co-Immunoprecipitates using zebrafish 
Tdrd1-specific antibodies in testis showed interactions between Tdrd1 and 
Zili and Ziwi.  Mass spectrometry on Tdrd1 Immunoprecipitates identified Ziwi 
and Zilli, Vasa and the Tudor domain-containing proteins Rnf17 (24 peptides 
in testis and 6 in ovary) and Tdrd5 (Huang et al, 2011) suggesting that Rnf17 
and Zili zebrafish interact.   
TDRD5 co-localised with MIWI in IMC, CBs, and Tudor/Piwi-containing 
nuclear bodies (T/PNBs).  Tdrd5 -/- mutants showed significant 
disorganisation of the IMCs and the CBs, co-localisation of MIWI and 
reduced expression of Act and CREM targets (Yabuta et al 2011).  Yabuta 
(2011) revealed that the phenotype of Rnf17-/- mutants is similar to that of 
Tdrd5 and Miwi-/- mutants, in which that RNF17 may function cooperatively 
with the IMCs and the CBs for the stabilization of the CREM target genes and 
other spermiogenic genes.  The developed haploid genome and fertile 
offspring following injection of oocytes with round spermatids obtained from 
Tdrd5-/-mice, raises the possibility that the mutants for Rnf17, Tdrd6, or Miwi, 
which show phenotypes similar to those of mutant Tdrd5, bear round 
spermatids with a functional haploid genome (Yabuta et al, 2011). 58 
 
Arkov and Ramos (2010) reviewed that PRMT5 is the factor responsible for 
the sDMA modification and that it may control the subcellular localization of 
PIWI proteins in germ cells and is required for transposon silencing.  Arginine 
methyltransferase 5 (Prmt5) is essential for early development as well as for 
the derivation and maintenance of pluripotent ES cells.  It has a role in the 
establishment of unipotent primordial germ cells from embryonic stem cells 
(Tee et al, 2010; Nagamatsu et al, 2011).  ICM outgrowths from ES cells 
showed predominant expression of PRMT5 in the cytoplasm of all ICM 
outgrowth cells, including Oct4-positive pluripotent cells, suggesting the 
involvement of PRMT5 in development and proliferation of the epiblast in vivo 
and in vitro (Tee et al, 2010).  Microarray analysis of somatic cells 
reprogramming of MEFs with prmt5, klf4 and Oct3/4 and Nanog-GFP 
reporter gene showed that gene expression of these cells became ES cell-
like.  Induction in these cells was referred to prmt5, which is critical for germ 
cell specificity.  RT-PCR for prmt5 knockdown revealed a reduction in the 
number of Nanog-GFP colonies.  Results indicated that Prmt5 participates in 
the reprogramming process of somatic cells mediated by Sox2, klf4, Oct3/4 
and c-Myc (Nagamatsu et al, 2011).  Prmt5 was highly expressed in our 
blastocyst array, indicating a possible arginine N-methyltransferase activity. 
Immunoprecipitated 3xFlag-HA-MIWI complexes from adult testis were 
analysed by MudPIT represented associations of PRMT5 and its cofactor 
WDR77 with MIWI by 20 peptides (21% protein coverage) for PRMT5 and 14 
peptides (18.4% protein coverage) for WDR77.  Flag-HA-tagged MIWI2 or 
MILI Immunoprecipitated from embryonic testis also showed interaction 
between PRMT5/WDR77 and MIWI2 and MILI (Vagin et al, 2009).  Myc-
tagged MILI, MIWI or MIWI2 were co-expressed with Flag/HA-tagged PRMT5 
or WDR77 in HEK 293 cells and showed interaction between PIWI proteins 
with WDR77 but not PRMT5, suggesting a role of WDR77 as interaction 
bridge between PIWIs and PRMT5 (Vagin et al, 2009). 59 
 
WDR77 is uniformly distributed in the nucleus and cytoplasm of the 
embryonic gonocytes.   At later stages WDR77 is localised to the CB of 
round spermatids (Vagin et al, 2009).  PRMT5 is expressed in the early 
mouse embryo and at the early stages it is nuclear.  At E4.5, Prmt5 is 
expressed in the nuclei of differentiated TE cells but is down-regulated 
transiently in the pluripotent ICM epiblast cells.  However, at E6.5, Prmt5 was 
detected in the pluripotent epiblast cells of the post-implantation embryo, but 
predominantly in the cytoplasm (Tee et al, 2010).  Miwi mutants have been 
shown to disturb WDR77 localization to CB, without affecting the uniform 
cytoplasmic localisation of PRMT5 (Vagin et al, 2009). 
Prmt5 and Wdr77 are highly expressed in the mouse blastocyst in response 
to maternal diets compared to the significantly changed Rnf17.  Affymetrix 
1422844_a_at and 1434552_at are slightly increased in response to 
maternal LPD but failed to reach significance (Papenbrock et al, unpublished 
data) (Fig 1.9). 
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Fig 1.9: Microarray data show expression of prmt5 and Wdr77 
comparing to Rnf17 in mouse blastocysts in response to maternal LPD.  
Affymetrix 1438820_at for Rnf17 is significantly increased in the mouse 
blastocysts in response to maternal LPD.  No significant changes were 
observed in Prmt5 and Wdr77 in response to maternal LPD.  Affymetrix 
1427439_s_at for Prmt5 and 1430289_a_at for Wdr77 are down regulated in 
response to LPD of 0.98 and 0.93 respectively, whereas Affymetrix 
1434552_at and 1422844_a_at for Wdr77 are up-regulated in response to 
LPD of 1.09 and 1.03 respectively (Papenbrock et al, unpublished data). 
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The crystal structure of a Tudor domain from the mammalian SURVIVAL 
MOTOR NEURON (SMN) protein revealed a β-barrel structure enclosing a 
pocket lined with aromatic amino acids (aromatic cage), that is required for 
the recognition of methylated lysine/arginine-containing ligands (Arkov and 
Ramos, 2010; Chen et al, 2009).  The Tudor domain of SMN is needed for 
binding to methylated SmD1 and SmD3 (two SM proteins) by sDMA.  Tudor 
domains have highly conserved amino acids and predicted structure, which 
suggests that the structure of the Tudor domain in SMN is likely to be very 
similar to those found in other Tudor domain containing proteins (Fig 1.10) 
(Thomson and Lasko, 2005). 
 
 
 
Fig 1.10: Amino acid sequences of Tudor domain as described by 
Thomson and Lasko (2005) compare the Tudor domain of SMN (Homo 
sapiens) to 11 Tudor domains of TUD.   Hydrophobic residues are 
highlighted in blue and negatively charged residues are highlighted in pink. 
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Mutagenesis of SND1 aromatic residues showed disturbances in the binding 
affinity to the sDMA peptides (Ke et al, 2010).  SND1 carries a bifurcated 
Tudor, called the extended Tudor domain or the maternal Tudor domain that 
is essential for binding to sDMA.  The SND1 extended Tudor domain 
contains three parts, the canonical tudor domain, the linker α-helix and the 
fifth SN-like domain.  The Tudor domain module is embedded between two 
segments of the fifth SN-like domain, the N-terminal two β-strands and the C-
terminal with three α-helices and three β-strands.  The maternal Tudor 
domain sequence contains the canonical Tudor domain, the linker α-helix 
and the N-terminal two β-strands of the SN domain. 
The UniProt database shows that Rnf17 contains four maternal Tudor 
domains in the long protein and two in the short protein, compared with 5 and 
3 respectively in the work by Pan et al (2005).  The alignment of Tudor 
domains of human RNF17 and human SND1 -Ke (2010)- showed that 
Tudor1 and Tudor4 for Rnf17 (row1 and 3) have the highly conserved 
aromatic side chains, as described above, whereas the aromatics of Tudors 
2 and 3 are poorly conserved (row 4 and 5) and probably do not bind to 
sDMA. 
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Taken together, Rnf17/Tdrd4 long and short proteins contain multiple Tudor 
domains, but each carries a consensus sequence for sDMA binding, however 
their function; specifically in the context of the other Rnf17 domains, has not 
yet been revealed by study.  However, mouse knockout for Rnf17/Tdrd4 
revealed crucial role or Rnf17 in spermatogenesis (Pan et al, 2005). 
The structural analysis of Rnf17 raises several questions: 
  Does interaction between RNF17 and MIWI family proteins have a role in 
localizing RNF17 to the nuage or a related structure? What are the 
implications of the nuage targeting elements on Mxd activity (Yin et al, 
1999)?  
  Are RNF17 and piRNAs found in the same complex that participates in 
transposon silencing? 
  PRMT5/WDR77 interacts with MIWI, Is this interaction related to the 
RNF17/MIWI interaction and function in embryo growth? 
  How are the different isoforms controlled spatially during embryo growth? 
1.4.5 Expression of Rnf17 and members of Myc/Max/Mxd 
network in Microarray data 
A number of Microarray datasets related to mouse early embryo 
development showed changes in the expression of key growth regulatory 
genes, specifically Rnf17, members of Myc/Max/Mxd network and genes' 
heterodimers with Max (Mga and Mnt).  These data described the gene 
expression in the mouse preimplantation embryo.   
Differential regulation of Rnf17 was observed in response to maternal diet 
(Papenbrock et al, unpublished data) and in a culture condition model 
(Giritharan et al, 2007).  A set of Affymetrix probes are described to monitor 
Rnf17 expression in the mouse embryo, however: Affymetrix 64 
 
probe1438820_at showed significant differences in maternal diet and culture 
condition studies.  Rnf17 was increased 1.9 fold in mouse blastocyst in 
response to maternal LPD compared to maternal NPD (Table 1.1).  In culture 
conditions, Rnf17 increased 1.81 and 1.86 fold in mouse blastocyst cultured 
IVC and IVF respectively, compared to those in vivo; however the differences 
were significant only in the IVC culture (P=0.01) (Table 1.2).  The same 
Affymetrix probe, 1438820_at, showed that Rnf17 expression is increased 
during the preimplantation period (from oocyte to blastocyst) (Zeng et al, 
2004; Fig 1.11). 
In the same Microarray studies (Table 1.1 & 1.2) changes in expression 
levels of c-Myc were described using probe set 142492_a_at.  Significant 
changes in mouse blastocyst for c-Myc (P=0.05) in response to maternal 
LPD showed 1.07 fold increase compared to maternal NPD.  c-Myc showed 
decreased expression with IVC and IVF compared to the control (in vivo) by 
0.4 and 0.74 fold respectively,  but did not reach significance (P=0.23 and 
0.66 respectively). 
Members of Mxd family did not change expression in mouse blastocyst in 
response to maternal LPD (Table 1.1) as noticeably as in IVC or IVF culture 
conditions (Table 1.2).  Expression of members of Mxd family differs through 
the preimplantation stage.  Zeng et al (2004) showed in a longitudinal study 
using Microarray GEOD 1749 (www.ebi.ac.uk ) that, after fertilisation, Mxd1 
and Mxd4 are highly expressed at 1cell stage, followed by Mxd2 at 2cell and 
Mxd3 at 8 cell embryos (Fig 1.11). 
The two poorly described Max family interactors, Mga and Mnt were 
differentially regulated.  There was significant increase in Mga (1.34 fold) IVC 
compared with in vivo (P=0.05) and ~1.2 fold increase in mouse blastocysts 
in response to maternal LPD (P<0.05) using different probe sets.  Mnt shows 
1-2 fold increase IVC compared with in vivo but this did not reach statistical 
significance.  However, Mnt was significantly increased (P<0.05) in 65 
 
blastocyst in response to maternal LPD (1.2 fold) (Table 1.1& 1.2).  
Expression of Mga and Mnt also varied during different preimplantation 
stages, in the Microarray GEOD 1749.   
The Dppa4 gene is expressed in ES cells in the same pattern as the 
pluripotency markers (such as Oct3/4, Sox2 and nanog) and is down-
regulated at the time of differentiation (Madan et al 2009; Masaki et al, 2007; 
Siegel et al, 2009).  Dppa4 has the SAP domain (SAF (scaffold attachment 
factor), Acinus and PIAS (protein inhibitor of activated STAT)) that has an 
affinity for DNA and suggests a role of DPPa4 in modulating chromatin 
structure and in gene regulation (Masaki et al, 2010). 
By Microarray analysis, Madan et al (2009) compared global gene 
expression in wild-type and Dppa4-defficient ES cells.  This showed that 78 
non-redundant genes were significantly altered.  Two genes out of the 78 
were up-regulated, whereas 76 were down-regulated.  Genes required for ES 
cell pluripotency/self-renewal (Oct3/4, Sox2, nanog, Ronin or Myc) were not 
differentially regulated.  17 of the 67 down-regulated transcripts were more 
than 2-fold altered in Dppa4-/- ES cells.  The 17 transcripts encode proteins 
which are suggested to function in germ cell development and fertility; such 
as Dazl, MVH/Ddx4, Rhox5 and Maelstrom.   
Interestingly, the Rnf17 was one of the 17 transcript down-regulated genes in 
the Madan’s study (Table 1.3).  Although suppression of Dppa4 induces 
differentiation in ES cells and Rnf17 is expressed at terminal differentiation 
(Madan et al, 2009; Masaki et al, 2007; Siegel et al, 2009), the down 
regulation of Rnf17 in Dppa4-/- ES cells may reveal a role of Dppa4 in the 
regulation of the transcription of genes or influencing the stability of a specific 
transcript by modulating chromatin structure (Madan et al, 2009; Masaki et al, 
2010). 
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Table 1.1: Affymetrix Microarray data and bioinformatics analysis (Papenbrock 
et al, unpublished data) show differential changes in expression of Rnf17 and 
Myc/Max/Mxd in mouse blastocyst in response to maternal LPD.  Highlighted 
rows represent Affymetrix probes of significance differentially regulated (P<0.05). 67 
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Table 1.3: Microarray analysis by Madan et al (2009) show down regulation of 
number of transcripts in Dppa4 knocked down ES cells.  Those transcripts 
including Rnf17 are encoded proteins suggested functioning in germ cell 
development and fertility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Gene Name  Probe set  p value  adj.  p value 
Rnf17  142508_at  6,82E-05  0,01923974 
Rnf17  1438820_at  9,51E-05  0,02323373 
Mael  1436837_at  6,02E-08  0,00026482 
Dazl  1449502_at  2,42E-06  0,0020456 
Dazl  1419542_at  3,19E-07  0,00054046 
Rhox5  1423429_at  9,75E-06  0,00536097 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.11: Microarray data show expression of genes involved in 
Myc/Max/Mxd throughout mouse preimplantation development.  (A) 
Affymetrix probe 1438820_at for Rnf17 is highly expressed compared to 
different probes used for Rnf17.  (B) The highly expressed Rnf17 Affymetrix 
probe shows high expression compared to differentially regulated genes that 
involved in Myc/Max/Mxd network (Myc, Mga and Mnt) (Papenbrock et al, 
unpublished data). 
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1.4.6 Rnf17 interaction with members of Myc/Max/Mxd 
network 
Yin et al, (1999 and 2001) described the interaction between Rnf17 and the 
members of the Myc/Max/Mxd network using the yeast two-hybrid method 
(Y2H).  The Y2H method is a system that provides a convenient assay for the 
study of protein-protein interactions and is used as a tool to identify proteins 
(genes) based on their ability to interact with other target proteins.  As shown 
in Figure 1.12, initially a whole library of sequence is screened for interaction 
between the target-prey and candidate bait proteins (Stephens and Banting 
2000). 
 
 
 
 
 
 
 
 
Fig 1.12: Yeast two-hybrid system.  (A) in the absence of an activation 
domain (AD), the DNA binding domain (BD) that expressed as a fusion with 
protein X (called the bait) is capable of activating transcription.  (B) The AD 
that expressed as a fusion with protein Y (the prey) is similarly incapable of 
activating transcription in the absence of a BD.  (C) Interaction between the 
two fusion proteins by which interaction between X and Y results in 
reconstitution of an active transcription factor and subsequent transcription of 
a reporter gene such as LacZ providing a mean to assay the interaction 
between the two fusion proteins (Stephens and Banting, 2000).   71 
 
In studies by Yin, a yeast expressing pGAD-RNF17 was transformed with 
pGBT9 vectors encoding c-MYC, MAX, MXD1, MXD2, MXD3 or MXD4.  
RNF17 showed a strong interaction with MXD1, MXD3 and MXD4, a weak 
interaction with MXD2, and a very weak interaction with c-MYC.  No 
interaction was seen between RNF17 and MXD or unrelated bHLH proteins, 
ID1 (Inhibitor of DNA binding 1) or MyoD (Myoblast determination protein).   
The interaction between MXD1 and RNF17 required only an intact ZIP 
domain of the MXD1 and at least two distinct regions for RNF17 (Yin et al, 
1999).  PGBT9-MXD1 incorporating a deleted first helix of the MXD1 HLH 
domain (delH1), interacted strongly with RNF17, but not with MAX.  In 
contrast, pGBT9-MXD1 with a deleted ZIP domain (delZIP) failed to interact 
with RNF17.  A deletion series of RNF17 from the amino (N-terminus) and 
carboxy (C-terminus) termini was expressed as fusion proteins in the 
pGAD10 vector and tested for interaction with the PGBT9-MXD1.  Loss of 42 
residues from the N-terminus enabled interaction with the MXD1 bait as 
strongly as the original construct because it retained a large segment of the 
RING finger.  The removal of an additional 88 amino acids, the region 
between amino acids 44 ± 132, including all of the RING finger resulted in a 
considerable loss of interaction.  A segment from RNF17 containing only the 
C-terminal 52 amino acids or further deletions from the C-terminal was 
entirely inactive and failed to interact with MXD1. 
1.4.7 Expression of Rnf17 in tissues and cell models 
Tissue expression of Rnf17 showed a signal of ca.4.5 kb transcript 
expressed in RNA from NIH 3T3 fibroblasts and Friend murine 
erythroleukemia cells.  Also, RNA in mouse tissues of adult and embryos was 
tested for the endogenous distribution of Rnf17 and the adult testis showed 
the highest expression level compared to other tested tissues (Yin et al, 
1999). 72 
 
Bone marrow stem (BMS) cells that were transdifferentiated into male germ 
cells (BM-GC) expressed germ cell-specific genes including the Rnf17 
(Nayernia et al, 2006).  The Stra8-enhanced green fluorescence protein 
(eGFP) transgenic mouse line, expressing eGFP specifically in male germ 
cells, was used to derive male germ cells.  Expression of Rnf17, germ-cell-
specific genes (fragilis, stella, Mvh and Oct4), molecular markers of 
spermatogonia (Dazl, Piwil2, Stra8, Rbm, Hsp90a and c-kit) and the stem 
cells fraction (β1- and α6-integrins) were detected in BM-GC and testis 
tissues, but not in BMS cells.   
Another study by Lavagnolli et al, 2009 suggested an in vitro model to study 
differentiation of GC in reprogrammed somatic cells.  Lavagnolli’s group 
revealed that near diploid ES-somatic cell hybrids (ES-SCH), resulting from 
the fusion of mouse ES and spleen cells (somatic cells), were able to 
differentiate in vitro into presumptive GC in the presence of retinoic acid 
through formation of embryoid bodies (EB).  The resulting presumptive GC 
reacted positively with anti-EMA (epithelial membrane antigen), Vasa, 
Fragilis and Dazl antibodies and expressed GC-specific genes, including the 
Rnf17. 
1.4.8 Subcellular localisation of Rnf17 and its relation to Myc 
and Mxd 
Two studies of Yin et al (1999 & 2001) indicated that RNF17 and MXD family 
members can each influence the subcellular distribution of their binding 
partners when co-expressed in cultured cells.  An RNF17-GFP fusion protein 
was shown to be expressed in the cytoplasm of NIH 3T3 fibroblasts, whereas 
a MXD3-GFP fusion protein showed nuclear localisation.  Interaction 
between the two fusion proteins resulted in a shift of RNF17-GFP to the 
nucleus when MXD3-GFP was in excess, whereas increasing RNF17-GFP 
shifted the MXD3 to the cytoplasm (Yin et al, 1999).  In the following study by 
Yin et al (2001), MXD2 was tested under conditions of stable expression with 73 
 
non-GFP tagged proteins.  MXD2 localised in the nucleus of control cells and 
in the cytoplasm of the pooled Rnf17 cells, whereas c-MYC and MAX were 
confined to the nucleus in both cells.   
A series of terminal truncations of RNF17 encoded GFP fusion protein was 
expressed in NIH 3T3 cells to define the minimum requirement for the 
cytoplasmic RNF17-granule formation (Pan et al, 2005).  A 45-a.a region of 
RNF17 (residues 243-287) allowed the formation of punctated GFP-RNF17 
granules, whereas in those without this 45-a.a region the GFP-RNF17 was 
distributed diffusely.  Immunoprecipitation and GST pull-down showed that 
RNF17L and RNF17S associate in vivo and that RNF17 (1-626) binds 
(homodimerises) to GST-RNF17 (1-287) but not control GST.   
Pan et al, (2005) confirmed the previous observations that RNF17 is a 
cytoplasmic protein in male germ cells and identified two proteins, as 
predicted.  Cytoplasmic and nuclear fractions of testicular extracts 
demonstrated that both RNF17 proteins were present in the cytoplasm; 
however, they were also detected in the nucleus but in much lower 
abundance. 
In the Pan study (2005), it was the first time that Rnf17 was identified in a 
perinuclear dot-like structure which they termed the “Rnf17 granule”.  Indirect 
immunofluorescence on testis sections using anti-serum 1774 (rabbit 
polyclonal antibodies raised against the N-terminal 100 residues of RNF17) 
confirmed the cytoplasmic localisation of the RNF17 in all germ cells; 
spermatogonia, spermatocytes and spermatids.  In addition, double 
immunostaining of adult testis sections with anti-RNF17 and anti-SP10 
antibodies to stain the acrosomes (SP-10 is an intra-acrosomal protein) then 
counterstained with DAPI the RNF17 granules appeared as large prominent 
dots in pachytene (VIII) and diplotene (XI) spermatocytes at late stages, as 
well as late stages of spermatids. 74 
 
Pan et al (2005) distinguished the RNF17 granules as distinct organelles 
from CB and lysosomes in male germ cells.  Double immunostaining of testis 
sections with anti-RNF17, anti-TDRD1, -TDRD6 (Tudor domain-containing 
proteins and components of CB) and anti-LAMP2 (lysosome component) 
revealed that RNF17 granules were distinct from the CB and lysosomes.  
Immuno-EM showed that RNF17 granules are spherical electron dense 
organelles, not surrounded by membranes, with diameter of 0.5 µm and 
smaller than CB (1- 2 µm). 
1.4.9 Rnf17 is required for spermatogenesis 
Rnf17-deficient (Rnf17–/–) mice displayed normal development but were 
infertile (Pan et al, 2005).  Pan et al, 2005 showed that testis and 
seminiferous tubules of 8-week-old Rnf17–/– mice were smaller than those of 
the wild-type and the epididymis contained apoptotic round spermatids, but 
no sperm.  Also, adult Rnf17–/– testis, Leydig cells and Sertoli cells were 
normal in number, size and morphology.  Germ cells developed into round 
spermatids, but failed to differentiate into elongating spermatids.  Testes from 
Rnf17–/– mice at day 28 contained round spermatids but lacked elongating 
spermatids.  Rnf17–/– mice displayed a reduction in the expression of genes 
that initiate transcription post-meiotically, but not those which transcribe in 
meiosis such as Miwi, Pabpc3 (poly A-binding protein) and Ldh3 (lactate 
dehydrogenase 3, C chain).  No changes in expression of genes that 
regulate spermiogenesis were observed. 
1.4.10 Rnf17 creates Mxd-null phenotype and may regulate 
some of c-Myc target genes 
Yin et al (2001) showed that the over-expression of Rnf17 inhibited the 
function of the MXD protein creating a “de facto Mxd-null” or Mxd-attenuated 
phenotype.  Analysis of the pooled Rnf17 cells with the neo-control cells 
(pooled G-418-resistant clones with empty pMSG-MT neo vector) revealed 75 
 
that the pooled Rnf17 cells were more prone to apoptosis and showed 
equivalent sensitivity to apoptotic stimuli as c-Myc transfected cells.   
Yin et al (2001) identified that the inactivation of Mxd by Rnf17 and ensuing 
de-repression of c-Myc would enable Rnf17 to regulate some of the c-Myc 
target genes.  To confirm this notion, they examined expression of a c-Myc 
target gene, ornithine decarboxylase (ODC), which is positively regulated by 
c-Myc and antagonised by Mxd, and reported elevated levels of the ODC in 
response to Rnf17 expression. 
1.5 Aim and hypothesis 
Both maternal protein under nutrition in vivo and embryo culture in vitro can 
induce changes in cellular proliferation and gene expression in embryos and 
adulthood non-communicable diseases.  One major objective of this project 
is to study the effect of maternal protein diets on cell proliferation and 
differentiation in mouse embryo in particular concerning Rnf17, which has 
been shown to interact with the Myc/Max/Mxd signalling network.   
We hypothesise that Rnf17 induces cell proliferation in the preimplantation 
embryo by creating a Mxd-null phenotype, it can bind all MXD proteins and 
exclude them from participating in nuclear transcriptional repression, and 
thus, presumably, enhance cell proliferation.  Our hypothesis will be 
examined under abnormal or stress preimplantation embryo environments, 
such as maternal diets.  Previously, maternal LPD was shown to differentially 
regulate the expression of Rnf17 and members of Myc/Max/Mxd.   
This project will aim:  
1.  To evaluate Rnf17 over-expression in F9 cells, as a model for 
preimplantation embryos, to address whether it could modulate Myc 
activity.   76 
 
2.  Using a microinjection technique, designed siRNA oligonucleotides 
targeting Rnf17 will be injected into mouse embryos to knockdown 
Rnf17 expression.  From the resulting embryos the potential role of 
Rnf17 will be examined.   
3.  Using RT-qPCR the expression of Rnf17 (and members of the 
Myc/Max/Mxd family) will be examined in response to maternal low, 
high and control normal protein diets (LPD, HPD, NPD) in mouse 
blastocysts at E3.5 and in mouse foetal testes at E17.5. 
4.  Using immunostaining and confocal microscopy the expression 
pattern of RNF17 in preimplantation embryos and its subcellular 
localisation will be examined under normal conditions and in response 
to maternal LPD, HPD and control NPD mouse blastocysts at E3.5 
and mouse foetal testes at E17.5.   
These data should provide an overview of the expression of Rnf17 and the 
Myc/Max/Mxd network in preimplantation embryos, in changes that may 
occur in response to maternal dietary protein manipulation.   
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2.  Materials and Methods 
2.1 Preparation of Rnf17 constructs 
2.1.1 Amplification of target sequences TA cloning of 3´A 
overhangs PCR products 
Rnf17 fragment was deposited as Mmip-2/Rnf17 according to Yin et al, 1999 
with GenBank Accession no. AF190166.Rnf17 template was supplied from 
Jieyan Pan (University of Pennsylvania, USA).Primers for Mmip-2/Rnf17 
fragment (951bp) were designed with restriction sites of HindIII at forward 
primer and Xbal at reverse primer:  
F: 5′ AAGCTTCCACCATGGCGGCAGAGGCTTCG 3′  
R: 5′ TCTGAGTCATTTTCTAGAGGGGTAACA 3′ 
Phusion® Hot Start “High-Fidelity DNA Polymerase” was used for PCR.  50μl 
of PCR reactions incubated for enzyme activation at 98°C for 30 seconds.  35 
cycles were run for denaturation at 98°C for 10 seconds, primers annealing at 
55°C for 30 seconds and extension at 72°C for 30 seconds. 
PCR products (inserts) were scaled for 50µl on 1% agarose gel.  Rnf17 band 
was cut, weight and solubilised in a ratio of 100mg insert: 300µl QXI 
Solubilisation Buffer (QIAE II Gel Extraction Kit).  The solution centrifuged 
onto NucleoSpin Plasmid spin column and then washed with Wash Solution 
(NucleoSpin® Plasmid).  The DNA eluted in 50µl autoclaved H2O.The blunt-
ended PCR products were modified by Taq polymerase to add an adenosine 
(A) residue to the 3′ ends of the product.  Reactions were incubated at 74°C 
for 30minutes.   
pGEM®-T Easy vector system was used as a ready linearised vector plasmid 
with a single 3′-terminal Thymidine (T) overhang at each end.  The treated 
insert with 3′ A-overhang was ligated to the pGEM®–T Easy vector to 
produce a PCR-TA clone.  The ligation reactions incubated at 4°C overnight.  
Negative control reaction was set with no insert (-insert).     80 
 
2.1.2 Transformation of Rnf17-TA clone into E.  coli SURE™ 
Competent cells 
Rnf17 insert and TA (Rnf17-TA) clone was transformed into E.coli SURE™ 
strain.  Frozen competent cells were thawed on ice before re-incubated with 
β-Mercaptoethanol on ice for 10 minutes with gentle swirl every 2 minutes.  
1µl ligation reactions was added and kept into ice for 30 minutes.  The cells 
were chemically transformed by heat shocked at 42°C water bath for exactly 
45 seconds.  The cells placed on ice immediately for 2 minutes, then 
incubated at 37°C with 450µl LB/Amp medium with shaking (250rpm) for 60 
minutes.  The cells/ligation mixture centrifuged at 13,000rpm for 5-10 
minutes, the supernatant removed, and the cells re-suspend with fresh 100 µl 
LB/Amp medium.  The suspension is plated onto LB/Amp agar and incubated 
at 37°C overnight.  Competent cells transformed without DNA was set as 
negative control (-ve control) and competent cells control DNA supplied with 
Competent cell kit was used as positive control (+ve control).Next day, the 
plates were checked for colonies growth.  A number of colonies were picked 
and incubated with LB/Amp medium overnight on the shaking incubator at 
37°C. 
2.1.3 Extraction of plasmid DNA of the PCR-TA clone 
The DNA plasmid extracted using NucleoPlasmid kit following manufacturer 
instruction.  Briefly, the overnight culture of plasmid transformed centrifuged 
and the bacterial pellet re-suspended with Re-suspension buffer and lysed by 
SDS/alkaline Lysis Buffer.  The lysate cells incubated at room temperature 
for 10 minutes then neutralised with Neutralising Buffer then centrifuged.   
The column was washed with washing solution.  The column was dried and 
DNA was eluted with 50µl autoclaved water.  The extracted DNA of both 
PCR-TA clones was double cut with restriction enzymes.   
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2.1.4 Preparation of vectors and ligation to the prepared 
inserts 
The pGL3-Control was modified for cloning Rnf17 by replacing the luc+ with 
a synthetic polylinker (HindIII_EcoRI_AgeI_SpeT_EcoRV_PstI_XbaI) via a 
HindIII and XbaI sites and double stranded link oligonucleotides was inserted 
incorporating a series of recognition sites for restriction endonucleases that 
single cutters within the vector: 
F: 5’ agcttgaattcaccggtactagtgatatcctgcagt 3’ 
R: 5’ acttaagtggccatgatcactataggacgtcagatc 3’ 
In a total of 20µl the linker pGL3-Control were double cut with Xbal and 
HindIII followed with gel purification.  1µl Rnf17 insert ligated to 2.5µl pGL3-
linker with 1µl 10X Ligation Buffer and 0.5µl T4 Ligase.  The ligation 
reactions incubated at 4°C overnight.  Negative control reactions were set 
with no insert (-insert).   
2.1.5 Transformation of constructs and plasmid extraction 
Ligations of Rnf17-pGL3-linker was transformed into E.coli JM109 High 
Efficiency Competent Cells of 1x108cfu/µg DNA, grown into LB/Amp medium 
and plated onto LB/Amp agar with X-gal and IPTG solutions.  In the next day 
the plates were checked for colonies growth.  A number of colonies were 
picked and incubated with LB/Amp media overnight on the shaking incubator 
at 37°C.  The plasmid extracted using NucleoPlasmid kit following 
manufacturer instruction. 
2.1.6 Large scale of DNA extracting 
The DNA plasmid extracted using GenElute™ Plasmid Miniprep Kit following 
manufacturer instruction.  Briefly, the overnight culture of 100µl plasmid into 
50ml LB growth media is centrifuged and the bacterial pellet re-suspended 
with Re-suspension buffer and the DNA lysate by SDS/alkaline Lysis Buffer.  
The lysated cells incubated at room temperature for 5 minutes then 
neutralised with Neutralising Solution followed by Binding solution to facilitate 82 
 
DNA binding to the silica membrane of the column.  The lysate is cleared 
with a Midiprep Filter Syringe.  The GenElute Midiprep Binding Column is 
prepared and washed twice with Column Preparation Solution.  Column was 
dried and DNA is eluted with 1ml Elute solution.  The DNA was precipitated 
1:10 volume of 3M Sodium Acetate pH 5.2, and 1:1 isopropanol.  The mixture 
spin and the pellet washed with 1:1 of 70% Ethanol.  The pellet was dried 
and the DNA diluted to with dH2O and stored at -20°C. 
2.2  Myc responsive construct 
Map sequence of commercial construct pMyc-TA-Luc (Clontech, UK) was 
deposited to design oligonucleotides for c-Myc reporter construct.   Myc 
oligonucleotides were designed of double-stranded DNA including the TAT 
box as well as overhang nucleotides complementary to restriction sites; NheI 
and HindIII on both 5’ (underlined): 
5’CTAGCCACGTGCACGTGCACGTGCACGTGCACGTGCACGTGAGATC
TGGGTATATAATGGA3’          
3’GGTGCACGTGCACGTGCACGTGCACGTGCACGTGCACTCTAGACCC
ATATATTACCTTCGA5’ 
Reverse and the forwards inserts were annealed at 65°C and diluted 
to10ng/µl.  In a total of 100µl, pGL3-Basic vector were double cut with NheI 
and HindIII and 10X Core Buffer followed with gel purification.  In a total of 
10µl ligation reaction, 1µl of diluted Myc inserts were ligated to 2µl of the 
linearised pGL3-Basic. 
2.3  c-Myc expression plasmid 
pEF-c-Myc expression vector is supplemented from Yongfeng Shang 
(Harvard Medical school, USA).  The vector was designed to encode c-Myc 
cDNA downstream Elongation factor promoter (pEF) at EcoRI restriction site 
into pUC vector.  The plasmid was cultured for large scale.  pEF-c-Myc 
plasmid was diluted indH2O and 1µl is transformed into E.coli JM109 High 
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Efficiency Competent Cells of 1X107cfu/µg DNA.  Selected colonies were 
prep-culture and then single cut with EcoRI.  Large DNA scale was set in 
50µl LB/Amp growing media, followed by single cut with EcoRI. 
2.4  Production of Rnf17-RNAi construct and Rnf17 sensor 
2.4.1 Rnf17-RNAi oligonucleotides design and annealing 
The RNA interference (RNAi) construct was designed following Ambion 
guideline for siRNA design (www.ambion.com).  TheRnf17 target site for 
siRNA was selected to be down the length of Rnf17 sequence and 
immediately downstream AA dinucleotides.  The selected target sequence 
(AACTCAGATCTGCTCCTTCTC) is located in position 722 in mmip-2 gene 
sequence (GenBank: AF190166, Yin et al). 
The forward oligonucleotides consist of 19 nucleotide (nt) sense siRNA 
sequence followed by 9nt loop which linked the reverse complementary 
antisense siRNA sequence.  Additional 5 T’s were added to the 3'end of the 
oligonucleotide.  To be cloned into the pSilencer™ 1.0 U6 vector, overhang 
nucleotides with complementary restriction sites; EcoRI at 5' and ApaI at 3' 
ends were added on the complementary reverse oligonucleotide. 
Rnf17 wild type (Rnf17-RNAi-wt) was designed to induce RNAi of the target 
Rnf17-sensor.  Rnf17 mutant (Rnf17-RNAi-mut) nucleotides was set as a 
non-targeting negative control RNAi with the same nucleotide composition as 
the Rnf17-RNAi-wt but lacks significant sequence homology to the genome 
(as shown below).   
Rnf17-RNAi-wt   
F:5 
′CTCAGATCTGCTCCTTCTCTTCAAGAGAGAGAAGGAGCAGATCTGAGT
TTTTT 3′ 
R:5 
′AATTAAAAAACTCAGATCTGCTCCTTCTCTCTCTTGAAGAGAAGGAGC
AGATCTGAGGGCC 3′ 
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Rnf17-RNAi-mut 
F:5′CTCAGATCACGAGGTTCTCTTCAAGAGAGAGAACCTCGTGATCTG
AGTTTTTT 3′ 
R:5′ATTAAAAAACTCAGATCACGAGGTTCTCTCTCTTGAAGAGAACCTC
GTGATCTGAGGGCC 3′ 
The forward and the reverse oligonucleotides were dilute to 1µg/µl in dH2O 
according to the manufacturer’s instructions (Invitrogen™).  50µl annealing 
mixture was assembled for 2.5µl forward, 2.5µl reverse, and 5µl 5X GoTaq 
Buffer and 40µl dH2O.  The mixture was incubated in 80°C and cool down to 
RT.  For ligation the annealed sense and antisense were diluted to 4ng/µl 
and 20ng/µl. 
2.4.2 Preparation of pSilencer™ 1.0 U6 vector and insertion 
of the Rnf17-RNAi insert 
The pSilencer™ 1.0 U6 vector was cultured in large scale.  To insert the 
Rnf17oligonucleotides, 50µl pSilencer™ 1.0 U6 vector was linearised by 
sequential double cut with EcoRI then column purified, followed by ApaI cut 
and gel purification. 
In a total of 10µl ligation reaction, 1µl of diluted Rnf17-RNAi inserts were 
ligated to 2µl of the linearised pSilencer™1.0-U6.  1µl of ligation reactions 
were transformation into E.coli JM109 High Efficiency Competent Cells of 
1X108cfu/µg DNA.  The pellets of the cultured clones were re-suspended, 
lysat then neutralised and centrifuged to collect the DNA in the supernatant.   
DNA was precipitated and then re-suspended in 50µl dH2O. 
Extracted plasmid for Rnf17-RNAi expression vector was single cut with 
BamHI and HindIII to confirm the insertion of siRNA template insert.  The 
selected plasmids DNA were amplified by large DNA scale extraction. 
2.4.3 Rnf17-Sensor oligonucleotides design and annealing 
Rnf17-sensor was designed to insert a target sense sequence of Rnf17 
between PstI and EcoRI of a pGL3-Control vector-containing polylinker.  The 85 
 
insertion of Rnf17-sensor sequence is targeting the antisense sequence of 
the Rnf17-RNAi.  The designed forward and the reverse primers were 
annealed same as Rnf17-RNAi and diluted to 20ng/µl and 4ng/µl for ligation.   
F: 5’ AATTCTCAGATCTGCTCCTTCTCTGCA 3’ 
R: 5’ GAGAAGGAGCAGATCTGAG 3’ 
2.4.4 Preparation of pGL3-Controlvector and insertion of the 
target sequence 
The pGL3-Control was modified for cloning by insertion of a synthetic 
polylinker (HindIII_EcoRI_AgeI_SpeT_EcoRV_PstI_XbaI) downstream the 
luc+ by partial digestion with XbalI.  In a total of 20µl reaction, pGL3-Control 
was double cut with EcoRI and PstI followed by gel purification to remove the 
synthetic polylinker.   
For ligation, 2µl of linearised plasmid were ligated to 1µl of the 20ng/µl diluted 
oligonucleotides and transformed.  DNA extracted and single cut with EcoRI 
or EcoRV were set to ensure the replacement of the sensor template.  The 
selected plasmids DNA were amplified by large DNA scale extraction. 
2.4.5 Transfection of Rnf17-RNAi and Rnf17-sensors into F9 
cells 
F9 embryonal carcinoma cells or Raw 264.1 murine macrophage cells were 
transfected at densities of 0.5x106 or 1x106/ml/well.  Transfection reaction 
and cell culture was set.   A constant amount of Rnf17-Sensor was co-
transfected together with doses of Rnf17-RNAi-wt or Rnf17-RNAi-mut 
expression plasmids, followed by Luciferase and Protein Assays. 
2.5  Cell culture for transfection assay and Luciferase assay 
F9 embryonal carcinoma cells and Raw 264.1 murine macrophage cells were 
used for transfection.  Cells were thaw and washed with complete medium of 
DMEM.   Cells were grown in a sterile and humidified atmosphere of 5% CO2 86 
 
for 48 hours.  Nunclon flask of 80 cm2 surface area was pre-coated with 0.2% 
gelatine for 30 minutes and washed twice with complete medium.  Cells were 
cultured with 25ml complete medium and 250µl penicillin-streptomycin 
(1:100) in the gelatine pre-coated flask.  Cells were examined daily for 48 
hours using phase contrast of inverted microscope.  When confluent, culture 
media is removed and cells were released from the surface of the flask with 
6ml trypsin.  De-attached cells were washed from trypsin and sub-culture for 
transfection and Luciferase assays.   
For transfection assay and Luciferase assay, cells were counted using 
haemocytometer and plated out onto 8-well plate at a density of 1x105 per2ml 
per well and incubated at 5%CO2and 37°C overnight.  Before cells are plated, 
the 8-well dish was pre-coated with 0.2% gelatine for 30 minutes and washed 
two times with complete medium.  Next day, the healthy adherent cells were 
washed two times with DMEM without FCS (DMEM-FCS) to remove the 
serum protein and incubated with 0.5ml DMEM-FCS up to time of 
transfection.  Cells transfected in duplicate or replicate with 90µl transfection 
reactions.  In a total of 200µl, tube A contained 1µg DNA and 100µl DMEM-
FCS was incubated for 20minutes with tube B contained 3µl polyethylenimin 
(PEI) transfection reagent and 100µl DMEM-FCS.  After the addition of the 
transfection DNA, cells incubated at 5%CO2 and 37°C for 4 hours, after which 
1ml DMEM with 20% FCS was added to the cells and re-incubated overnight. 
Next day, cells transfected for Luciferase assay were rinsed two times with 
2ml of 1x PBS, lysed with 50µl of 5-fold dilution of 5x concentrate extraction 
buffer in dH2O.  Lysed cells were harvested, centrifuged and supernatant 
assayed for Luciferase activity.  5µl of supernatant added to 50µl of 
Luciferase assay reagent and luminescence of the sample is determined by 
luminometer (Turner Design TD-20/20 luminometer, DL-Ready™).  Bio-Rad 
Assay (Bradford) was performed, following manufacturer’s instructions, to 
normalise the reporter gene activities to amount of protein in the extract with 
bovine serum albumin (BSA) as a standard protein.   96 plates including the 87 
 
BSA in one raw and samples in following raw were read in 
spectrophotometer to determine OD of all plate wells at 570nm.   
Luciferase activity (LU) of transfected reporter constructs was measured and 
protein assay were normalised to a standard curve of BSA by dividing the LU 
by cell extracts (5µl) and then divided by protein concentration.  The 
expressed value is LU/µg represent Luciferase activity per µg extracted 
protein.  The transfection performed in triplicates and results represented by 
mean value and standard curve for LU/µg.  Student’s t-test was performed to 
evaluate the significance of LU/µg represented in P value of ≤ 0.05.   
2.6  Endpoint PCR 
2.6.1  Primer design 
Primers for Rnf17 were designed for Rnf17S and Rnf17L as deposited in 
GenBank by Pan et al(2005),Rnf17S; AY854010 and Rnf17L; AY854011. 
2.6.2  RNA extraction and DNA synthesis 
F9 cells were cultured at density of 5-10 X106.  Once confluent, cells were 
trypsinised and washed with PBS.  Total cellular RNA isolation was 
performed by TRI reagent (Sigma-Aldrich, UK) according to the 
manufacturer’s procedure.  Briefly, washed cells were lysed with 1 ml TRI 
Reagent.  Proteins, DNA and RNA were separated into 3 phases by the 
addition of 0.2ml chloroform.  The upper phase contained the RNA were 
precipitated in a clean tube with 0.5ml isopropanol and washed with 80% 
ethanol.  The dried pellet of the RNA was suspending in 100µl DEPC-treated 
water. 
RNA was treated with DNase I to purify from genomic contamination.  The 
reaction was set for treated sample (+DNase I) and untreated sample (-
DNase I) as a negative control and incubated at 37ºC for 30 minutes.  All 
samples were purified with TRI reagent followed by chloroform separation, 
precipitated with isopropanol and washed with 80% ethanol.   88 
 
For cDNA synthesis, 2µl of extracted RNA was eluted into 10µl DEPC-H2O at 
70ºC for 5 minutes.  The Sensicript Reverse Transcript (RT) reaction was 
performed for the sample (+RT) and negative control without RT (-RT) and 
incubated for 60minutes at 42ºC. 
2.6.3  PCR reaction and PCR cycle 
PCR was performed using Taq polymerase enzyme.  The reaction was set 
for the treated sample of +RT and +DNase I and for negative control of –RT 
and –DNase I for both the short and the long Rnf17.  The PCR cycling 
conditions was run for 35 cycles started with enzyme activation at 95°C for 2 
minutes followed by denaturation at 95°C for 30 seconds.  Primers annealing 
was set at 54°C for 60 seconds and finally extension at 72°C for 30seconds. 
2.7  Quantitative real-time PCR (RT-qPCR) 
2.7.1  Animal procedures and sample collection 
All animal procedures were performed in accordance with the Animals 
(Scientific Procedures) Act, 1986 under UK Home Office Project Licence.  
Virgin MF1 female mice (7–8.5 weeks) were mated naturally overnight with 
MF1 studs under standard rodent chow and tap water.  On the morning after 
mating (E0.5), plug-positive females were randomly assigned to receive a 
control normal protein diet (18% casein; NPD), a low protein diet (9% casein; 
LPD) or a high protein diet (30% casein; HPD) until day of sample collection. 
For blastocyst collection, pregnant female mice were killed at E3.5 by 
cervical dislocation and blastocysts were collected by flushing dissected uteri 
with pre-warmed H6 medium supplemented with 4mg/ml BSA (Sigma, St.  
Louis, MO; embryo culture tested; H6 BSA) from all diet groups.  Each 
blastocyst was washed through three 5µl drops of nuclease-free PBS-PVA 
(1mg/ml) which had been exposed to UV at 3X103 µJ/cm.  Blastocysts 
transferred either individually or pooled into 5 into nuclease-free thin walled 
tubes (ThermoFisher scientific, UK) in a minimal volume (<1µl).  Blastocysts 
were immediately snap-frozen on dry ice prior to storage at -70°C. 89 
 
For foetal testes collection, pregnant female mice were killed at E17.5 by 
cervical dislocation and foetuses were collected into ice-cold phosphate-
buffered saline (PBS).  Testes were extracted from individual foetus and 
washed in cold-ice PBS before incubated with RNA Latter buffer at 4°C for 
24 hours.  Next day testes were stored at -80°C until time for RNA extraction.   
2.7.2 RNA extraction from E3.5 blastocysts 
Poly A+ RNA was extracted from single blastocysts or 5 pooled blastocysts 
using the Dynabeads® mRNA DIRECT™ Kit (Invitrogen, UK) according to 
manufacturer procedure.  Briefly, frozen stored embryos were lysed with 
lysis-binding buffer followed by incubation with prewashed Dynabeads® 
Oligo (dT)25 at room temperature for 10 minutes on a roller.   The beads with 
bound poly A+ RNA were separated employing a Dynal MPC-P-12 magnet 
rack (Dynal Biotech).  The supernatant was kept for DNA extraction for 
embryo sexing.  After two washes with wash buffer A and three washes with 
wash buffer B, the poly A+ RNA was eluted from Oligo (dT)25 beads in 10ml 
nuclease-free water (Anachem, Luton, UK) by incubating at 65°C for 2 
minutes.   
2.7.3 RNA extraction from E17.5 foetal testes 
Total RNA was extracted using the RNeasy Micro kit (QIAGEN) following the 
manufacturer’s instructions, including the optional DNase I step.  RNA quality 
and quantity was determined by spectroscopy at 230, 260 and 280nm using 
a Nanodrop (Nanodrop Technologies).   
2.7.4 cDNA synthesis from extracted RNA 
cDNA was synthesised using 8µl RNA eluted from E3.5 blastocysts or 2µg 
RNA eluted from E17.5 foetal testes.  The RT Kit (QIAGEN, UK) was used 
for cDNA preparation, using a random priming strategy, according to the 
manufacturer’s instructions.  cDNA was synthesised in a total volume of 20 µl 90 
 
reaction (+RT).  A negative control (-RT) was prepared in the same reaction 
without addition of Sensicript enzyme. 
2.7.5 Primers design and standard curve 
Intron-spanning primers were designed using the Roche Applied Science 
Universal ProbeLibrary Assay Design Centre and synthesised by Invitrogen 
Custom Oligo service (Table 2.1).The designed primers were selected for the 
criteria of large intron-spanning assays and small amplicon size.  Primers 
were designed to amplify the short or the long Rnf17 transcripts, c-Myc, 
Mxd3 and Line-1 in mouse E3.5 blastocysts or E17.5 foetal testes.   
The short Rnf17 (Rnf17S) primers were designed to amplified 2230nt 
between exons 25 and 26 (alternative spliced), whereas primers for long 
Rnf17 (Rnf17L) were designed to amplify 1808nt between exons 29 and 30 
(Fig 2.1). 
All primers, except Mxd3, were tested for standard curve using F9 cells as a 
template.  Mxd3 were tested for standard curve using foetal testes as a 
template.  RNA were extracted and synthesised cDNA were amplified using 
the designed primers.  The products were run into 2% agaross gel for gel 
extraction using QIAquick Gel Extraction Kit (QIAGEN, UK) following 
manufacturer’s procedure.  Quantitative analysis of the DNA were performed 
using Nanodrop and a series dilutions of 1:100 were set using a minimum 3 
log range to calculate the Efficiency(E) according to the formula E =101/slope. 91 
 
 
 
 
 
 
Fig 2.1: Schematic diagrams show primer design for Rnf17 for RT-
qPCR.  (A) Primers for Rnf17S set on exons 25 and 26 and primers for 
Rnf17L set on exon 29 as shown by arrows.  F: Forward, R: Reverse.  (B) 
Size of Intron spanning as designed by Roche Applied Science Universal 
Probelibrary Assay Design Centre for Rnf17S and Rnf17L. 
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2.7.6 Quantitative real-time PCR (PCR-qPCR) cycle 
RT-qPCR reactions were prepared using Precision Mastermix (Primerdesign, 
UK) containing SYBR Green, with a final concentration of 300 nM each of 
forward and reverse primers and 2µl cDNA in 20µl reaction volume.  Each 
sample was analysed in duplicate, using clear 96-well plates (Axygen).  
Absence of contaminating genomic DNA was confirmed by analysis of 
negative control samples with no added RT (-RT).  Duplicate reactions 
containing water in place of cDNA (no template controls; NTC) were also 
included for each assay as negative control.  Thermal cycling and 
fluorescence detection were performed using a DNA Engine thermal cycler 
and Chromo4 Real-Time Detector (BioRad, UK) with Opticon Monitor v3.1 
software.  Thermal cycling conditions were 95°C 10minutes enzyme 
activation, then 50 cycles of 95°C for 15seconds followed by 60°C for 
1minutes, with a final extension step of 10minutes at 72°C.  For blastocysts, 
50 cycles were performed due to the low starting material.  Melting curves 
were produced for each sample by measuring fluorescence levels at 0.2°C 
steps from 60°C to 95°C and hold 15seconds, for confirmation of specific 
target amplification.   
2.7.7 Determination of the most stable reference gens in 
E17.5 foetal testes 
A panel of reference genes including Tuba1, MapK1, Canx, Tbp, Sdha, and 
18S were selected to test their level of expression stability in foetal testes 
under condition of maternal diets for RT-qPCR data normalisation.  Primers 
were designed for 8 commonly used housekeeping genes (Tuba1, MapK1, 
Canx, Tbp, Sdha, and 18S) using Rocha Approch as shown in Table 2.1.The 
expression levels of these genes was determined in 8 samples per diet 
group; LPD, NPD and HPD of foetal testes.  Expression stability for each 
gene (termed M value) was calculated as the mean standard deviation of the 
log transformed expression ratios across samples for this gene relative to 
other reference genes remaining in the gene panel.  Mean Ct values were 94 
 
calculated on the basis of two replicates for each sample and converted to 
relative quantities using the comparative Ct methods (delta Ct).  Reference 
gene stability was determined using the Visual Basic Application (VBA) 
applet for geNorm (Vandesompele et al, 2002; 
http://medgen.ugent.be/genorm/) and Normfinder (Andersen et al, 2004; 
www.mdl.dk). 
2.7.8 Data analysis and statistical testing 
Raw fluorescence readings were exported from Opticon Monitor software in 
term of threshold cycle (Ct).  Ct values were converted to relative expression 
values using the delta Ct (dCt) method normalised to the most stable 
reference genes.  The geometric mean of two selected reference gene for 
mouse E3.5 blastocysts (our lab data; Lucas et al, 2011) or mouse E17.5 
foetal testes was calculated for each sample and used to normalise the 
expression of each tested gene for comparison between treatment groups 
and sexes.  Results between dietary treatment groups were expressed as the 
mean expression value in relative to reference genes. 
2.8  Embryo sexing 
DNA collected through RNA extraction from E3.5 blastocysts were used for 
embryo sexing.  DNA was precipitated 1:10 volume of 3M Sodium Acetate 
pH 5.2 and washed with 70% alcohol.  The pellet was dried and the DNA 
diluted with nuclease-free water. 
Sry and Zfy genes were amplified for the Y-specific target sequences and the 
DXNds3, a polymorphic microsatellite locus located on X chromosome was 
used as a control sequence.  Primers and methods were applied as 
described in Kunieda et al, 1992.  Briefly, for each primer two sets were 
designed for an inner and outer set (Table 2.2) 95 
 
Two-step PCR using two pairs of primers was used by addition of Taq 
polymerase (QIAGEN).   First PCR amplified the prepared DNA with outer 
primers and the PCR product was amplified in second PCR with the inner 
primers.  PCR products were screened onto 2% agarose gel. 
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2.9  Immunostaining 
2.9.1 Production of RNF17 antibody (anti-RNF17) 
Anti-RNF17 produced and affinity purified by Dr C.H.  Barton.   Briefly, A 
cDNA fragment from Rnf17 (long isoform supplied from Dr Jieyan Pan, 
University of Pennsylvania, USA) encoding 1-316 residues and was used to 
produce polyclonal anti-RNF17.  Primers for Rnf17 fragment were designed 
containing restriction sites BamHI forward primer and EcoRI reverse primer 
as indicated by underlining:  
F: 5′ATCGGATCCATGGCGGCAGAGGCTTCG3′:  
R: 5′GTAGAATTCTCATTTTCTAGAGGGGTAACA 3′.   
The amplified PCR product was gel purified and Taq tailed to be cloned into 
T-Easy.  The construct was transformed into JM109X108cuf/µg competent 
cells and DNA was extracted from positive colonies.  Single cut with EcoRI 
was performed to linearise the construct and cloned into pGEX-2TK 
expression vector (Amersham Pharmacia, UK).  The protein was produced 
as a fusion protein with glutathione-S transferase (GST) (Sigma-Aldrich, UK) 
and the construct was transformed into E.coli cells.  RNF17-GST fusion 
protein was purified by affinity chromatography using glutathione-Sepharose 
beads and used for production of rabbit polyclonal antibody (Pineda, 
Germany).   
2.9.2 Preimplantation embryo immunolabelling 
Embryos were collected from mothers fed chow or LPD, HPD or control NPD 
from E0.5 to E3.5.   Embryos at different preimplantation stages were flushed 
in H6BSA either from the oviduct or from the uterus to collect zygote, 2-cell, 
4-cell, 8-cell, morula and blastocysts.  Flushed embryos were treated with 
acid tyrodes (AT) for zona pellucid removal and washed in H6BSA before 
fixed in 4% (V/W) paraformaldehyde (PFA) in PBS for 10 minutes.  Embryos 
were permeablised in 1% Tween diluted in PBS (V/V; 1%PBS-T) at room 
temperature (RT), blocked in 5% goat serum in PBS (V/V) and labelled with 98 
 
anti-RNF17 polyclonal antibody at a dilution of 1:1000 in 1%BSA in PBS 
(W/V) for 1 hour at RT or overnight at 4˚C.  After three washes with 1%PBS-
T, goat anti rabbit-Alexa 488 was added at a dilution of 1:300 in 1% BSA for 
1 hour at RT followed with three washes with 1%PBS-T.  Nuclei were stained 
with DAPI 1:500 in 1%PBS-T and embryos were rinsed twice in 1%PBS-T, 
mounted on polylysine slides in Vectashield (Vector Labs) and observed 
under Leica SP5 Confocal microscope.   
Negative control was performed by incubating blastocysts with non-
immunised or immunised rabbit sera (from the same rabbit used to antibody 
production) at the same dilution used for anti-RNF17 and same procedure.  
Negative controls for secondary antibody (goat anti rabbit Alexa fluor 488) 
was applied by incubating treated blastocysts with Alexa fluor 488 without the 
primary antibody.   
2.9.3  Foetal testis immunofluorescence staining and 
histological analysis 
Testes were collected from foetus derived from pregnant MF1 mice female 
fed LPD, HPD and control NPD from day of plug E0.5 up to day of dissection 
(E17.5).  Foetus testes from each mother were embedded in O.C.T.  
embedding medium and snap freeze individually into dried ice before stored 
at -80⁰C.Cryostat testes were sectioned for 6µm using microtom (Leica CM 
1850 UV).  Cryostat sections were attached to polylysine slides and left to dry 
at room temperature for at least 2 hours before stored in -80⁰C or stained.  
Slides were washed with PBS and tissues fixed with 4%PFA, permeablised 
with 1%PBS-T.  Sections were washed three times with 1%PBS-T before 
stained with anti-RNF17 diluted for 1:1000 in 1%BSA in PBS for 1hour or 
overnight.  The slides washed with PBS and stained with secondary antibody 
Alexa fluor 488 diluted 1:300 in 1%BSA in PBS for 1hour at room 
temperature.  Sections were washed with PBS and the nuclei were stained 
with DAPI followed by another wash before mounted in Vectashield (Vector 
Labs) and observed under Leica SP5 Confocal microscope.   99 
 
For morphological analysis Haematoxylin and Eosin (H&E) staining was 
performed.  Briefly, frozen sections were rinsed with distilled water and nuclei 
stained with haematoxylin, differentiate with 0.3% acid alcohol and cytoplasm 
stained with eosin (H&E; Sigma-Aldrich).  All sections were then mounted 
with Pertex. 
2.9.4 Immunostaining for cultured cells 
F9 cells or Cos-1 cells were immunolabelled with anti-RNF17 after treated 
with experimental conditions.  Cells were cultured on coverslip within 9- or 6-
well dishes and treated with experimental condition.  For immunostaining, 
cells were washed with ice cold PBS for three times before fixed with 4% 
PFA and washed again with PBS.  Cells were permeablised with 1%BS-T, 
blocked with 1%FCS diluted in PBS and washed with 1%PBS-T.  Anti-RNF17 
were diluted for 1:1000 in 1%PBS-T and applied for 1 hour or overnight.  
Stained cells were washed with 1%BS-T before addition of 1: 300 Alexa fluor 
488 in 1%PBS-T and rewashed again.   Nuclei were stained with DAPI 1:500 
diluted in 1% PBS-T, cells washed with 1%PBS-T and coverslip were 
mounted on polylysine slides with Vectasheid. 
2.9.5 Fluorescence confocal microscopy and 
quantification of fluorescence intensity 
Immunolabelled samples were examined by a X63 glycerol-immersion 
objective on a converted Leica SP5 confocal microscopy (Leica, German) 
with excitation source of a 488 nm wavelength argon laser.  Detected 
fluorescence signals for Rnf17 density by SP5 confocal microscopy was 
quantified for stained embryos E3.5 blastocysts and E17.5 foetal testes using 
Volocity® v6.0.1 software (PerkinElmer's).  The software detects the voxel 
number which makes up an object 3D dataset equivalent of a pixel.  The 
software counts the voxel number and calculates the voxel volume as voxel 
intensity per area (µm3) through z-axis.   100 
 
Anti-RNF17 stain was measured by using Volocity® v6.0.1 software for 
intensity level in nucleus or cytoplasm.  RNF17 foci number were counted 
within each nuclei per embryo (E3.5 or 17.5) at different stages for E3.5 and 
different diet groups for both E3.5 and E17.5.  The intensity levels of counted 
RNF17 foci were measured at the same time.  Mean average of foci number 
and foci intensity level for ach nuclei were calculated per embryos and used 
to compare between stages and between different diet groups. 
2.10  Western blotting 
F9 cells or Cos-1 cells were culture under experimental conditions and 
proteins were extracted using 5x fold diluted reporter lysis buffer (Promega).  
Lysate fractions for supernatant and pellet were collected and used for 
western blotting.  Protein level from both fractions was measured by BCA 
Assay (Thermo Scientific) with addition of 0.1%SDS solution. 
Cell extracts were boiled with 5X SDS loaded buffer and about 10µg/µl of 
protein was separated by SDS-PAGE (8% acrylamide) and transferred to 
nitrocellulose (PVDF) membrane (Schleicher & Schuell BA 85).  After 
blocking with 10% (W/V) skimmed-milk powder in 0.1% PBS-T for 1 hour, the 
blots were incubated overnight at 4˚C with anti-RNF17 diluted to 1:1000 in 
5% blocking solution.  After three washes in 0.1% PBS-T, the membrane was 
incubated for 1 hour at RT with goat anti mouse secondary antibody diluted 
to 1:2000 in 5% blocking solution.  Stained membrane was washed for three 
times and antibody detection was visualised by Odyssey (LICOR). 
2.11  Microinjection of Rnf17_siRNA 
Female FVB/N mice were superovulated by interperitoneal injection of 
pregnant mares serum (PMS, 5 i.u; Folligon, intervet) and human chorionic 
gonadotropin (hCG, 5 i.u; Chorulon, Intervet) at an interval of 48 hours.  
Embryos were collected at zygote stage from oviduct or swollen ampullae of 
pregnant female mice and cumulus cells were removed by hyaluronidase.  101 
 
Embryos were cultured in KSOM at 37◦C in an atmosphere of 5%CO2 before 
microinjection or up to 2-cell stage. 
Short interference (siRNA) sequences were microinjected to knockdown 
Rnf17 in mouse embryos.  Four oligonucleotide sequences for Rnf17 
(Rnf17_siRNA) and a negative control siRNA sequence (AllStar_siRNA) 
were designed and sense and antisense sequences were annealed by 
manufacturer (QIAGEN, UK) (Table 2.3).  According to manufacturer 
protocol, siRNA oligonucleotides were diluted in RNase-free water to obtain 
10µM solution and stored at -20˚C until time of microinjection.  Each 
Rnf17_siRNA was microinjected individually into the cytoplasm of zygote 
stage 2-cell stage.  Microinjection needles were back filled with 
approximately 20µM siRNA dilution and delivered into each embryo.  The 
injected embryos were in vitro cultured in groups in KSOM medium and 
overlaid with mineral oil at 37˚C in an atmosphere of 5% CO2 for three days 
for immunostaining or freezing for RT-qPCR.  Embryo development was 
assessed by phase contrast microscopy (X 200).   
 
 
 
 
 
 
 
 
 
 
 
   
Table 2.3: Details of designed siRNA sequences by Qiagen for 
Rnf17 knockdown. 102 
 
2.12  Statistical analysis 
All data were analysed by using SPSS for Windows (IBM SPSS, version 21).  
The distribution of collected data for each experiment were checked using 
histograms using SPSS.  Statistical significance was assumed with a value of 
P≤0.05. 
Data collected in Chapter 3 and Chapter 4 to compare between the level of 
RNF17 in the cytoplasm and the nucleus (in F9 cells and mouse embryo) 
were not normally distributed.  Data were analysed using a Mann- Whitney 
U-test and data were expressed as mean with standard deviation 
representing error bar. 
For the effect of maternal diets on gene expression, data were normalised 
using a random effects regression model that allows for variability within dam 
across-offspring and across-dam (Kwong et al, 2004).  Data were analysed 
with one-way ANOVA for significant variances among the dietary groups, and 
post-hoc tests was applied using the Tukey HSD test indicating the mean 
score for diet groups and are shown in representative figures.  To compare 
the main effects of diet and sex with unequal (n) variance (Chapter 5), a two-
way ANOVA was used to detect significant differences between treated 
groups.  The data were expressed as mean with their standard errors (mean 
± SE) of 10 to 11 examined samples (n= 10 to 11).  Data collected from each 
examined sample as mean of two biological replicates.  
Data collected from expression plasmids represent the Luciferase activity of 
expression plasmid used in the experiment.  In Chapter 3, data were 
analysed with one-way ANOVA for significant variances among the dose-
dependent groups, and post-hoc tests was applied using the Tukey HSD test.  
In Chapter 6, data were analysed using Student's t-test.  All data were 
expressed as mean with their standard deviation representing error bars for 
three replicates.  The experiments were repeated for five times.  
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3.  A Cell Culture Model of RNF17 Expression and 
Function 
 
3.1  Introduction 
Rnf17 is a germ cell-specific gene which is expressed in early mouse embryo 
development (Giritharan et al, 2007) and in mouse adult testis and is required 
for male germ cell differentiation (Pan et al, 2005).  Rnf17 was identified as 
Mmip2 by Yin et al (1999 and 2001), following its isolation in a Y2H screen as 
an MXD protein interactor.  Pan et al (2005) described Rnf17 encodes a 
protein containing both RING finger and Tudor domains and is a component 
of a novel nuage that displays a perinuclear location in male germ cells.   
RNF17 interaction with members of the Myc/Max/Mxd network has been 
described using the Y2H.  Yin et al (1999) showed that RNF17 interacts with 
members of the MXD family.  Interaction of Rnf17 with all four members of 
MXD family modulates the activity of c-MYC, as RNF17 recruits MXD 
proteins from the nucleus, where they antagonise Myc, to the cytoplasm (Yin 
et al, 2001).  This activates the transcription of Myc-responsive genes by 
increasing the levels of Myc-Max dimers and facilitating Myc activities, 
including cell proliferation, and reducing the activity of Mxd i.e. terminal 
differentiation.  In the Yin et al (1999) study, GFP expression plasmids 
encoded RNF17 or MXD3 were co-transfected in NIH3T3 fibroblasts in 
different molar ratios and the localisation and expression of the different 
GFPs were examined by epifluorescence microscopy.  At equal molar ratios 
of transfection, MXD3 was detected in the nucleus, whereas RNF17 was 
localised in cytoplasmic foci.  Over-expression of MXD3 allowed RNF17 to 
enter the nucleus whereas over-expression of RNF17 co-localised MXD3 
into RNF17 foci in the cytoplasm. 
RING domain-containing proteins exert E3 ubiquitin ligase activity (van Wijk 
et al, 2009) which results in degradation of their target protein by the 106 
 
proteasome.  Van Wijk (2009) demonstrated that the human RNF17 RING 
domain was able to interact with the E2 protein, UBE2U.  Cano et al (2010) 
found a group of 15 E3 ligases coupled to RNA-binding domains (KH 
domains) provided them with a unique mRNA stability regulating activity.  
RNF17, described in this study is an E3 ligase based on the presence of a 
RING domain and carries multiple Tudor domains for interaction with 
dimethylated arginines on target proteins such as PIWI suggesting that it has 
additional as yet not described activities. 
MXD1 is a target protein for Rnf17 in the ubiquitinylation process.  
Phosphorylation of MXD1 at Ser 145, by RSK and S6K or PI3/Akt pathways, 
is necessary for proteasome degradation of MXD1 through the 
ubiquitinylation pathway (Zhu et al, 2008; Chou et al, 2009). 
3.1.1 Aim of experiment 
The aim of this experiment is to investigate whether Rnf17 modulates c-Myc 
function by developing a functional assay for Rnf17 over-expression and co-
transfection with a c-Myc responsive construct in F9 cells.   
The second aim is to find out whether RNF17 functionally interacts with MXD 
through the ubiquitin-proteasome pathway.  Flag-tagged expression plasmids 
for RNF17 and MXD1 will be co-transfected into Cos1 cells treated with 
proteasome inhibitor MG132. 
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3.2  Methods 
3.2.1.  Production of Rnf17-SV40construct and transfection 
efficiency into F9 cells 
CMV promoter has been found to be poorly expressed in embryonic stem 
cells and F9 cells (Dr Neil Smyth, unpublished observation).  Therefore, in 
this experiment the SV40 early promoter and enhancer system was used 
based upon the efficient expression of the pGL3-Control plasmid Luciferase 
in a transient transfection experiment.  This plasmid was modified firstly to 
remove the Luc cassette via a HindIII and XbaI digest and then double 
stranded link oligonucleotides were inserted, incorporating a series of 
recognition sites for restriction endonucleases that only cut once within the 
vector. 
The Rnf17-SV40 construct was designed to position the SV40 promoter 
upstream of the Rnf17 gene fragment.  Initially, the pGL3-Control vector 
was tested in F9 cells to examine the transfection efficiency of the SV40 
promoter in F9 cells (Dr C.H.  Barton).  1 µg DNA of empty vector SV40-
pGL3-control was transfected into F9 cells without (0.0 µg) or with (3.0 µg) 
transfecting agent, PEI.  Transfection activity was measured by the 
induction of Luciferase activity in the SV40-pGL3-control.  As shown in Fig 
3.1 (data from Dr C.H.  Barton), SV40-pGL3 is significantly delivered into 
cells using 3.0 µg of PEI (P≤0.05).   108 
 
 
 
Fig 3.1: Induction of Luciferase activity in SV40-pGL3-control in F9 cells 
using transfecting agent (PEI).  Luciferase activity of 1.0 µg of SV40-pGL3-
control is significantly increased using 3.0 µg PEI for transfection compared 
to control (0.0 µg PEI). Bar graphs are the mean of Luciferase activity of 
three replicates and error bars represent standard deviation.   
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To generate the Rnf17-SV40 construct, Rnf17 fragment was amplified by 
endpoint PCR (Fig 3.2A) followed by gel purification.  The blunt-ended PCR 
product was modified by Taq polymerase to add the 3′ A-overhang and then 
ligated to pGEM®-T Easy vector (Fig 3.2B).  The TA product was 
transformed into E.coli SURE™ strain and white/blue screening assay was 
recorded as shown in Table 3.1.  The DNA plasmid was extracted from 4 
white colonies (Fig 3.3A).  A single cut of the extracted plasmid DNA with 
EcoRI dropped out 951bp of the Rnf17 insert (Fig 3.3B).  This indicates that 
the selected colonies carried the target product.  A double cut with XbaI and 
HindIII was performed on a selected colony of the Rnf17-pGEM®-T Easy 
and this dropped out the Rnf17 insert, 951bp (Fig 3.4A). 
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Fig 3.2: Amplification of 951bp Rnf17 fragments by PCR endpoint 
using Phusion® Hot Start High-Fidelity DNA Polymerase.  (A) The PCR 
product run in duplicate; 1 & 2 with both being the correct size of Rnf17 
fragment (951bp).  (B) PCR products were gel purified followed by Taq 
treatment and revealed the same size for amplified Rnf17 fragment (951bp).   
  Lane 1 and 2 (A): duplicate for PCR product 
  1Kb, Invitrogen DNA ladder. 
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Table 3.1: Number of colonies resulted from transformed Rnf17-pGEM®-
T Easy vector into E.coli SURE™ strain competent cells with LB/Amp.  
White colonies represent positive colonies with insert (+insert).  Blue colonies 
represent those without insert (-insert).   
Ligation 
White colony 
(+insert) 
Blue colony  
(-insert) 
Rnf17-pGEM-T Easy 
vector 
94  1 
Ligation with no insert 
(negative control 
0  10 
Only competent cells 
(positive control) 
0  235 112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.3 (continued) 
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Fig 3.3: DNA plasmid extracted from PCR-pGEM®-T Easy clone of 
Rnf17.  PCR product for Rnf17 was ligated into pGEM®-T Easy and 
transformed into E.coli SURE™ strain.  White/ blue screening was applied by 
Xgal/IPTG and white colonies were selected for DNA plasmid extraction 
(Lane 1 to 4).  (A) Uncut DNA plasmid (B) Restricted DNA plasmid with 
EcoRI reduced the size of Rnf17 insert to 951bp from the pGEM®-T Easy.   
  Lanes 1 to 4 (A): Uncut DNA plasmids  
  Lanes 1 to 4 (B): Cut DNA plasmids with EcoRI 
  M: Invitrogen DNA ladder   114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.4: Preparation of Rnf17 insert and pGL3-linker for ligation.  (A) 
PCR-pGEM®-T Easy of Rnf17 clone was double cut with XbaI and HindIII 
and gel purified.  (B) The uncut and double cut pGL3-linker.  The pGL3-link 
plasmid was linearised by double cut with XbaI and HindIII and gel purified. 
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pGL3-Control had been modified for cloning by replacing the luc+ with a 
synthetic polylinker (pGL3-linker), and the pGL3-linker was double cut with 
XbaI and HindIII restriction endonucleases and gel purification conducted to 
remove the polylinker (Fig 3.4B).  The Rnf17 insert was ligated to the pGL3-
link plasmid and transformed into the E.coli JM109 high efficiency competent 
cells of 1X108 cfu/µg DNA.  The pGL3 link plasmid does not contain Lac-Z 
gene, thus no x-gal and PTG were used for blue/white screening. X-gal and 
PTG was only used for blue/white screening with positive control (Table 3.2).  
6 colonies for Rnf17-pGL3-link were selected for DNA extraction.  The 
extracted DNA plasmids were cut with BamHI and HindIII, this included extra 
nucleotides between the XbaI (1943 bp) and the BamHI (2442 bp) of about 
508 bp.  As shown in Fig 3.5, the size of the dropped out band from the 
pGL3-link was 1459 bp, the 508 bp between the XbaI and the BamHI plus 
the 951 bp of the Rnf17 insert.   
 
 
Table 3.2: Number of colonies resulted from transformed Rnf17-pGL3-
Link plasmid into E.coli JM109 high efficiency competent cells with 
LB/Amp. X-gal and PTG was only used for blue/white screening with positive 
control.   
   
Ligation 
White colony 
(+insert) 
Blue colony  
(-insert) 
Rnf17-pGL3-link  131  0 
Ligation with no insert 
(negative control) 
5  0 
Only competent cells 
(positive control) 
0  >300 116 
 
 
 
 
 
Fig 3.5: Preparation of Rnf17-SV40.  (A) 6 (1-6) colonies of the 
transformed Rnf17-pGL3 ligation were selected for plasmid extraction.  
Double cut with BamHI and HindIII was performed and the gel shows the 
cut (c) and the uncut (uc) plasmids compared to cut and uncut pGL3-control 
vector. The cut plasmids dropped out 1459 bp including the 951 bp of Rnf17 
and the 508 bp -extra nucleotides- between XbaI and BamHI.  M: Invitrogen 
DNA ladder 
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3.2.2 c-Myc Luciferase Reporter gene constructs   
To measure the activation pathway of the Rnf17 and c-Myc in F9 cells, a 
sensor construct for c-Myc was developed to encode five tandem copies of 
the E-box consensus sequence, located upstream of a minimal promoter 
that contained a TATA box, with a Luciferase reporter gene downstream.  
The construct was designed to measure the Luciferase activity in response 
to the binding of the transcription factor (c-Myc) to the E-box, which 
activates the transcription of Luciferase.  The construct oligonucleotides for 
c-Myc were annealed and ligated into the pGL3-Basic vector between NheI 
and HindIII restriction sites (Fig 3.6). 
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Fig 3.6: c-Myc Luciferase Reporter gene constructs.  (A) The designed 
construct amplified by transformation followed by single cut with NheI (N) 
and HindIII (H) to confirm that both enzymes can cut at the designed sites.  
(B) The construct was double cut with NheI and HindIII to confirm that the 
selected clone contained the target insert.  Comparing the size of the cut 
DNA plasmid with the uncut one (uc) and with the single cut in (A) indicated 
that the c-Myc oligonucleotides of 60bp was dropped out.  (C) The c-Myc 
reporter gene construct was amplified for large DNA extract and the plasmid 
is confirmed to have the right insert by HindIII cut.  The cut plasmids were 
compared to uncut (uc) one.   
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3.2.3 Cell transfection for RNF17 expression and 
proteasome inhibition by MG132 
Cos1 cells were transfected with RNF17 expression plasmids and/or 
MXD1 plasmids, using Fugene as transfection agent.  Transfected Cos-1 
cells or F9 cells were treated for 24 hours with MG132 (1:1000 µM) 
dissolved in DMSO as a vehicle control.  Transfected cell extracts were 
examined by Western blotting and cells were cultured on a cover slip for 
immunostaining. 
3.2.4 Testing of RNF17 antibody (anti-RNF17) 
The negative control for immunostaining was applied by staining cultured 
F9 cells or Cos1 cells.  F9 cells were stained with secondary antibody only 
under the same conditions for anti-RNF17 staining.  Alexa fluor staining did 
not detect nonspecific proteins in F9 cells (Fig 3.7A). 
Untransfected Cos1 cells were stained with anti-RNF17 to confirm that 
endogenous RNF17 was not expressed in Cos1 cells and also to test that 
anti-RNF17 was not detecting nonspecific proteins as shown in (Fig 3.7B). 
3.2.5 Production of RNF17-expression constructs. 
Protein expression constructs were produced for short RNF17 (Flag-tagged 
RNF17S) and RNF17 protein C (Flag-tagged RNF17C) by a third year 
undergraduate student -Laura Cross- and Dr C.H.  Barton. 
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Fig 3.7: Negative control for anti-RNF17 immunostaining of culture 
cells.  (A) Cultured F9 cells were stained with secondary antibody Alexa fluor 
488 in 1%PBS-T.  (B) Un-transfected Cos1 cells were stained with anti-
RNf17 in 1%PBS-T.  Nuclei were stained with DAPI and cells were visualised 
by confocal microscopy under emission of 488 and 550 nm.  DAPI and 
merge images show that anti-RNF17 is not detecting nonspecific proteins.   121 
 
3.3 Results 
3.3.1  Expression of endogenous Rnf17 in F9 cells by 
endpoint PCR and RT-PCR 
Since there are multiple isoforms of Rnf17, it was important to evaluate which 
transcripts were expressed in F9 cells, using the endpoint PCR approach.  
F9 cells were cultured to semi-confluence, harvested, RNA extracted and 
cDNA prepared.  Rnf17 primers were designed to amplify specific diagnostic 
fragments from the short Rnf17 and the long Rnf17 transcripts.  As shown in 
Fig 3.8, Rnf17S of 471 bp and Rnf17L of 568 bp were expressed in F9 cells, 
compared to the negative controls not containing reverse transcriptase 
enzyme (-RT) or not treated with DNaseI.  An uncharacterised band of about 
150 bp was amplified using primers for Rnf17S (red arrow in Fig 3.8) and the 
RT treated with DNaseI confirmed that the 150 bp was not associated with 
genomic DNA contamination. 
This experiment clearly established that the long and short Rnf17 transcripts 
were expressed in F9 cells and as such made it a suitable model system for 
functional studies.  The origin of the 150 bp product is not clear, although 
other transcripts have been described for this gene in AceView. 
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Fig 3.8: Expression of Rnf17 in F9 cells by endpoint PCR.  Rnf17L and 
Rnf17S were set as deposited by Pan et al, (2005) in GenBank to amplify 
568 bp for (A) Rnf17L and (B) 471 bp for Rnf17S.  Red arrow in (B) shows 
uncharacterised band of about 150 bp that amplified using the Rnf17S 
primers and the white arrow is genomic DNA-derived product.  RNA 
extracted from F9 cells and synthesised cDNA was treated with (+) or 
without (-) reverse transcriptase (RT) and DNaseI.   
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3.3.2 Cellular localisation of RNF17 in F9 cells 
F9 cell extracts were separated into soluble and insoluble fractions and each 
was blotted in three replicates on SDS-PAGE.  RNF17 was expressed in the 
insoluble fraction with bands corresponding to the expected size of long 
RNF17 and short RNF17 (Fig 3.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.9: Expression of endogenous RNF17 in F9 cells by Western 
blotting.  F9 cell extracts of soluble and insoluble fractions were blotted on 
SDS-PAGE in three replicates.  Two isoforms for RNF17 long (RNF17L) and 
RNF17 short (RNF17S) were detected in insoluble fraction of F9 cells.  
Tubulin was used as a control for cytoplasmic (soluble) protein. 124 
 
F9 cells were cultured on a coverslip for immunostaining and stained for 
RNF17.  The expression of RNF17 was visualised by confocal microscopy 
and the level of RNF17 intensity was measured by Volocity software.  RNF17 
was found predominantly in the nucleus and excluded from the nucleolus.  
RNF17 also displayed appearance as foci in the cytoplasm.  RNF17 was not 
expressed in mitotic cells (Fig 3.10 arrow A).  It was noted that the 
cytoplasmic RNF17 foci were located close to the nuclear membrane and 
very few were scattered in the cytoplasm (Fig 3.10 arrow B). 
Using Volocity software, voxel number and level of fluorescence intensity for 
RNF17, foci were counted in the nuclei or the cytoplasm in 64 cells at 
different staining times.  Voxel number of RNF17 in the nucleus was higher 
than in the cytoplasm per cell (24-fold) (Fig 3.11A).  No significance 
differences were seen within fluorescence intensity level for RNF17 in the 
nucleus than in the cytoplasm, although the difference was about 10% (Fig 
3.11B).   
The results indicated that the level of RNF17 was equally distributed between 
the cytoplasm and the nucleus.  However, the accumulation of RNF17 foci 
around the nuclear membrane may reflect the reduced voxel count in the 
cytoplasm compared with that in the nucleus.   
It is noted here that the error bar was too large, which may indicate artificial 
counting of the voxels.  Additionally, some of F9 cells displayed variable foci 
sizes which indicated aggregation of foci expression.  This was counted as 
one foci by the software and represented in the error bar.   
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Fig 3.10: Cellular localisation of RNF17 in F9 cells.  F9 cells were cultured 
on coverslip and immunostained with anti-RNF17 (middle panel), nuclei were 
stained with DAPI (left panel), merge images shown in right panel and cells 
were screened by confocal microscopy.  RNF17 is predominantly inside the 
nucleus with foci appearance in the cytoplasm of F9 cells.  RNF17 was not 
expressed in mitotic cells (A; yellow arrow).  Cytoplasmic RNF17 foci were 
close to the nuclear membrane (B; white arrow).   
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Fig 3.11 (continued) 
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Fig 3.11: Expression level of endogenous RNF17 in F9 cells.  Cultured 
F9 cells were immunostained with anti-RNF17 and numbers of voxel or 
intensity level of RNF17 were measured in the cytoplasm or nucleus per cell 
using Volocity software.  (A) Voxel number of RNF17 in the nuclei and in the 
cytoplasm per cells.  (B) Mean level of fluorescence intensity of RNF17 in the 
nucleus and the in the cytoplasm of F9 cells.  Bar graphs show the mean of 
examined cells (n=64), and error bars represent standard deviation.     128 
 
3.3.3 Over-expression of Rnf17 induces c-Myc Luciferase 
activity 
A constant amount of a c-Myc Luciferase reporter gene construct (1µg) was 
co-transfected into F9 cells with either pEF-c-Myc expression vector (control) 
or the Rnf17 expression vector.  In all transfections, the level of total DNA 
was normalised with pUC plasmid.  Transfecting the pEF-c-Myc expression 
plasmid into F9 cells (0.25 µg) significantly increased the Luciferase activity 
of the c-Myc reporter construct (P ≤0.05) about 29-fold, compared to the 
control with the c-Myc Luciferase reporter gene construct.  Further increases 
in the amount of pEF-c-Myc expression plasmid decreased the Luciferase 
response (Fig 3.12A) and this may have been due to the inhibition or 
squelching of the transcription of c-Myc (Cahill et al, 1994). 
The Rnf17 expression vector increased the c-Myc-responsive Luciferase 
activity at 0.5 µg by 2-fold (Fig 3.12B) compared to Rnf17-untreated controls, 
but did not reached significance.  Although the induction of c-Myc Luciferase 
activity was not significant, this may suggest that over-expression of Rnf17 
recruits Mxd out of the nucleus to the cytoplasm releasing Max (Yin et al, 
1999).  The released Max can then interact with c-Myc, inducing transcription 
via binding to the E-box of the c-Myc Luciferase reporter gene construct.  
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Fig 3.12 (continued) 130 
 
Fig 3.12: Induction of c-Myc Luciferase reporter gene in response to c-
Myc and Rnf17 in F9 cells.  F9 cells were co-transfected with constant 
amount of 1.0 µg of c-Myc Luciferase reporter gene construct and 
increasing amounts (0.0, 0.25, 0.5, 0.27 µg) of either (A) pEF-c-Myc 
expression plasmid or (B) Rnf17-SV40.  DNA concentrations were 
normalised using pUC18 empty vector.  Bar graphs show mean of three 
replicates, and error bars represent standard deviation. 
   131 
 
3.3.4 RNF17 induced degradation of MXD1 by ubiquitination 
mechanism 
To test whether MXD is a target protein for the E3 ligase activity of the RING 
domain within RNF17, Flag-tagged expression plasmids for MXD, RNF17S 
and RNF17C (Protein C isoform) were used.  A constant amount of Flag-
tagged RNF17S or RNF17C (1 µg) was co-transfected into Cos1 cells with 
Flag-tagged MXD, or without Flag-tagged MXD as a control.  Transfected 
cells were treated with proteasome inhibitor MG132 (1:1000 µM), control 
cells were treated with an equivalent dose of DMSO alone for 24 hours.  Cell 
extracts of soluble and insoluble proteins were analysed with anti-Flag by 
Western blotting. 
RNF17C and RNF17S were expressed in the soluble and insoluble extracts 
(Fig 3.13 lane 1 & 7).  RNF17C completely disappeared from the soluble 
fraction following treatment with MG132 and accumulated into the insoluble 
fraction (Fig 3.13 lane 2).  Addition of MG132 induced the appearance of 
RNF17S into the insoluble fraction and some loss from the soluble fraction 
(Fig 3.13 lane 8).   
MXD1 was exclusively localised in the insoluble fraction with molecular 
weight 26kDa as expected (Fig 3.13 lane 5).  MG132-treatment promoted the 
accumulation of higher molecular weight forms of MXD1 and these probably 
were ubiquitinylated forms.  Ubiquitin of molecular weight 8.5 kDa is known to 
conjugate to the target proteins and form a polyubiquitin chain.  The ubiquitin-
tagged proteins, MXD1, could be seen on the gel of the insoluble fraction as 
a ladder of higher molecular weight of about 34.5, 43.0, 51.5 and 60.0 kDa; 
these were more distinct in the transfection with RNF17C (Fig 3.13B lane 6). 
Co-transfection of Flag-tagged MXD1 with Flag-tagged RNF17C or Flag-
tagged RNF17S reduced the expression of MXD1 and levels of RNF17C or 
RNf17S in the insoluble fraction (Fig 3.13B lane 3 & 9).  Inhibition of 132 
 
proteasomal activity with MG132 enabled the accumulation of MXD1 in the 
insoluble fraction and induced the appearance of RNF17C, but not RNF17S 
(Fig 3.13B lane 4 & 10).   
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Fig 3.13 (Continued) 134 
 
Fig 3.13: RNF17 induced MXD1 degradation in the presence of 
proteasomal inhibitor MG132 in transfected Cos1 cells.  Cultured Cos1 
cells were co-transfected with Flag-tagged-RNF17S or -RNF17C plasmids 
and/or Flag-tagged-MXD1 construct.  Transfected cells were treated with 
MG132 or control cells treated with DMSO for 24 hours.  (A) Soluble and (B) 
insoluble fractions from harvested cells were blotted on western blot gel.  Co-
transfection of RNF17 with MXD1 degraded MXD1 in the absence of MG132 
(B: Lane 3 & 9) whereas MXD1 accumulated in the presence of MG132 (B: 
Lane 4 & 10).  Transfection of MXD1 alone forms polyubiquitin chain in 
presence of MG132 (B: Lane 6) represented in a ladder of higher molecular 
weight bands of about 34.5, 43.0, 51.5 and 60.0 kDa compared to DMSO-
treated cells (B: Lane 5). 
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3.3.5 Expression and subcellular localisation of RNF17 in 
MG132-treated cells 
Cultured F9 cells were incubated with or without the proteasome inhibitor 
MG132 for 4 hours or 24 hours.  Cells were immunostained with anti-RNF17 
and expression was visualised by confocal microscopy.  Compared to the 
endogenous expression pattern of RNF17 in F9 cells, RNF17 had lost the 
nuclear-punctated-structure and had become diffused in the nuclei of 
MG132-treated cells or control cells (DMSO treated) (Fig 3.14).  RNF17 was 
completely absent from the cytoplasm. 
In transfected Cos1 cells, RNF17C and RNF17S displayed a punctated 
appearance in the cytoplasm of DMSO-treated Cos1 cells (control) and 
accumulated in the peri-nuclear vicinity.  In MG132-treated cells, RNF17C 
had diffused in the nuclei, whereas RNF17S displayed punctated appearance 
in the nuclei (Fig 3.15). 
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Fig 3.14 (Continued) 137 
 
Fig 3.14:  Effects of proteasome inhibitor MG132 on endogenous RNF17 
expression and cellular localisation in F9 cells.  Cultured F9 cells were 
treated with MG132 for (A) 4 hours or (B) 24 hours and immunostained with 
anti-RNF17 (middle panel).  Nuclei were stained with DAPI (left panel), cells 
screened by confocal microscopy and merged images shown in right panel.  
Control cells were treated with DMSO.  RNF17 lost its foci structure and 
disappeared from the cytoplasm but diffused into the nucleus.   138 
 
Fig 3.15 (Continued) 139 
 
Fig 3.15: Effects of proteasome inhibitor MG132 on expression and 
cellular localisation of RNF17 expression plasmids transfected into 
Cos1 cells.  Cultured Cos1 cells were transfected with (A) expression 
plasmids for RNF17C or (B) RNF17S for 24 hours.  Transfected cells were 
treated with MG132 and control cells were treated with DMSO for 24 hours 
and stained with anti-RNF17 (middle panel).  Nuclei were stained in DAPI 
(left panel), cells screened by confocal microscopy and merged images 
shown in right panel.  RNF17C was diffused in the nucleus and in the 
cytoplasm of MG132-treated cells compared to control cells (arrows).   
RNF17S entered the nucleus and cytoplasmic foci reduced their number and 
accumulation in MG132-treated cells compared to control DMSO-treated 
cells (arrows). 
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3.4  Discussion 
Four isoforms for Rnf17 have been annotated in Uniprot, and two of them, 
the Rnf17S (3.5 kb) and the Rnf17L (5.2 kb), were identified by Pan et al 
(2005).  Using endpoint PCR, the expression of Rnf17 in F9 cells was 
detected.  Results in Fig 3.8 show expression of Rnf17S and Rnf17L 
transcripts and an uncharacterised band of about 150 bp using the short 
Rnf17 primers was identified.  Whether this undefined band is expressed in 
early embryos, needs further validation.  In addition, it was unclear, given the 
known exons annotated for Rnf17 in Ensemble and AceView, which exons 
could encode this transcript or its coding potential.  However, the product is 
RNA-derived, as it was not amplified in RT-negative controls and did not 
disappear from DNaseI treatment of the RNA, unlike the detected band of 
290 bp detected from DNaseI untreated RNA.  This indicates that it was not a 
product of genomic DNA contaminant. 
To test the endogenous localisation of RNF17 in F9 cells, and anti-RNF17 
rabbit polyclonal antibody was generated.  Western blotting showed that the 
anti-RNF17 sera specifically recognised the short and long RNF17 isoforms 
(Uniprot).  Using the generated anti-RNF17, RNF17 isoforms were detected 
by Western blot (Fig 3.9).  The subcellular localisation of endogenous RNF17 
in F9 cells was determined by immunostaining.  RNF17 was expressed in the 
nucleus and localised in cytoplasmic foci located close, specifically 
surrounding, the nuclear membrane (Fig 3.10) and this was consistent with 
RNF17 immunoreactivity being identified in the insoluble fraction.  This is 
distinct from the immunoreactivity of Tubulin which segregated in the soluble 
fraction.  The database shows a consensus sequence for a bipartite NLS 
stretch amino acids within RNF17 with two stretches of K/R residues 
conforming to the consensus {(K/R)-X10-12-(K/R)(K/R) where X represents 
any amino acid residues} (AceView).  Two bipartite NLS spanning residues 
326-342 (RKELCCDVYSSLEKKKV) and residues 458-474 141 
 
(RKYSQIKDATILEKKMK) of RNF17 isoforms: Long, short and protein C, 
revealed the ability of RNF17 to enter the nucleus.   
Increased expression of the c-Myc protein in vitro enables increased binding 
to the E-box sequences of the c-Myc reporter construct, and a direct output 
to this binding is the activation of transcription of Luciferase which can be 
readily measured in extracts from cells.  c-Myc over-expression in F9 cells 
was tested-as a control experiment- and the results showed a significant 
induction of the Luciferase reporter construct.  Higher levels of c-Myc 
expression caused “squelching” which has been described previously for 
over-expression of transfection factors and has been related to the removal 
of a limiting pool of co-activators into non-functional complexes not bound to 
DNA (Cahill et al, 1994).  Interestingly, the over-expression of Rnf17 did not 
cause this squelching and Rnf17 is believed not to bind co-activators and 
thus is consistent with the proposed mechanism for Rnf17 in creating a MXD-
null phenotype (Yin et al, 1999).   
Co-transfection of Rnf17 and c-Myc expression plasmids had shown that 
Rnf17 induced c-Myc activity in F9 cells.  One possibility is that this may be 
achieved by interacting with Mxd (Yin et al, 1999).  However, it is possible 
that Rnf17 alters Mxd stability via acting as ubiquitin ligase (Pickart, 2001; 
van Wijk et al, 2009).   
Comparing the intensity of the band for MXD1 in the absence of RNF17 in 
MG132-treated or untreated cells in Western blot experiments revealed a 
regulatory role for proteasome in MXD1 degradation by another E3 ligase.  
MXD1 was found exclusively in the insoluble fraction, whereas RNF17 can 
be seen in the soluble and insoluble fractions.  The insoluble fraction 
contained nuclear and insoluble proteins whereas the soluble fraction 
contained cytosolic proteins.  The strong band for RNF17C in the insoluble 
fraction probably reflected the immunostaining signals in the nucleus and in 142 
 
the cytoplasmic foci.  The weak band for RNF17S in the insoluble fraction of 
Western blotting probably indicated the cytoplasmic foci localisation of 
RNF17S.   
The results in Fig 3.13 may indicate that different isoforms of RNF17 exhibit 
certain preferences in their substrate specificity.  For example, the oncogene 
c-IAP contains a RING motif and has the properties of ubiquitin E3 ligase 
targeting MXD1 and promotes cell proliferation via cooperation with Myc (Xu 
et al, 2007).  The c-IAP1 mediates the ubiquitinylation of TRAF2 (li et al, 
2002 from Xu et al, 2007), whereas c-IAP2 degrades TRAF1 (Lee et al, 2004 
from Xu et al, 2007).  Yin (1999 and 2001) found that RNF17 is strongly 
interacts with MXD1, MXD3 and MXD4 but weakly interacts with MXD2.  It 
would be interesting to test whether RNF17S or RNF17C have the specificity 
of ubiquitin-degradation for the members of the MXD family.   
Changing ratios of RNF17:MXD has been shown to change their cellular 
localisation (Yin et al 1999).  MG132 had inhibited proteasomal activity and 
blocked degradation of MXD1 which suggests the possibility of holding 
RNF17 in the nucleus.  Immunostaining results showed that treated Cos1 
cells with MG132 induced movement of the RNF17 construct into the 
nucleus, suggesting a target protein for RNF17 localised in the nucleus. 
From the subcellular localisation experiments, the distribution of protein from 
transfected plasmids of RNF17S was found exclusively in the cytoplasm, 
while RNF17C was in both the nucleus and the cytoplasm.  Treating cells 
with MG132 induced more RNF17C to enter the nucleus and reduced the 
number of clusters of cytoplasmic RNF17S.  The localisation of both RNF17 
proteins mirrored the band intensity in the Western blot experiments with or 
without MG132-treatment.  It is not clear how this differential localisation is 
controlled, however it could involve the Tudor domains that are present in the 143 
 
RNF17S protein which are lacking the protein C isoform (Uniprot).  Thus, 
Tudor domains could impair the activity of the NLS. 
Based on the subcellular localisation and Western blot results, a conclusion 
that RNF17 is shuttled between the nucleus and the cytoplasm in response 
to proteasomal activity, and acts as E3 ligase to degrade MXD via 
ubiquitinylation is reached.  It is possible that Rnf17 functions to create a 
Mxd-null phenotype by ubiquitinylation.  Rnf17 could modulate c-Myc in early 
development, such that changes in Rnf17's expression could bring about 
changes in the relative levels of cell populations within the developing 
embryo and have effects on developmental outcomes. 
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4.  Expression Patterns of Rnf17 during Mouse 
Preimplantation Embryo Development 
4.1  Introduction 
Preimplantation development is the period from fertilisation to implantation 
that varies in stage and duration from species to species.  Growing oocytes 
accumulate RNAs and proteins that constitute the maternal contribution to 
early development (Hamatani et al, 2004; Zeng and Schultz, 2005).  After 
fertilization, subsequent cleavage division occurs with the first mitotic division 
to produce the 2-cell embryo and continues to form a blastocyst.  In the 
mouse, there are two major transcriptional waves throughout preimplantation 
development.  Each transcriptional wave is combined with maternal transcript 
degradation and new zygotic gene activation (ZGA) at each developmental 
stage (Hamatani et al, 2004; Schultz, 2002).  A minor zygotic genome 
activation starts after fertilisation and is characterised by maternal transcript 
degradation and new zygotic transcription synthesis and mRNA expression.  
This is followed by a major ZGA that contributes to a dramatic synthesis of 
zygotic transcripts at 2-cell up to blastocyst stages.  Another gene 
reprogramming occurs during the 4-cell and 8-cell stages and distinctively 
separates the 8-cell from the 2-cell embryo (Zeng et al, 2004; Hamatani et al, 
2004). 
MAX expressed in mouse oocyte and cleavage embryos was found 
continually in all embryonic and extra-embryonic structures of the early post-
implantation embryos (Domashenko et al, 1997; Shen-Li et al, 2000).  The c-
Myc mRNA was detected at the late 2-cell and 4-cell stages and reached a 
maximum at the morula stage before declining upon blastocyst formation 
(Domashenko et al, 1997).  Following IVF or IVC, c-MYC displayed a strong 
signal from 1-cell up to 4-cell, before the signal decreased in morulae and 
was not detected in blastocysts (Suzuki et al, 2009).  Microarray analysis 
revealed that Mxd2 is expressed between the 4-cell and 8-cell stages, 148 
 
followed by an immediate decrease from the 8-cell to morula stage 
(Hamatani et al, 2004).   
Two transcripts for Rnf17 are described in adult mouse testis; Long Rnf17 
(Rnf17L) and Short Rnf17 (Rnf17S) and RNF17 is located in a perinuclear 
nuage in male germ cells (Pan et al, 2005).  Microarray data showed that 
Rnf17 is also expressed in early embryo development.  Affymetrix probe, 
1438820_at, showed that Rnf17 expression is increased through the 
preimplantation period (from oocyte to blastocyst) (Zeng et al, 2004).  The 
same Affymetrix probe showed that Rnf17 is significantly increased in the 
mouse blastocyst in response to maternal LPD (Papenbrock et al, 
unpublished data) and following blastocyst cultured IVC or IVF (Giritharan et 
al, 2007) using Affymetrix probe1438820_at.   
4.1.1 Aim of experiment 
The aim of this experiment is to investigate the expression of Rnf17 mRNA in 
mouse cleavage stages.  Members of the Myc/Max/Mxd network and the 
transposon element (Long interspersed element 1; line-1) were examined at 
the same stages.  The expression of mRNA of examined genes was detected 
by RT-qPCR using extracted RNA from single embryos at different 
preimplantation stages.   
The second aim is to detect subcellular localisation of RNF17 protein during 
preimplantation development and compare this to the adult mouse testis.  In 
this experiment, rabbit polyclonal anti-RNF17 generated in our laboratory 
was exploited and using confocal microscopy.   
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4.2 Methods 
4.2.1 Creating standard curve for data normalization 
Primers designed for Rnf17, c-Myc, Mxd3 and Line-1 were tested using 
synthesized cDNA of F9 cells.  For RT-PCR reactions, three replicates of all 
samples were performed and data were exported from the Opticon Monitor 
Analysis Software, following Opticon Monitor v3.1 software guidelines.  
Figure 4.1 shows expression of Rnf17S, Rnf17L, c-Myc, Mxd3 and Line-1 
and control Tubulin α-1.   
The amplified PCR products for Rnf17S, Rnf17L, c-Myc and Line-1 were 
visualized by gel electrophoresis on a 2% agarose gel, whereas no band was 
detected for Mxd3 (Fig 4.2).  Thus, the Mxd3 reaction was tested on cDNA 
prepared from foetal testis (E17.5).  Mxd3 was expressed in foetal testis and 
a band for Mxd3 PCR product was detected on 2% gel (Fig 4.3). 
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Fig 4.1: Expression of designed primers for RT-PCR.  Specificity of 
designed primers was tested to detect expression of (A) Rnf17S, (B) Rnf17L, 
(C) c-Myc, (D) Mxd3 and (E) Line-1 using cDNA prepared from cultured F9 
cells.  (F) Tubulin α-1 (Tuba1) was used as a control.  Expression of tested 
genes is displayed by threshold cycle (Ct) in all graphs exported from Optical 
Monitor Microsoft. 151 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.2 (Continued) 152 
 
Fig 4.2: Electrophoresis of RT-qPCR products on a 2% agarose gel.  F9 
cells were used as template to test designed primers for candidate genes.  
(A) Rnf17S, Lanes 1, 2 and 3 were merged for gel extraction.  (B) Rnf17L.  
(C) c-Myc.  (D) Mxd3; no PCR products can be seen for Mxd3.  (E) Line-1.  
(F) Tubulin α-1 (Tuba1)  
  Lanes 1, 2 & 3 for A, B, C, D, E & F: +DNaseI/+RT.   
  Lanes 4, 5 & 6 for A, B, C & D: +DNaseI/-RT.   
  Lanes 7, 8 & 9 for A, B, C & D: -DNaseI/-RT.   
  Lanes 10, 11, 12 for A, B, C & D: -DNaseI/+RT.   
  Lane 13 for A, B, C & D: no template control (NTC). 
  Lanes 4 & 5 for E & F: -DNaseI/+RT 
  Lanes 6 & 7 for E & F: +DNaseI/-RT. 
  Lanes 8 & 9 for E & F: no templatecontrol (NTC) 
  M: DNA marker (HyperLadder II). 
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Fig 4.3: Expression of Mxd3 in foetal testis.  Specificity of designed 
primers was tested to detect expression of Mxd3 using cDNA prepared from 
foetal testis E17.5.  (A) Expression of Mxd3 is displayed by threshold cycle 
(Ct) in a graph exported from Optical Monitor Microsoft.  (B) PCR product for 
Mxd3 is screened on 2% agarose gel. 
  Lanes 1, 2 & 3: prepared cDNA with addition of reverse transcriptase 
(+RT).   
  Lanes 4 & 5: prepared cDNA without addition of reverse transcriptase (-
RT).   
  Lane 6: no template control (NTC).   
  M: DNA marker (HyperLadder II). 
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Serial dilutions were set up from 100 pg/µl to 1 ag/µl (Fig 4.4).  All samples 
were run in replicate, and mean Ct values for each dilution were calculated to 
plot standard curves for each primer pair.  Primer Efficiency (E) was 
calculated from the formula E =101/slope as shown in Figure 4.5. 
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Fig 4.4: Amplification of RT-qPCR product for standard curve.  Graphs 
exported from Opticon Monitor software represent serial dilutions generated 
from F9 cells template for (A) Rnf17S, (B) Rnf17L, (C) c-Myc and(D) Line-1, 
whereas those for (E) Mxd3 were generated from foetal testis E17.5.  
Dilutions were set up from 100 pg/µl to 1 ag/µl.   
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Fig 4.5: Standard curve generated from serial dilutions and calculated 
Efficiency of primers used in RT-qPCR.  Mean Ct values was calculated 
for primer Efficiency and graphing the log of the serially diluted DNA samples 
from 100 pg/µl to 1 ag/µl vs. Ct value for each dilution. 157 
 
4.3 Results 
4.3.1 Expression of Rnf17, Myc, Mxd3 and Line-1 during 
preimplantation mouse embryo development 
Expression of Rnf17, c-Myc, Mxd3 and Line-1 were examined in 2-cell, 4-cell, 
8-cell, morula and blastocyst stages by RT-qPCR.  Embryos were collected 
from mothers fed chow from the day of plug up to the date of embryo 
collection and cDNA was synthesised. 
Rnf17S, Rnf17L, c-Myc, Mxd3 and Line-1 were expressed in all examined 
embryo stages and PCR products were visualised on 2% agarose gel 
electrophoresis (Fig 4.6).  Primary data for the expression of examined genes 
and control Tuba were represented in the mean Ct values of the two 
replicates at one RT-qPCR cycle, and are shown in Table 4.1.  Expression of 
Rnf17S and c-Myc were increased in parallel with the control Tuba1 in 
embryos developing from 2-cell up to blastocyst stages and the increased 
expression was associated with a reduction in Ct values of 6.48, 8.75 and 
4.95, respectively.  Expression of Rnf17L and Mxd3 displayed little change 
from the 2-cell to the blastocyst changes of 1.97, 0.74 in Ct, respectively. 
PCR products were analysed by generating a melting curve in Figure 4.7 
(bottom panel).  The melting curve of a product is sequence specific: thus it 
distinguishes between specific and nonspecific PCR products.  Figure 4.7 
shows that the melting curve peak for Rnf17S (76.2ºC), Rnf17L (77.98ºC) 
and c-Myc (83.4ºC) are all amplified through all embryo stages.  However, 
the melting curve peak for Mxd3 (85ºC) is amplified only at 8-cell, morula and 
blastocyst. 
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Fig 4.6: Expression of Rnf17S, Rnf17L, c-Myc, Mxd3 and Line-1 during 
mouse preimplantation development.  RT-qPCR reaction was run in 
duplicate and PCR product size and expression were compared to positive 
control; Tuba1.  NTC: no template control used as negative control.  One 
replicate of 2-cell is missing from Rnf17S (Lane1).   
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Table 4.1: Ct values of Rnf17S, Rnf17L, c-Myc and Mxd3 compared to 
control Tuba1 during mouse preimplantation development.  Data 
represented in mean value of two biological replicates.   
 
 
 
   
  Rnf17S  Rnf17L  c-Myc  Mxd3  Tuba1 
2-cell  35.47*  34.61  35.69  34.71  26.63 
4-cell  32.48  34.20  29.25  34.32  27.22 
8-cell  31.81  34.06  29.04  33.94  24.95 
Morula 
29.78  33.96  28.04  33.92  22.16 
blastocyst  28.99  32.64  26.94  33.97  21.68 
*One replicate 160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.7 (Continued)   161 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.7 (Continued)   162 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.7: Expression of Rnf17, c-Myc and Mxd3 through preimplantation 
development using RT-PCR.  Data graph for Log scale (top) and melting 
curve (bottom) exported from Opticon Monitor Microsoft for Rnf17S, Rnf17L, 
c-Myc and Mxd3 compared to control Tuba1.  (A) 2-cell, (B) 4-cell, (C) 8-cell, 
(D) morula, (E) blastocyst.  Melting curve peaks for Rnf17S, Rnf17L and c-
Myc were amplified at all stages of the developed mouse embryo.  Melting 
curve for Mxd3 (yellow) amplified at 8-cell, morula and blastocyst stages. 
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4.3.2 Subcellular localisation of RNF17 throughout 
preimplantation development 
For negative control experiments, blastocysts were collected from mothers 
fed chow and incubated with pre-immune or immunised sera diluted 1:1000 
in 1% BSA followed by secondary anti-goat/anti-rabbit conjugated with Alexa 
fluor 488.  Diffuse and non-specific staining was seen with pre-immune and 
immune sera (Fig 4.8 A & B), probably reactions of non-specific proteins 
because what is eliminated following purification and a distinctive reaction 
with expected RNF17 was seen as shown below.   
The second negative control was run by incubating blastocysts with the 
secondary antibody Alexa fluor 488.  No fluorescence signal was detected in 
embryos incubated with secondary antibody indicating that no reaction with 
non-specific proteins has taken place (Fig 4.8C).   
Mouse embryos were collected at different preimplantation stages and 
immunostained with anti-RNF17 and nuclei were labelled with DAPI.  
Embryos were examined by fluorescence microscopy.  The data from 
examined embryos is shown in Table 4.2.   
 
 
   164 
 
Table 4.2: Number for embryo stained with anti-RNF17.  Embryos were 
collected at different cleavage stages from mothers fed chow from day of 
plug (E0.5) up to day of embryo collection. 
 
 
   
Embryos 
stages 
Number of examined embryos 
Zygotes  2 embryos from 1mother 
2-cell  8 embryos from 3 mothers 
4-cell  9 embryos from 3 mothers 
8-cell  14 embryos from 4 mothers 
Morula  17 embryos from 6 mothers 
Blastocyst  17 embryos from 5 mothers 165 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.8: Negative control experiments for anti-RNF17 validation and 
protein detection in mouse blastocyst.  Mouse blastocysts were 
immunostained with (A) pre-immune- or (B) immune-sera collected from 
immunised rabbits with the RNF17-fusion protein showed diffused and 
indistinctive staining of non-specific proteins.  (C) Mouse blastocyst stained 
only with secondary antibody Alexa fluor 488 display no fluorescence signal 
indicating no cross-reaction with non-specific proteins.  Nuclei were stained 
with DAPI, and embryos visualised by confocal microscopy. 166 
 
RNF17 displayed distinct subcellular patterns during preimplantation 
development.  RNF17 was deposited abundantly in the nucleus, and 
excluded from the nucleolus.  RNF17 was also diffuse in the cytoplasm of 
early and late stages and displayed different patterns of subcellular 
expression at 4-cell and 8-cell (Fig 4.9). 
The nuclear pattern of RNF17 was diffuse in the nuclei of zygote, 2-cell, 
morula and blastocysts (Fig 4.9 A, B, E & F), but was punctated in the nuclei 
of 4- and 8-cell embryos (Fig 4.9 C & D).  RNF17 was diffuse in the 
cytoplasm of the zygote and 2-cell before the fluorescent signal became 
weaker at 4-cell and partially disappeared from the cytoplasm at 8-cell.  
RNF17 gradually increased in the cytoplasm of the morula with foci-like 
expression, and, thereafter, disappeared in the late blastocyst.   
Using Volocity software, the intensity level for RNF17 in the nuclei was 
shown to increase relative to that in the cytoplasm by about 78% to 90% 
through the different preimplantation stages.  The highest level was at 4-cell 
(90%) and 8-cell (91%), reflecting the disappearance of RNF17 from the 
cytoplasm of the 4-cell and 8-cell stages.  The intensity level of RNF17 
between the nuclei and the cytoplasm of blastocysts was the lowest 
throughout all the preimplantation stages (78%) (Fig 4.10).  The mean 
number of RNF17 foci was increased at the 8-cell stage (Fig 4.11). 
RNF17 was not expressed in the nucleus of mitotically divided cells.  This 
was observed in cleaved embryos, morulae and blastocysts (Fig 4.12). 
RNF17 was detected in the polar body of 2-cell stage before it became 
weaker at the 4-cell, then not detected in the following stages; 8-cell, morula 
and blastocyst (Fig 4.13). 
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Fig 4.9 (Continued) 168 
 
Fig 4.9 (Continued) 169 
 
 
Fig 4.9 (Continued) 170 
 
Fig 4.9: Subcellular localisation of RNF17 during preimplantation 
development.  Mouse embryos from mothers fed chow were collected at 
different cleavage stages; (A) zygote, (B) 2-cell, (C) 4-cell, (D) 8-cell, (E) 
morula and (F) blastocyst.  Embryos were immuno-labelled with affinity 
purified anti-RNAf17 and nuclei stained with DAPI.  RNF17 is predominantly 
within the nuclei and diffuse in the cytoplasm of early (zygote and 2-cell) and 
late (morula and blastocyst) stages.  RNF17 shows a punctuate distribution 
in the nuclei of 4- and 8-cell stages 
  Top panels: staining of the nuclei with DAPI 
  Middle panels: RNF17 signal 
  Bottom panels: overlays (merge) of the two signals 
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Fig 4.10: Mean intensity level for RNF17 in the nucleus and the 
cytoplasm throughout preimplantation stages.  Mouse embryos were 
collected at different cleavage stages from mothers fed chow from day of 
plug (E0.5) up to day of embryo collection.  Collected embryos were stained 
with anti-RNF17 and the level of fluorescence intensity was visualised by 
Leica SP5 confocal microscopy and measured using Volocity software.  The 
intensity level of RNF17 was first determined in the nuclei then subtracted 
from total level of the embryo to calculate intensity level for RNF17 in the 
cytoplasm.  Bar graphs show mean of examined embryos (n at each stage) 
and error bars represent standard deviation.   172 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.11: Number of RNF17 foci and mean intensity level of RNF17 foci 
in the nuclei of 4-cell and 8-cell embryos.  Mouse embryos at 4-cell and 8-
cell stages were collected from mothers fed chow and immunolabelled with 
anti-RNF17.  Using Volocity software the number and intensity of RNF17 foci 
in the nuclei was calculated.  Bar graphs show mean of examined embryos 
(n at each stage) and error bars represent standard deviation.   173 
 
 
Fig 4.12(continued) 174 
 
Fig 4.12: Expression of RNF17 in embryos during preimplantation 
development.  (A) Embryos were immuno-labelled with anti-RNAf17 and 
nuclei stained with DAPI; dotted areas show blastomeres during mitosis.  (B) 
Highly magnified cells show that anti-RNF17 is not detected in mitotic 
blastomeres at 8-cell and morula stages. 
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Fig 4.13: Expression of RNF17 in polar bodies during preimplantation 
development.  Mouse embryos collected at different cleavage stages were 
immunolabelled with anti-RNF17 and nuclei stained with DAPI.  RNF17 was 
detected in the polar body at 2-cell stage and gradually the signal reduced 
from 4-cell to 8-cell.  No signal was detected for RNF17 at morula stage. 
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4.4 Discussion 
In this chapter it is the first time that the expression of Rnf17 mRNA by RT-
qPCR and the subcellular localisation of RNF17 protein were detected using 
confocal microscopy throughout the early embryo cleavage stages.  Raw 
data for Ct values in RT-qPCR experiments showed that the expression of 
mRNA for Rnf17S and c-Myc increased throughout preimplantation 
development; i.e. between the 2-cell stage (E1.5) and blastocyst (E3.5).  
Rnf17S was highly expressed during preimplantation compared to Rnf17L.   
Our results showed that expression of Rnf17 mRNA and RNF17 protein in 
the preimplantation embryo were consistent with Microarray data (E-GEOD-
1749), as annotated by European Bioinformatics Institute (www.ebci.ac.uk) 
for the expression of Rnf17 mRNA in mouse oocyte and cleavage stages.  
The expression of RNF17 protein in the zygote may suggest a ubiquitination 
role of maternal RNF17 in degrading maternal proteins.  Proteins involved in 
the ubiquitinylation pathway are up-regulated in the zygote, where they have 
been suggested to contribute to maternal proteins degradation (Wang et al, 
2010; Hamatani et al, 2004).  For example, a RING-finger containing protein, 
Ret Finger Protein-Like 4 (RFPL4) is an E3 ubiquitin ligase expressed in 
oocyte and is involved in degrading maternal transcripts (Suzumori et al, 
2003).  At the 2-cell stage, ZGA transition allows the degradation of maternal 
transcripts and initiates the expression of zygotic transcripts (Schultz, 2002).  
Expression of nuclear RNF17 protein at the 2-cell stage may suggest a 
changed distribution for RNF17, with enhanced nuclear localisation, and 
reveals that RNF17 is functioning as a transcriptional factor at time of ZGA. 
Immunostaining results showed that RNF17 protein was punctated in the 
nuclei of the 4- and 8-cell embryos, whereas it started to disappear from the 
cytoplasm.  Epigenetic chromatin remodelling occurs at ZGA and involves 
post-transcriptional modifications of nucleosomal histones, either repressive 
or activating.  Several protein domains were found in chromatin-associated 177 
 
proteins, such as Chromo, MBT and Tudor domains (Kim et al, 2006).  A 
chromatin-associated domain array (CADOR) chip which reads the 
interaction of protein-domains with methylated histone tails, examined the 
binding of histone peptides with Tudor domain-containing proteins including 
RNF17 (Kim et al, 2006).  This study used a human cDNA library and 
showed that Tudor domains of JMJD2 were bound to di- and tri- methylated 
H4K20 and to H3K4me3 and H3K9me3 (Kim et al, 2006; Huang et al, 2006) 
whereas Tudor domains of TDRD3 were bound with a symmetrically 
arginine-methylated (sDMA) peptide from the splicing factor SmD3 (SmD3-
Rme2s) (Kim et al, 2006).  SmD1 and SmD3 have been described to bind to 
the Tudor domain of SMN by sDMA (Ke et al, 2010).  The highly conserved 
amino acids for Tudor domain-containing proteins (Thomson and Lasko, 
2005) suggest a similar binding behaviour to that of TDRD3 or that of JMJD2.  
These findings may explain the punctated nuclear localisation of RNF17 that 
suggests the binding of RNF17 Tudor domains to histone tails, or SmD via 
sDMA for post-transcriptional modifications.   
Rnf17 interacts with members of the Mxd family.  In this chapter, expression 
of Mxd3 throughout early cleavage stages was detected in order to 
investigate the role of the interaction between Rnf17 and Mxd in the 
preimplantation embryo.  Our results showed that Mxd3 mRNA, a member of 
the Mxd family, is first expressed at 8-cell and continued to blastocysts.  
Microarray analysis showed that Mxd2 increases in expression from the 4- to 
8-cell stage (Hamatani et al, 2004).  This indicates variability of the 
expression level of Mxd family at different cleavage stages.  However, yeast 
two-hybrid screening and GST pull-down experiments showed that the 
interaction between RNF17 and MXD2 is the weakest of all the Mxd family 
members (Yin et al, 1999).  Using electrophoresis mobility shift assays also 
revealed that RNF17 was less effective in reversing the effect of MXD2 than 
other Mxd members (Yin el al, 1999).  This indicates that a strong interaction 
between Rnf17 and Mxd3 may reduce the expression level of Mxd3 in the 178 
 
embryo.  Another possibility is that immunostaining showed that RNF17 is 
exclusively expressed in the nucleus of 4- and 8- cell embryos, which may 
suggest interaction between RNF17 and MXD at this stage to increase Myc 
expression and induce cell proliferation.   
PIWI proteins regulate the silencing of transposable elements via RNA-
dependent DNA methylation in a process involving the interaction of PIWI 
with piRNA via Tudor domain-containing proteins (Seto et al, 2007; Hawkins 
et al, 2011).  In Hamatani et al (2004) Microarray analysis showed that PIWI2 
peaked at the 4-cell.  Studies showed a functional link between retro-
transposable activity and early embryo development.  For example, murine 
ERV-L (MuERV-L) revealed the high contribution of transposable elements in 
2-cell stage embryos and increased at 8- to 16-cell compared to LINE which 
was the highest fraction of transposons in growing oocytes (Ohnishi et al, 
2010; Peaston et al, 2004).  Using RT-qPCR, expression of Line-1 
throughout preimplantation development was detected, and together with 
expression of RNF17 this may suggest a functional role for RNF17 in Piwi-
piRNA interaction and transposable element silencing.   
Immunostaining experiments showed that RNF17 protein disappears from 
mitotically divided cells in preimplantation embryos (Fig 4.12), and in F9 cells 
in Chapter 3 (Fig 3.11), which may indicate a role of RNF17 in mitosis cell 
entry or exit.  Mitosis is a highly regulated process that ensures segregation 
of chromosomes into two daughter cells, and this is achieved by maintaining 
careful coordination of the protein levels of many mitotic regulators including 
RING-containing proteins (reviewed by Nigg, 2001).  For example, the Bub1-
related 1 (BubR1) and Mitotic Arrest Deficient-Like 2 (Mad2) gene are 
essential components of the mitotic checkpoint pathways.  They inhibit the 
ubiquitin ligase activity of the Anaphase Promoting Complex/ Cyclosome 
(APC/C) during mitosis by binding and sequestering Cdc20, an APC/C 
activator.  This property of the BubR1 and Mad2 is important to ensure cells 179 
 
with unaligned chromosomes do not prematurely enter anaphase (Chan and 
Yen, 2003; Fang et al, 1998; Guo et al, 2012).  In contrast, the expression of 
other RING-containing proteins is essential for mitosis entry.  For example, 
the Checkpoint with forkhead and RING finger (CHFR) protein is a ubiquitin 
ligase and exhibits RING domain-dependent auto-ubiquitinylation activity in 
vivo that makes it capable of catalyzing its own ubiquitinylation (Privette and 
Petty, 2008).  CHFR protein plays an important role in regulating mitosis at 
early to mid-prophase (by regulating the G2–M transition), and might have 
further roles in spindle formation, centrosome separation and chromosome 
segregation (Chaturvedi et al, 2002; Privette and Petty, 2008; Castiel et al, 
2011).  CHFR also plays a role via ubiquitinylation, in mediating the function 
of Still protein in centrosome organization, entry into mitosis and cell 
proliferation.  Still (Sil, SCL/TAL1 interrupting locus) is a cytosolic and 
centrosomal protein expressed in proliferating cells and accumulates in a 
cell-cycle-dependent manner, reaching peak levels at the G2–M boundary  
(Castiel et al, 2011).  Taken together, it is possible that the disappearance of 
RNF17 protein in mitotically divided cells is required for mitosis cell entry.  
RNF17 is bound to itself in GST pull-down assay and both isoforms (RNF17L 
and RNF17S) were co-Immunoprecipitated from adult mouse testis 
suggesting a possible heterodimer complex (Pan et al, 2005).  This may raise 
the possibility that RNF17 possess auto-ubiquitinylation activity that allows it 
to catalyse its own ubiquitinylation at the time of cell cycle entry and to 
enhance the disappearance of RNF17 from mitotic cells.  Clearly, the 
inhibition of ubiquitin ligase activity of RNF17 via mitotic checkpoint pathways 
is important to ensuring a correct chromosomal alignment during the mitosis 
phase and the correct segregation of chromosomes into two daughter cells. 
RNF17 is detectable in first and second polar bodies and this was seen in 
zygote and 2-cell stages, and weakly in 4-cell (Fig 4.13), however our results 
had not discriminated between the first or the second polar bodies at these 
different stages.  First and/or second polar bodies chromosome analysis is 180 
 
now used extensively in preconception or prenatal genetic diagnosis (PGD) 
in ART clinics.  PGD studies revealed that chromosomes extruded into the 
first and second polar bodies mirror the genetic and reproductive potentials 
for those remaining in the oocyte following meiosis resumption or second 
meiotic division of the fertilised oocyte (Evsikov and Evsikov, 1994; 
Wakayama and Yanagimachi, 1998; Durban et al 1998; Geraedts et al, 
2011).  Thus it is possible that the RNF17 signal that is observed in the polar 
body is because the polar bodies contain the counterparts of the 
chromosomes expressing RNF17.  This signal was observed to remain until 
the polar bodies degenerated in the apoptotic-like process.   
To summarise, Rnf17 mRNA is expressed in preimplantation embryos 
predicting a role in embryo growth and development.  Expression of RNF17 
protein at the zygote stage revealed that further expression of RNF17 is 
transcribed from maternal RNF17.  The expression of RNF17 protein in the 
nuclei of the cleaved embryo suggested a transcriptional function for RNF17 
proteins.  It is suggested that RNF17 may bind to histone H3 and/or H4 tails 
and is involved in post-transcriptional modifications that are required for 
embryo growth and development.   
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5.  Effect of Maternal Diet on Expression of Rnf17 
in Mouse Blastocysts and Foetal Testis 
5.1 Introduction 
Maternal dietary protein restriction during preimplantation development is 
associated with embryo development, specifically blastocyst proliferation.  
LPD (9% casein) has been shown to influence embryo proliferation by 
increasing the blastocyst number and inducing blastocyst TE proliferation 
(Eckert et al, 2012).  Although Rnf17 function has not been studied in the 
early embryo, Affymetrix Microarray and bioinformatics analysis performed 
by our laboratory (Papenbrock et al, unpublished data) revealed 
differential regulation of c-Myc and Rnf17 expression in blastocysts in 
response to maternal LPD compared to control NPD.  No data were 
reported for long-term effects of differential regulation of Rnf17 or 
members of the Myc/Max/Mxd network on embryo development in 
response to maternal diets. 
Maternal diets have also been shown to affect the level of gene 
expression by inducing or modifying DNA methylation and epigenetic 
changes (Cooney et al, 2002; Wolff et al, 1998; Morgan et al, 1999; 
Sinclair et al, 2007).  DNA methylation is required to silence the 
expression of transposable elements which is important for genomic 
integrity and germ cell development (De Fazio et al, 2011).  No data has 
been reported on the effects of maternal LPD or HPD on the expression or 
silencing of transposable elements in the preimplantation embryo or in 
developed germ cells.  DNA methylation-mediated silencing of 
transposable elements occurs through the piRNA pathway which involves 
interactions of PIWI proteins with piRNA via Tudor domain-containing 
proteins (Beyret et al, 2012; Suh and Blelloch; 2011; Thomas and Lin, 
2009).  Tudor domain-containing proteins (TDRD1 and TDRD9) interact 
with PIWI proteins (MILI and MIWI2) in cytoplasmic chromatoid bodies to 184 
 
silence transposon elements through the piRNA pathway (Shoji et al, 
2009).  piRNAs were found to be Immunoprecipitated with MILI from 
neonatal and adult mouse testes (Aravinet al, 2006; 2007).   
RNF17 is a Tudor domain-containing protein and Immunoprecipitates with 
MIWI in adult mouse testis (Vagin et al, 2009) and with the ZILI zebrafish 
homologue of mouse MILI in zebrafish testis and ovary (Huang et al, 
2011).  The D.melanogaster Kumo protein homologue of mouse RNF17 
interacts with nuage components, in germline cells of Drosophila egg, and 
this interaction is required for the localisation of piRNA pathway proteins to 
the perinuclear nuage for transposon repression (Anand and Kai, 2012).  
Microarray analysis identified that Rnf17, Tdrd7 and Piwil2/Mili are 
expressed in mouse germ cells at E15.5 and are involved in germ cell 
development.  The study suggests a role of expressed genes in regulating 
DNA methylation and epigenetic modification in, a stage of de novo DNA 
methylation. 
1.1.1 Aim of experiment 
The aim of these experiments is to investigate the short and the long term 
effects of maternal LPD or HPD on the expression of Rnf17 mRNA and 
RNF17 protein in mouse embryos.  For short term effects, mouse 
blastocysts at E3.5 were examined, whereas for long term effects the 
E17.5 mouse foetal testis were examined using RT-qPCR.   
The second aim is to use the anti-RNF17 to detect whether maternal LPD 
or HPD alters the expression of RNF17 protein or changes its subcellular 
localisation in mouse E3.5 blastocysts and E17.5 testis.   
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1.2 Methods 
5.2.1 Creating a standard curve for data normalization 
Six reference genes (Tuba1, 18S, Sdha, Mapk1, Canx and Tbp) were 
selected, from the most commonly used housekeeping genes, for 
normalization of the examined genes in E17.5 foetal testis under maternal 
LPD or HPD compared to the control NPD.  The efficiency of the designed 
primers for selected reference genes Tuba1, 18S, Sdha and Tbp was 
previously calculated by our laboratory (Lucas et al, 2011).  The efficiencies 
of the designed primers for Mapk1 and Canx were calculated by generating 
standard curves from reactions with serial dilutions of the previously 
prepared products from F9 cDNA (Fig 5.1 & Fig 5.2). 
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Fig 5.1: Primer specificity for Mapk1 and Canx.  Primers for Mapk1 (A, C, 
E) and Canx (B, D, F) were tested using F9 cell cDNA.  Ct plots (A, B), 
melting curve graphs (C, D) and product sizes (E, F) are shown from 
reactions.  Expected sizes for the products are: MapK1 (74 bp) and Canx (66 
bp). 
  Lane 1-3: mRNA treated with reverse transcriptase (RT) 
  Lane 4-6: mRNA without RT 
  Lane 7: no template control. 
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Fig 5.2: Determination of Efficiency for Mapk1 and Canx primers.  Serial 
dilutions from (100 pg/µl) to (1 ag/µl) were generated from the products 
shown in (Fig 5.1) and used in reactions with Mapk1 primers (A, C) and Canx 
(B, D).  The efficiency was determined by plotting the log concentration of the 
serially diluted DNA against the Ct value determined for each DNA dilution.   
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5.2.2 Determination of the most stable genes for data 
normalization in E17.5 foetal testes in response to 
maternal LPD, HPD and control NPD 
RT-qPCR was run to assess the expression of selected 6 reference genes 
(Tuba1, Mapk1, Canx, Tbp, Sdha, and 18S) in 8 samples from different 
mothers in each diet group; LPD, HPD or control NPD.  Raw expression 
values were represented by mean Ct values of two biological replicates of 
each sample.  Results showed a wide range of mRNA expression for the 
tested genes (Ct: between 13 and 23) (Fig 5.3) with no variations between 
diet treatments (LPD, HPD and control NPD).  These results reflect the 
stability of tested reference genes under our experimental conditions. 
Figure 5.4 shows the expression stability (M) of reference genes determined 
by GeNorm and NormFinder.  Both softwares ranked Mapk1 as the most 
stable gene with a lower M value (M= 1.049 for GeNorm and M= 0.156 for 
NormFinder) in E17.5 foetal testis in response to maternal NPD, LPD and 
HPD.  The second most stable gene was Tbp (M= 1.110) ranked by 
GeNorm, whereas 18S (M= 0.281) was ranked by NormFinder (Table 5.1).  
For data normalisation the geometric mean for Mapk1 and Tbp was 
calculated and used as the normalisation factor to normalise the expression 
of the target genes.   
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Fig 5.3: Box plots representing mean Ct values for the 6 reference 
genes assayed in E17.5 foetal testis under maternal LPD, HPD and 
control NPD.  Extracted RNA from diet foetal testes was subjected to RT-
qPCR to examine stability of a number of reference genes under diet groups.  
Each box plot is based on the mean of biological duplicate Ct value for 8 
samples per diet group.  Boxes represent the lower and upper quartile 
ranges, the line between upper and lower boxes represent the median and 
whiskers indicate the maximum and the lower data value ranges. 
 
 
Table 5.1: Ranking of the candidate reference genes according to their 
stability in tested samples of foetal testis in response to maternal diet. 
 
 
 
 
Stability 
GeNorm  NormFinder 
Gene name  M values  Gene name  M values 
Most stable  Mapk1  1.049  Mapk1  0.156 
  Tbp  1.110  18S  0.281 
  18S  1.214  Tbp  0.367 
  Sdha  1.273  Sdha  0.488 
  Canx  1.732  Canx  1.433 
Least stable  Tuba1  2.246  Tuba1  2.515 191 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.4: Stability values (M) for six reference genes tested in E17.5 
foetal testis collected from different mothers fed LPD, HPD and control 
NPD.  Average expression stability (M) values were ranked by (A) GeNorm 
and (B) NormFinder.  High M values represent genes that have low stability; 
whereas low M values represent the most stable gene.   192 
 
5.3 Results 
5.3.1  Effect of maternal LPD or HPD on expression of Rnf17 
and members of Myc/Max/Mxd network in mouse blastocyst 
According to the results in Chapter 4, genes with early Ct values were tested 
using RNA extracted from single blastocysts, (Rnf17S, c-Myc and Lin-1) and 
genes that expressed late Ct values were tested using RNA extracted from a 
pool of five blastocysts (Rnf17L and Mxd3).  The five pooled embryos were 
considered as a single embryo and were only collected from one mother.  
Single or pooled samples were analysed in duplicate and mean Ct values 
were normalised to the most stable reference genes (Tuba1 and Ppib) by 
calculating the geometric mean of selected reference genes.  Table 5.2 
shows the numbers (n) of statistically analysed embryos within each dietary 
group. 
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Table 5.2: Number of embryos analysed for RT-qPCR within each 
dietary group. 
 
 
   
  NPD  LPD  HPD 
 
 Single embryo 
Rnf17S 
16 embryos from 
9 mothers 
16 embryos from 
11 mothers 
14 embryos from 10 
mothers 
c-Myc 
16 embryos from 
9 mothers 
16 embryos from 
11 mothers 
14 embryos from  
10 mothers 
Line-1 
8 embryos from 
6 mothers 
8 embryos from 
5 mothers 
7 embryos from 
5 mothers 
 
 Pooled embryos*    
Rnf17L 
50 embryos from 
8 mothers 
45  embryos from  
8 mothers 
50  embryos from  
10 mothers 
Mxd3 
40  embryos from 
8 mothers 
35  embryos from  
7 mothers 
40  embryos from  
8 mothers 
 
* Five embryos collected from same mother were pooled together and were 
considered as a single embryo per RT-qPCR.   194 
 
The expression of Rnf17S, Rnf17L, c-Myc, and Mxd3 were not significantly 
different in mouse blastocysts from LPD or HPD maternal diet treatments 
compared to the control NPD.  However, the expression of Rnf17L was 
decreased 40% in LPD blastocysts compared to HPD blastocysts (Fig 5.5).   
The expression of Mxd3 was the lowest among the examined genes.  
Although Line-1 was not significantly different between the dietary groups, 
Line-1 was 20% lower in LPD blastocysts and 30% lower in HPD than control 
NPD (Fig 5.5). 
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Fig 5.5: Expression profile of Rnf17, members of the Myc/Max/Mxd 
family and Line-1 in mouse blastocyst in response to maternal LPD, 
HPD and control NPD.  Single blastocysts were analysed for Rnf17S, c-Myc 
and Lin-1, whereas a pool of five blastocysts were analysed for Rnf17L and 
Mxd3.  Relative expression represents normalisation of examined gene to the 
geometric mean of two reference genes; Tuba-1-α and Ppib.  Bar graphs 
show mean of examined embryos (Table 5.2) and error bars represent 
standard error of mean.   196 
 
5.3.2 Effect of gender on expression of Rnf17 and members 
of Myc/Max/Mxd network in mouse blastocysts in 
response to maternal LPD, HPD and control NPD 
Embryo sexing was applied through detection of Sry and Zfy genes on the Y 
chromosome.  Male-specific fragments were represented by two bands 
amplified by primers for Sry (147 bp) and Zfy (217 bp) genes, whereas a 
single band was observed for DXNds (111 bp) fragments from both male and 
female (Fig 5.6).  Samples not showing any amplified bands were excluded 
from the statistical analysis.  The numbers of embryos examined are shown 
in Table 5.3. 
 
 
 
 
 
 
 
 
 
Fig 5.6: An example of blastocyst sex determination from single mouse 
embryo DNA.  (A) Male embryo with Y-specific target sequences (Zfy and 
Sry) and a polymorphic microsatellite locus located on X chromosome 
(DXNds3).  (B) Female embryo with DXNds3.  Products of second-step PCR 
with DXNds3-specific primers (Lane 1) and with Zfy and Sry (Lane 2). 197 
 
Table 5.3: Number of embryos examined for embryo sexing within each 
dietary group.  The test was performed for Rnf17S and c-Myc from the 
same embryos.   
 
 
 
 
 
 
As shown in Figure 5.7A, Rnf17S expression was increased in male 
blastocysts than female blastocysts derived from LPD and NPD groups.   
The expression of c-Myc was analysed in individual blastocysts used for 
Rnf17S.  The expression of c-Myc was more sensitive to maternal LPD in 
male blastocysts and was significantly reduced compared to female 
blastocysts (P≤0.05).  c-Myc increased by 50% in HPD male blastocysts than 
in LPD blastocysts but did not reach significance, whereas female HPD 
blastocysts had greater levels than the control (Fig 5.7B). 
It is important to mention here that embryo sexing results showed an unequal 
ratio of male to female in the HPD group.  As shown in Table 5.3, two male 
embryos relative to 5 female embryos were analysed for Rnf17S or c-Myc 
expression.   198 
 
 
 
Fig 5.7 (continued) 199 
 
Fig 5.7: Effect of gender on expression of Rnf17S and c-Myc in mouse 
blastocysts in response to maternal LPD, HPD and control NPD.  Two-
step PCR method were used to amplify sex-determining primers from single 
mouse blastocysts DNA to examine expression of (A) Rnf17S and (B) c-Myc.  
Relative expression represent normalisation of examined gene to the 
geometric mean of two reference genes; Tuba-1-α and Ppib.  Bar graphs 
show the mean of examined embryos (Table5.3) and error bars represent 
standard error of mean.    200 
 
5.3.3 Expression of Rnf17 and members of Myc/Max/Mxd 
network in mouse E17.5 foetal testes in response to 
maternal LPD, HPD and control NPD 
Testes of foetuses derived from LPD mothers had a significantly increased 
expression of Rnf17S than control NPD (P≤0.05).  The expression of c-Myc 
was significantly decreased in foetus testes from HPD mothers compared to 
LPD (Fig 5.8).  The expression of the retro-transposable element Line-1 in 
foetal testis was investigated.  Line-1 was 50% reduced in LPD or HPD testis 
relative to control NPD, and this change was significant (P≤0.05). 
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Fig 5.8: Expression profile of Rnf17, c-Myc, Mxd3 and Line-1 in mouse 
E17.5 foetal testis in response to maternal LPD, HPD and control NPD.  
Mouse testes were collected from mothers fed LPD, HPD or control NPD 
from day of plug E0.5 until day of dissection E17.5.  Relative expression 
represent normalisation of examined gene to the geometric mean of two 
reference genes; Mapk1 and Tbp.  Bar graphs show means of examined 
samples (n=9 foetal testes from 8 different mothers per dietary group), and 
error bars represent standard error of mean. 
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5.3.4 Effect of maternal LPD or HPD on subcellular 
localisation of RNF17 through preimplantation 
development 
Mouse embryos were collected at 4-cell, 8-cell and blastocyst stages from 
mothers fed control, LPD or HPD from day of plug, immunolabelled with anti-
RNF17 and the nuclei were stained with DAPI and examined with SP5 
confocal microscopy.  The numbers of examined embryos are shown in 
Table 5.4. 
Figure 5.9 shows that RNF17 was prominently nuclear in all diet groups with 
no difference from the expression pattern shown in Chapter 4.  RNF17 was 
exclusively nuclear and not present in the cytoplasm of 4-cell and 8-cell 
embryos derived from the maternal LPD group.  4-cell and 8-cell embryos 
derived from the maternal HPD group showed a very weak signal for RNF17 
in the cytoplasm.  However, nuclear RNF17 was more punctate in LPD 
embryos than in HPD embryos.  It was noted that the signal obtained for anti-
RNF17 was not consistent in embryos from LPD mothers compared to those 
from HPD mothers. 
 
 
 
Table 5.4: Number of embryos immunostained per dietary group. 
 
  LPD  HPD 
4-cell  4 embryos from 3 mother   4 embryos from 2 mothers 
8-cell  8 embryos from 4 mothers  4 embryos from 3 mothers 
Blastocyst  5 embryos from 3 mothers  7 embryos from 4 mothers 203 
 
 
 
Fig 5.9 (continued) 
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Fig 5.9: Comparison between subcellular localisation of RNF17 in 
cleavage stage embryos in response to maternal HPD or LPD.  Mouse 
embryos from mothers fed HPD or LPD were collected at 4-cell, 8-cell, and 
blastocyst stages.  Embryos were immunolabelled with anti-RNF17 and 
nuclei stained with DAPI.  RNF17 is predominantly nuclear at all stages.  
RNF17 was seen in the cytoplasm of 4-cell and 8-cell HPD embryos but not 
LPD embryos.  No differences were seen in RNF17 distribution in the 
nucleus or the cytoplasm of HPD or LPD embryos.   205 
 
5.3.5 Effect of maternal LPD or HPD on subcellular 
localisation of RNF17 in E17.5 foetal testes 
The morphology of E17.5 mouse foetal testis was identified by staining 
cryostat sections of foetal E17.5 dissected from mothers fed chow with 
Haematoxylin and Eosin (H & E) and compared to stained sections with anti-
RNF17.  Figure 5.10 shows that germ cells termed prospermatogonia at this 
stage were surrounded by Sertoli cells and formed the testis cord embedded 
within the interstitial tissue of the testis. 
A very weak signal for RNF17 in the nuclei of prospermatogonia was 
observed.  However, RNF17 was highly expressed in foci-like structures in 
the nuclei of somatic cells of Sertoli cells and epithelial cells of the interstitial 
tissues (Fig 5.11).  This revealed no effect of maternal LPD or HPD on 
subcellular localization of RNF17 in E17.5 foetal testes compared to maternal 
control NPD.   
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Fig 5.10: Foetal mouse testis morphology.  Cryostat sections (6 µm) from 
mouse E17.5 testis collected from mothers fed chow from day of plug E3.5 
until day of dissection E 17.5.  The section shows a number of 
Prospermatogonia (SG) surrounded by Sertoli cells (SC) forming Testis cord 
(TC) into Interstitial tissue (IT).  (A) Immunostaining localization of RNF17 in 
nuclei of Sertoli cells stained with (a) anti-RNF17 and (b) merged image of 
anti-RNF17 and DAPI.  (B) H & E staining showing morphology of foetal 
testis displaying blue stain of nuclei with haematoxylin, and pink stain of the 
cytoplasm and extracellular matrix with eosin. 207 
 
 
 
 
Fig 5.11 (continued) 
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Fig 5.11 (continued) 
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Fig 5.11: Subcellular localisation of RNF17 in E17.5 foetal testis in 
response to maternal LPD, HPD and control NPD.  Cryostat sections (6 
µm) of E17.5 mouse testis collected and stained with anti-RNF17 and nuclei 
stained with DAPI.  No differences were seen in RNF17 localisation among 
diet groups (A) NPD control, (B) LPD and (C) HPD.  Strong signal for RNF17 
is evident in nuclei of Sertoli cells (SC) within foci-like structures, whereas 
Prospermatogonia (PG) gained a very weak signal for RNF17.   
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5.4  Discussion 
In this Chapter, for the first time the expression of Rnf17 mRNA and RNF17 
protein in mouse foetal testis was examined.  In this chapter, also the effect 
of maternal protein diets on expression of Rnf17 mRNA and RNF17 protein 
were investigated in the preimplantation embryo and foetal testes.  Although 
these results showed no significant effect of maternal LPD or HPD on the 
expression of Rnf17 mRNA in the blastocyst, the expression of Rnf17S 
mRNA was significantly increased in foetal E17.5 testes derived from 
mothers fed LPD compared to control NPD.  There was no effect of maternal 
LPD or HPD on the expression or localisation of RNF17 proteins in blastocyst 
or foetal testes.   
Using RT-qPCR, Figure 5.5 shows that expression of Rnf17S and Rnf17L 
was not significantly different in blastocysts between treatment groups of 
LPD and HPD relative to control NPD.  No effect of maternal diets was seen 
in the expression and subcellular localisation of RNF17 in mouse blastocysts.  
Rnf17 is a male germ-specific gene (Pan et al, 2005), thus, embryo sexing 
was applied to find out whether the effect of maternal protein diets on the 
expression of Rnf17 is sex-dependent.  Embryo sexing results (Fig 5.7) 
revealed that Rnf17S was more sensitive to maternal diet in male than in 
female blastocysts in the HPD group compared to LPD and control NPD 
groups.  However, c-Myc expression was significantly reduced in male, 
compared to female, blastocysts derived from maternal LPD compared to 
HPD and control groups, indicating that c-Myc was more sensitive to 
maternal LPD in the male blastocyst.  It is important to highlight here that the 
number of male blastocyst was not equal to female blastocysts in HPD 
group, thus no direct comparison can be made between sexes within this 
group.   
Previous studies showed that male blastocysts develop faster than female 
blastocysts.  The more quickly developing blastocyst is more sensitive to the 211 
 
environment in terms of proliferation and they need to protect themselves 
against environmental changes in order to maintain their rate of proliferation 
(reviewed in Erickson, 1997).  These findings are not consistent with our 
results which revealed decreased c-Myc mRNA, that heterodimerised with 
max to promote transcription and proliferation (Grandori et al, 2000).  One 
explanation is that c-Myc mRNA is measuring the effect of maternal diets on 
the transcriptional level which indicates the changes in steady state level of 
mRNA.  Thus, we need to measure protein levels to explain any contrary 
results, specifically that no differences between ICM and TE in expression 
and localisation of RNF17 protein was seen between the diet groups (Fig 
5.9). 
The sensitivity of the embryo to the environment has been explained by the 
DOHaD hypothesis, which proposes that changes in the embryo environment 
including, maternal diets or in vitro culture, may alter gene expression during 
embryo growth and affect adult later-life (Barker & Osmond, 1986; 
Barker,2000; Langley-Evans, 2006).  It has been reported that there is a 
short-term effect on expression of Rnf17 in mouse blastocyst exposed to 
environmental changes including embryo culture (Giritharan et al, 2007) or 
maternal LPD (Papenbrock et al, unpublished data).  However, our results 
implicated that there is no effect of maternal protein diets on expression of 
male germ-specific gene, specifically Rnf17.   
The expression of Mxd3 was very low in the mouse blastocyst as explained 
in Chapter 4.  Therefore, a five pooled blastocysts were considered as single 
embryo for each examined RT-qPCR cycle.  Together, the low expression of 
Mxd3 with non-affected expression of Rnf17 and c-Myc, within the treatment 
and control diet groups, revealed the interplay between Mxd and Rnf17 in 
modulating c-Myc to regulate embryo proliferation and differentiation under 
restricted environmental conditions.   212 
 
RT-qPCR showed that the expression of Rnf17 was induced in foetal testes 
in response to maternal protein diets, with a significant increase of Rnf17S in 
LPD group compared to control NPD.  However, the expression of c-Myc 
was reduced in foetal testes from maternal LPD and HPD groups compared 
to control NPD (Fig 5.8).  Maternal LPD has shown to induce adaptive 
responses in the blastocyst extra-embryonic region (extra-embryonic yolk 
sac) to protect foetal and postnatal growth (Watkins et al, 2008a).  A 
significant increase in the expression of Rnf17S in the LPD group compared 
to the control NPD in E17.5 testes may implicate adaptive responses 
induced in primordial germ cells by maternal LPD to protect the 
differentiation and development of foetal gonads.   
Immunostaining results in Figure 5.10 show that RNF17 was expressed in 
Sertoli cells with a very weak signal for RNF17 in prospermatogonia.  No 
effect of maternal diets was seen in the expression and localisation of RNF17 
protein in foetal testes.  However, the expression of RNF17 protein detected 
in cytoplasmic nuage in the germ cells of mouse adult testis is stage 
dependent (Pan et al, 2005).  The expression of RNF17 protein was 
described as stage dependent, of which RNF17L is expressed in 
spermatocyts, whereas RNF17S is expressed in spermatids.  These findings 
suggest that the expression of RNF17 isoforms is not continued through 
germ cell development and differentiation and may explain why there is 
expression of RNF17 in foetal testis somatic cells but not in germ cells.   
It is important to explain here, that although Rnf17 mRNA is expressed in 
foetal testis, the RT-qPCR was applied to the whole tissue of foetal testis 
including both somatic and germ cells.  Therefore, it is important to examine 
Rnf17 mRNA expression in separated testis cells.  This would give insight to 
the level of expression in each cell type as well as highlighting the function of 
Rnf17 in gonad development throughout foetal growth.   213 
 
Another possibility to explain the expression pattern of RNF17 in foetal testes 
cells would relate to the cell cycle status of differentiated germ cells.  After 
germ cell differentiation at E13.5, female germ cells enter meiosis, whereas 
male germ cells (spermatogonia) undergo mitotic arrest and resume meiosis 
after birth at round 10 days postpartum (Desjardins and Ewing, 1993).  This 
is consistent with our results in Chapter 4 that RNF17 is not expressed in 
mitotic divided cells either in preimplantation embryos or in F9 cells.  
Therefore, as shown in our results, it is expected that RNF17 is not 
expressed in spermatogonia during mitotic arrest but resumed after birth 
(Pan et al, 2005).   
Immunoprecipitation of RNF17 with MIWI in mouse adult testes (Vagin et al, 
2009) suggested a role of Rnf17 in the silencing of transposons.  However, 
the expression of RNF17 in Sertoli cells does not support this suggestion.  
Mutant Tdrd6 has no function in control transposons but has altered the 
expression of pre- and pri-forms of miRNAs (Vasileva et al, 2009).  piRNAs 
were not detected in mouse testis somatic cells, including Sertoli cells 
(Beyret and Lin, 2011), but studies have shown the expression of miRNAs in 
Sertoli cells and that they are targets of Sox9 (SRY-box containing gene 9) in 
foetal and adult testes.  For example, in foetal testes, pri-miR-202 is directly 
regulated by transcriptional factor Sox9 in the Sertoli cells of mouse foetal 
testes for male sex differentiation and testis development (Wainwright et al, 
2013).  miR-22 is involved in repressing oestrogen signalling within ovine 
foetal testes to induce testis differentiation (Torley et al, 2011).  In postnatal 
mouse testes a number of miRNAs are expressed in Sertoli cells, and 
function in androgen signalling for germ cell differentiation and development 
during spermatogenesis (Panneerdoss et al, 2012). 
Together with Pan’s results, it is speculated that RNF17 has a different 
expression pattern within germ cell tissues through development.  The 
expression of RNF17 in all germ cells in adult testes has a function in 214 
 
spermiogenesis, whereas the expression of RNF17 in Sertoli cells of foetal 
testis may be associated with the nuclear transcription factor Sox9 (Nel-
Themaat et al, 2009; reviewed in Park and Jameson, 2005).  This suggests a 
role of Rnf17 through Sox9 and it may target a miRNA for testis 
development, or endocrine signalling for germ cell differentiation.  
Additionally, the significant reduction of Line-1 in diet foetal testis, with 
equivalent effects of LPD and HPD (50%) compared to the control NPD, 
indicates the effect of maternal diets, but not Rnf17, on the expression of 
line-1 in foetal testes. 
In conclusion, our results revealed that there were no effects of maternal 
protein diets on the expression of Rnf17mRNA or RNF17 protein in mouse 
blastocyst or foetal testes.  There was no interaction between maternal 
protein diets and sexes at the preimplantation stage in terms of Rnf17 
expression.  However, foetal testes were sensitive to maternal LPD that gave 
a significantly induced expression of Rnf17.  Maternal LPD and HPD reduced 
the expression of c-Myc mRNA in foetal testes with early effect of maternal 
LPD on the male blastocyst.  RNF17 protein is predominantly localised in the 
nuclei of foetal testes somatic cells.  The RNF17 protein signal was weakly 
detected in mitotically arrested spermatogonia of foetal testes, confirming 
previous results in Chapter 4 that RNF17 is not expressed in mitotic cells.   
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6.  The Potential Function of Rnf17 in Mouse 
Blastocyst Development 
6.1 Introduction 
The function of Rnf17 has been studied in adult mouse testis but not in early 
embryo development.  Over-expression of Rnf17 enhances Myc activities by 
sequestering Mxd in in vitro models (Yin et al, 1999).  Pan et al (2005) 
showed that mutant Rnf17 mice (Rnf17–/–) developed normally, however, 
Rnf17–/– males are infertile, but females exhibit normal fertility and produce 
normal litter sizes.  In Chapter 3, the over-expression of Rnf17 plasmid 
induced Luciferase activity of c-Myc reporter gene in co-transfected F9 cells.  
Here, Rnf17 knockdown will be studied. 
The application of RNA interference in mammals has the potential to allow 
the efficient knockdown of specific genes and enables phenotypic 
characterisation in the absence of gene function.  RNA interference (RNAi) is 
a gene silencing mechanism through homologous short interfering RNA 
(siRNA), which elicits the destruction of corresponding mRNAs by the RNA-
induced silencing complex (RISC).  The siRNA expressing short hairpin 
RNAs (shRNA) can either be added to the cells exogenously or produced 
intracellularly from plasmid DNA templates (Agrawal et al, 2003).  In the 
RNAi reaction, the cellular RNase III enzyme, Dicer, cleaves the dsRNA into 
smaller multiple trigger molecules, siRNA, each of about 21–25 bps, that 
become incorporated into the RISC.  This complex pairs, via Watson-Crick 
base pairing, with the homologous mRNA in a sequence-specific manner.  
This then leads to the degradation of the target mRNA and a subsequent 
decrease in the encoded protein (Agrawal et al, 2003). 
6.1.1 Aim of experiment 
The aim of this experiment is to investigate the role of Rnf17 in modulating c-
Myc and subsequently in cell proliferation.  Rnf17 was down regulated by RNA 
interference  (RNAi)  technology  in  F9  cells  using  Rnf17-directed  siRNA 218 
 
expression plasmids.  Results were measured by Luciferase activity of Rnf17-
sensor plasmid (as explained in the methods) to determine the specificity of 
targeting Rnf17 in F9 cells. 
The second aim is to examine the role of Rnf17 in cell proliferation and embryo 
development in the preimplantation period.  Rnf17 was knocked down by a 
short interference (siRNA) oligonucleotide microinjection technique in mouse 
embryos at zygote or 2-cell stage.  Embryo development was estimated by the 
percentage  of  Rnf17  knockdown  by  RT-qPCR  and  by  evaluating  embryo 
developmental stage on day-3 post microinjection.   
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6.2 Methods 
6.2.1 RNA interference and cell transfection 
An Rnf17-sensor was produced to be inserted into pGL3-control for the 
selected target sequence AACTCAGATCTGCTCCTTCTC.  Rnf17 wild type 
(Rnf17-RNAi-wt) or a non-targeting negative control for RNAi Rnf17 mutant 
(Rnf17-RNAi-mut) were prepared to be inserted into pSilencer™ 1.0 U6 
vector.  Prepared constructs were dose-dependent transfection into F9 cells 
or Raw 264.1 murine macrophage cells.   
6.2.2 Production of expressing vectors for Rnf17-RNAi 
Annealed sense and antisense for mutant or wild type RNAi oligonucleotides 
were ligated to linearised pSilencer™ 1.0 U6 (pSil) (Fig 6.1A).  Following 
transformation, extracted DNA plasmids were single cut with BamHI to 
confirm the insertion of the 60 bp RNAi template insert.  There were two sites 
of BamHI in the pSilencer™ 1.0 U6 of 376 bp in which the RNAi template 
was inserted.  Figure 6.1B & C showed a dropped band of about 400 bp 
which represent the insertion of the RNAi oligonucleotides between the 
BamHI sites.   
A single cut with HindIII was also performed to confirm that the region 
between the ApaI and the EcoRI had been replaced by the Rnf17-RNAi 
inserts.  Figure 6.2 showed that Rnf17-RNAi did not cut with HindII 
confirming its replacement with the RNAi insert.   
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Fig 6.1 (continued) 
(A) 
(B) 
(C) 221 
 
Fig 6.1: Preparing of Rnf17-RNAi expressing constructs.  Annealed 
oligonucleotides for wild type and mutant Rnf17-RNAi were diluted to 4 and 
20 ng/µl and ligated into the linearised pSilencer™ 1.0 U6.  The cut plasmids 
dropped a band of 400 bp represent the size between two sites of BamHI in 
the pSilencer (376 bp) and the ligated insert (60 bp).  Clones not drop a band 
confirm no template inserted. 
(A) Uncut DNA plasmids of 4 clones of each dilution of Rnf17-RNAi-wt 
(Lane 1-8) and Rnf17-RNAi-mut (Lane 9-16) shows different sizes of 
plasmid.  Clones number 2 and 11 were running faster suggesting no insert.   
(B) Single cut with BamHI for Rnf17-RNAi-wt (Lane 1-8) compared to a cut 
pSilencer™ 1.0 U6 (pSil). 
(C) Single cut with BamHI for Rnf17-RNAi-mut (Lane 9-16) compared to cut 
pSil (Lane 17) and uncut pSil (Lane 18).   
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Fig 6.2: Single cut for Rnf17-RNAi expressing constructs with HindIII.  
DNA plasmids for (A) Rnf17-RNAi-wtand (B) Rnf17-RNAi-mut expressing 
plasmids shows no cut with HindIII, and confirming the insertion of Rnf17-
RNAi templates between ApaI and EcoRI sites which include the HindIII 
site.  The results were compared to cut and uncut pSil in (B).  Clones 
number 2 (A) and 11 (B) show different sizes compared to the pSil, and 
indicating no insertion of Rnf17-RNAi templates.  1kb: DNA ladder 
(Invitrogen). 
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6.2.3 Production of Rnf17-sensor construct 
Annealed sense and antisense oligonucleotides for Rnf17 sensor were 
ligated into linearisedpGL3-Control vector.  Following transformation, 
extracted DNA plasmids were single cut with EcoRI or EcoRV to ensure the 
insertion of Rnf17-sensor template.  The results showed a cut with EcoRI but 
not EcoRV, which is located upstream the Pstl (Fig 6.3). 
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Fig 6.3: Rnf17-sensor construct.  (A) Extracted DNA plasmids of Rnf17-
sensor template were single cut with EcoRV or EcoRI to confirm the 
insertion.  Rnf17-sensors construct was linearised with EcoRI but not 
EcoRV compared to single cut of pGL3-control with EcoRV or EcoRI.  (B) 
Schematic diagram for restriction map of the modified pGL3-Control 
showing the insertion of the Rnf17-sensor. 
  Lane1: Rnf17-sensor cut with EcoRV 
  Lane2:Rnf17-sensor cut with EcoRI 
  Lane3: uncut Rnf17-sensor 
  Lane4: pGL3-control cut with EcoRV 
  Lane5: pGL3-control cut with EcoRI 
  Lane6:uncut pGL3-control 
  1kb: DNA ladder (Invitrogen) 
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6.2.4 Microinjection of Rnf17_siRNA into mouse embryo 
Microinjection was performed using oligonucleotide sequences for Rnf17 
(Rnf17_siRNA) or a negative control siRNA sequence (AllStar_siRNA) 
designed by the manufacturer (QIAGEN, UK).  Rnf17_siRNA were injected 
individually into embryos collected from superovulated female FVB/N mice.   
Rnf17 knockdown was determined in microinjected embryos by RT-qPCR.  
RNF17 protein expression following embryo microinjection was evaluated by 
immunostaining using anti-RNF17.  Table 6.1 shows number of embryos 
examined by immunostaining.   
6.2.5 Quantitative real-time PCR (RT-qPCR) 
Microinjected embryos were examined by RT-qPCR.  The level of 
knockdown was calculated by normalising the Ct value of siRNA-
microinjected and siRNA-negative control embryos to the Ct value of the 
reference gene; Tuba-1-α (delta Ct; dCt).  The dCt value of siRNA-
microinjected was then normalised to the dCt of siRNA-negative control 
(delta delta Ct; dtdtCt) to calculate the change in the expression of the 
Rnf17_siRNA injected embryo compared to the negative control.  
Statistically, data collected are primary data and a significance test was not 
run.  The experiment was performed with error bars representing the 
standard deviation of biological duplicate of Ct values of four embryos 
analysed within four RT-qPCR cycles at different times.  Table 6.1 shows 
number of embryos examined by RT-qPCR.   
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Table 6.1: Number of embryos examined by RT-qPCR or 
Immunostaining following Rnf17_siRNA or control microinjection  
  RT-qPCR    Immunostaining 
AllStar_siRNA 
4 embryos from 4 
mothers 
20 embryos from 4 
mothers 
Rnf17_siRNA_1 
4 embryos from 4 
mothers 
10 embryos from 3 
mothers 
Rnf17_siRNA_2 
4 embryos from 4 
mothers 
13 embryos from 3 
mothers 
Rnf17_siRNA_3 
4 embryos from 4 
mothers 
7 embryos from 2 
mothers 
Rnf17_siRNA_4 
4 embryos from 4 
mothers 
4 embryos from 2 
mothers 227 
 
6.3 Results 
6.3.1 Rnf17-RNAi expressing constructs target Rnf17-sensor 
at low concentration in F9 cells 
Rnf17-RNAi-wt or Rnf17-RNAi-mut were co-transfected together with a 
constant amount of Rnf17-sensors (0.5 µg) into Raw264.7 cells, as a control 
experiment, and F9 cells.  The total amount of DNA was normalised to 2 µg 
with pUC plasmid (empty vector).   
Figure 6.4A shows that in the Raw cells, Luciferase activity of the Rnf17-
sensor significantly increased with 0.5 µg Rnf17-RNAi plasmid (P≤0.05) in 
response to the mutant RNAi expressing construct compared to the control 
untreated cells (0.0 µg Rnf17-RNAi).  Increasing the concentration of the 
Rnf17-RNAi expressing plasmids (1.0 µg) significantly reduced (P≤0.05) 
Luciferase activity of the Rnf17-sensor 4-fold in response to Rnf17-RNAi-wt 
plasmid compared to the control.   
Introducing Rnf17-RNAi expressing plasmids (wild and mutant types) into F9 
cells at 0.5 µg concentration was not able to inhibit the Luciferase activity 
from the Rnf17-sensor.  Luciferase activity for Rnf17-sensor was significantly 
increased 3-fold in response to Rnf17-RNAi-wt plasmid and 4-fold in 
response to Rnf17-RNAi-mut plasmid compared to the control (P≤0.05).  
Increasing the concentration of the Rnf17-RNAi expressing plasmids to 1.0 
µg decreased Luciferase activity of the Rnf17-sensor in response to Rnf17-
RNAi-wt and Rnf17-RNAi-mut plasmids compared to the 0.5 µg 
concentration, however Luciferase activity was still higher than the control 0.0 
µg Rnf17-RNAi (Fig 6.4B). 
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Fig 6.4 (continued) 
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Fig 6.4: Effect of Rnf17-RNAi expressing plasmids on Luciferase 
activity of the Rnf17-sensor in transfected cells.  (A) Raw cells and (B) 
F9 cells were transfected with a constant amount of Rnf17-sensors (0.5 µg) 
together with 0.5 µg or 1.0 µg of Rnf17-RNAi-wt or Rnf17-RNAi-mut 
expressing plasmids.  In Raw cells, Luciferase activity of Rnf17-sensors 
significantly induced at 0.5 µg concentration of Rnf17-RNAi-mut plasmids, 
whereas in F9 cells Luciferase activity is significantly induced at 0.5 µg of 
Rnf17-RNAi-wt and Rnf17-RNAi-mut (*; P≤0.05).  Bar graphs show mean of 
three replicates and error bars represent standard deviation.   230 
 
6.3.2 Efficiency level of Rnf17 knockdown in Rnf17_siRNA 
microinjected embryos. 
Using RT-qPCR, the mean Ct values of two biological replicates for four 
replicate experiments of Rnf17_siRNA were normalised to the reference 
gene (Tuba-1-α) and then to the negative AllStar_siRNA.  siRNA was 
injected into 2-cell stage embryos.  The level of Rnf17 knockdown varied 
between the four Rnf17_siRNA oligonucleotides.  Rnf17_siRNA_4 was about 
80% efficient in knocking down Rnf17 expression in the mouse embryo 
compared to the negative control (AllStar_siRNA), whereas the efficiency of 
Rnf17_siRNA_1 and Rnf17_siRNA_3 were the lowest in knocking down 
Rnf17 and ranged between 48 to 50% (Fig 6.5). 
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Fig 6.5: The efficiency of Rnf17_siRNA to knockdown Rnf17 in mouse 
blastocyst using RT-qPCR.  2-cell stage embryos were microinjected with 
different siRNA sequences targeting Rnf17 (Rnf17_siRNA_1 to _4).  
Injected embryos were in vitro cultured for 3 days before analysed for 
expression level of Rnf17.  All Rnf17_siRNA were able to knockdown Rnf17 
in mouse embryo with more than 80% efficiency for Rnf17_siRNA_4 
sequence.  Relative expression of Rnf17 was normalised to negative control 
injected embryos (dtdtCt).  Bar graphs show mean of dtdtCt of examined 
embryos (Table 6.1) and error bars represent standard deviation.   232 
 
6.3.3 RNF17 protein expression 
Embryos of the 2-cell stage were microinjected and cultured in vitro for three 
days post-injection.  RNF17 expression was reduced in Rnf17_siRNA 
compared to the negative control (AllStar_siRNA) microinjected embryos (Fig 
6.6 A-E).  Embryos microinjected with Rnf17_siRNA_4 (Fig 6.6E) displayed a 
weak RNF17 signal compared to the embryos injected with other 
Rnf17_siRNA.  No effect of Rnf17 knockdown was seen in nuclear 
localisation of RNF17 in all injected embryos with different Rnf17_siRNA 
oligonucleotides (Fig 6.6).   
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Fig 6.6 (continued) 234 
 
 
 
 
Fig 6.6: Expression and subcellular localisation of RNF17 in Rnf17 
knockdown embryos.  2-cell stage embryos were microinjected with (A) 
AllStar_siRNA, (B) Rnf17_siRNA_1, (C) Rnf17_siRNA_2, (D) 
Rnf17_siRNA_3 or (E) Rnf17_siRNA_4.  Injected embryos were in vitro 
cultured for 3 days before immunostained with anti-RNF17.  Embryo 
injected with Rnf17_siRNA_4 display faint signal for RNF17 compared to 
other Rnf17_siRNA embryos. 
 Left panels: staining of the nuclei with DAPI 
 Middle panels: RNF17 signal 
 Right panels: overlays (merge) of the two signals 
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6.3.4 Embryo development 
Embryo development was assessed on day 3 post-injected embryos at the 
zygote and at the 2-cell stage.  No significant differences were seen in 
embryo morphology within injected embryos.  However, embryos injected at 
zygote stage were able to develop to blastocyst (cell number >30 cells), 
whereas embryos injected at 2-cell developed to the compacted stage of the 
morula (cell number <15 cells) or early blastocyst (>25 cells) on day 3 post-
injection. 
55% of embryos microinjected with Rnf17_siRNA_4 at the zygote stage were 
able to develop into blastocysts compared to 60% embryos injected with 
AllStar_siRNA or 65% non-injected embryos (Fig 6.7A).  Embryos injected 
with Rnf17_siRNA_4 at 2-cell stage showed about 9% of embryos 
developing to blastocysts and 90% developing to morula compared to, 65% 
blastocyst and 35% morula with AllStar_siRNA, and 76% blastocyst and 23% 
morula for non-injected embryos (Fig 6.7B). 
The cell number was counted, on day 3 post-injection of 2-cell embryos, by 
counting nuclei labelled with DAPI in immunostaining method.  Embryos 
injected with Rnf17_siRNA_4 or AllStar_siRNA developed to the compacted 
morula stage, with cell a number of less than 15 cells.  Those embryos had a 
reduced cell number compared to the morula stage of non-injected embryos.  
However, there were no significant differences between embryos injected 
with Rnf17_siRNA_4, which showed about 13 cells, and embryos injected 
with negative control AllStar_siRNA which showed about 15 cells (Fig 6.8). 
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Fig 6.7 (continued) 
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Fig 6.7: Percentage of embryo development on day 3 post-
microinjection with Rnf17_siRNA_4.  Embryos microinjected with 
Rnf17_siRNA_4 or negative control AllStar_siRNA at (A) zygote or (B) 2-
cell stage were in vitro cultured for three days.  Non-injected embryos were 
in vitro cultured as negative control.  Embryos injected at 2-cell stage with 
Rnf17_siRNA_4 delayed development to early blastocyst compared to 
those injected at zygote stage. 
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Fig 6.8: Rnf17 knockdown reduced embryo cell number.  Microinjected 2-
cell embryos with Rnf17_siRNA_4 or negative control AllStar_siRNA 
developed to compacted morula stage and were reduced cell number 
comparing to morula of non-injected embryos.  Bar graphs show mean of cell 
number of microinjected embryos (n) and error bars represent standard 
deviation.   239 
 
6.4 Discussion 
In this chapter the potential function of Rnf17 in the development and growth 
of preimplantation embryos was investigated by RNA interference 
techniques.   Our results revealed that Rnf17 knockdown reduced the 
embryo cell number and may have the potential to delay embryo 
development.   
In Chapter 3 and 4 our results revealed that expression of Rnf17 in F9 cells 
and the preimplantation embryo were equivalent, and thus F9 cells provided 
a useful model for the study of expression and function of Rnf17 during 
embryo development.  Here, F9 cells were transfected with a U6 promoter 
plasmid coding for an RNA composed of two identical 19-nucleotide 
sequence motifs in an inverted orientation, separated by a 9- base pair 
spacer to form a hairpin dsRNA (Elbashir et al, 2001) capable of mediating 
target Rnf17 inhibition.  Transient transfected cells showed a decreased level 
of Luciferase activity of the Rnf17 sensor.  Rnf17-RNAi expression plasmids 
were capable of inhibiting the Rnf17-sensor at high concentration (1.0 µg) in 
raw cells as a control experiment.  However, this response was not seen 
within F9 cells.  The Luciferase activity of the Rnf17-sensor increased on 
introducing the Rnf17-RNAi expressing plasmid in F9 cells.  By increasing 
the dose of Rnf17-RNAi expressing plasmid, Luciferase activity of the Rnf17-
sensor was reduced but not below the control level.  Introducing a mutant 
sequence for Rnf17-RNAi induced Luciferase activity of the Rnf17-sensor, 
indicating that Rnf17-RNAi-mut is not compatible with the target sequence of 
the Rnf17-sensor.   
In a biological experiment, Rnf17_siRNA oligonucleotides were microinjected 
into zygote or 2-cell embryos.  Rnf17_siRNA effectively reduced levels of 
mRNA and protein RNF17 in microinjected embryos.  Rnf17_siRNA 
microinjected into 2-cell embryos showed delayed embryo development, 
indicating a reduction in embryo proliferation.  Rnf17 knockdown at 2-cell 
stage reduced the embryo cell number, although no significant reductions in 240 
 
cell number were seen between the Rnf17_siRNA and negative control 
(AllStar_siRNA) microinjected embryos. 
Injected embryos at zygote were 6-fold more developed to the early 
blastocyst than those injected at the 2-cell stage.  This may suggest that 
Rnf17_siRNA would not target or perturb the potential involvement of 
maternal Rnf17 in blastocyst development, but would target transcribed 
Rnf17 mRNA from the embryonic genome (Hamatani et al, 2004).  The 
delayed development of the blastocyst and reduced signal of RNF17 protein 
in Rnf17_siRNA injected embryos indicates that the reduction in Rnf17 
mRNA was sufficient to inhibit the expression of RNF17 protein.  This is 
consistent with the level of cells per embryo stained with anti-RNF17 as seen 
in Figure 6.6, which also indicates that not all cells within single embryos had 
Rnf17-knockdown.  For Rnf17_siRNA_1 and Rnf17_siRNA_2, about 40% of 
cells per embryo were labelled with anti-RNF17.  In the case of embryos 
injected with Rnf17_siRNA_3, about 60% of cells per embryo did not gain an 
anti-RNF17 signal, whereas those injected with Rnf17_siRNA_4 were 
completely (about 90%) without the anti-RNF17 signal.   
Rnf17 knockdown further suggests that Rnf17 is required during the early 
embryonic stages following embryonic genome activation and suggests a 
role for Rnf17 in the development of mouse blastocysts.  However, there is 
the possibility of the effect of experimental procedure on the expression of 
Rnf17, such as mouse superovulation or embryo culture.  Microarray analysis 
revealed that Rnf17 is differentially regulated at large antral follicles isolated 
from superovulated female mice and cultured in vitro to meiotic competence 
(Pan et al, 2005).  Also Rnf17 has been shown to be differentially regulated 
following IVC or IVF cultured mouse embryos compared to in vivo cultured 
(Giritharan et al, 2007).  These findings may explain variabilities in the non-
injected embryo development percentages in Figure 6.7 241 
 
In c-Myc mutant mice, the complete loss of c-Myc function blocks the 
proliferation of isolated mouse embryonic fibroblasts (MEFs) at E9.5 (Trumpp 
et al, 2001).  In the same study, for some organs (thymus, spleen, lymph 
nodes and bone marrow) the organ/body weight ratio was reduced and 
consequently had a decreased cell number in those organs (Trumpp et al, 
2001).  Our results showed that Rnf17 knockdown reduced the cell number in 
mouse embryos, therefore, it would be interesting to examine the expression 
of c-Myc in those embryos and also whether the knockdown of c-Myc 
compromises the expression level of Rnf17.  In both experiments for Rnf17 
knockdown, only the efficiency of Rnf17 knockdown was investigated in cells 
co-transfected with Rnf17-RNAi and mouse microinjected embryos with 
Rnf17_siRNA.  Further studies would be important in quantifying the levels of 
mRNA and protein for Rnf17 and c-Myc in Rnf17 or in c-Myc knockdown 
embryos.  This might give insight to the function of Rnf17 in embryo 
development and cell proliferation.   
In summary, down regulation of Rnf17by siRNA technology decreased cell 
proliferation in the preimplantation embryo.  However, no specific knockdown 
was a achieved in transfected F9 cells with Rnf17-RNAi plasmids.  Further 
experiments to investigate cell proliferation and protein level are required to 
answer the question whether the endogenous Rnf17 in F9 cells might provide 
a sink to mop up the Rnf17-RNAi plasmids, so that it is not targeting the 
Rnf17-sensor.  Our data also provide considerable results to suggest that 
Rnf17_siRNA could potentially be an experimental approach to identify a role 
for Rnf17 in cell proliferation and/or embryo development.   
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7.  General Discussion 
The preimplantation period of embryo development is critical as stresses can 
effect embryo development and postnatal health.  Alterations to the in vitro 
or in vivo embryo environment can influence blastocyst proliferation and 
differentiation, gene expression and embryo morphogenesis which may 
contribute to long-term health and adult-onset disease.  The aim of this PhD 
was to study one particular gene: Rnf17 that contributes to the cell signalling 
network comprising Myc/Max/Mxd, and functions to regulate cell proliferation 
and differentiation.   
The function of Rnf17 in embryo development is elusive; however, over-
expression of Rnf17 in cell culture models enhances Myc activity by 
sequestering Mxd (Yin et al, 1999).  Using RT-qPCR our results showed that 
Rnf17 is expressed in the preimplantation embryo and its expression is 
increased from the 2-cell to blastocyst stages, consistent with previous 
Microarray studies (Zeng et al, 2004).  However, the expression level for 
Rnf17L was reduced compared with that from Rnf17S.  Rnf17 mRNA and 
protein were detected during the cleavage stages of mouse embryos from 2-
cell to blastocyst.  Raw data for Ct values for RT-qPCR revealed increased 
expression of Rnf17S, Rnf17L and c-Myc throughout embryo development 
consistent with the database that detected Rnf17 in pre- and post-
implantation embryo (Smith et al, 2012).  The increased expression for 
Rnf17 and c-Myc during embryo cleavage implicates the possibility that 
Rnf17 modulates c-Myc activity in preimplantation embryos.  This was 
shown in vitro in Chapter 3, that over-expression of Rnf17 expression 
construct induced Luciferase activity of c-Myc reporter construct in co-
transfected F9 cells. 
No significant effects of a maternal LPD or HPD were seen on the 
expression of Rnf17S, Rnf17L, c-Myc and Mxd3 in mouse blastocysts.  
Previous studies have revealed the effect of maternal LPD on embryo 246 
 
growth regarding gene expression and signalling pathways, for example, the 
mTOR (mammalian target of rapamycin) and eukaryotic initiation factor 2 
(eIF2) signalling pathways that control protein synthesis in response to 
nutrient availability.  Degradation of MXD1 and inducing activity of c-Myc 
target genes (Zhu et al, 2008; Chou et al, 2009), suggest a role for E3 ligase 
via ubiquatinylation pathway downstream of the mTOR pathway for embryo 
proliferation and growth.  Although expression of Mxd3 was very low in 
mouse blastocysts, the result revealed the interplay between Mxd and Rnf17 
in modulating c-Myc at preimplantation stages, under environmental 
conditions which could influence embryo proliferation and differentiation.   
The expression of Rnf17 is associated with the regulation of some of the 
genes which have been identified as c-Myc targets (Yin et al, 2001).  
Therefore, it is possible to suggest here that some of these target genes are 
subject to the same regulation by Rnf17 as they are by c-Myc.  It is also 
possible to interpret that Rnf17 down regulates the expression of 
endogenous c-Myc as a means of compensating for its pro-apoptotic activity 
(Yin et al, 2001).  However, over-expression of Rnf17 sequestering Mxd 
raises the possibility that Rnf17 may deplete the nucleus of Mxd proteins 
leaving other Mxd-interacting proteins free to interact with other nuclear 
partners.  Therefore, it is expected that over-expression of Rnf17 induces 
cell proliferation and apoptosis, under appropriate conditions, as is expected 
for cells with over-expressed c-Myc (Yin et al, 2001). 
RNF17 protein was identified in a yeast two-hybrid screen by its ability to 
interact with members of the MXD family, a transcriptional repressor of Myc 
target genes.  The RNF17-MXD member interaction causes the loss of DNA 
binding by MXD-MAX heterodimers (Yin et al, 1999; 2001).  Using the 
proteasome inhibitor MG132 and Western blotting RNF17 and MXD co-
expression causes the loss of both factors via the ubiquitinylation pathway.  
MXD1 protein is also a target protein for the oncogene c-IAP (Xu et al, 2007).  247 
 
However, serum induction in cultured cells induced MXD1 degradation by 
phosphorylation at Ser 145 by p90 ribosomal kinase (RSK) and by p70 S6 
kinase (S6K) independent of c-IAP (Zhu et al, 2008).  PI3/AKT is another 
kinase that phosphorylates MXD1 at Ser 145, which inhibits the repressor 
function of MXD1 by interfering with its DNA binding (Chou et al, 2009).  
Activation of RSK leads to the activation of mTORC1 and subsequently of 
S6K (Wang et al, 2001; Raught et al, 2004), whereas mutations that activate 
the PI3K pathways will stimulate the mTORC1–S6K pathway (Carriere et al, 
2008; Roux et al, 2004).  Both RNF17 and c-IAP proteins contain a RING 
motif and have the properties of a ubiquitin E3 ligase.  The two proteins 
possess similar mechanisms of MXD protein degradation, suggesting a 
common means of promoting cell proliferation and controlling Myc/Max/Mxd 
network associations.  However, it is possible to suggest that the RING finger 
domain of RNF17 may bind other targets, perhaps as part of a higher order 
complex, in association with MXD proteins within the RSK and S6K or 
PI3/Akt pathways.   
It is also possible that the degradation of MXD1 in serum-induced cells (Zhu 
et al, 2008; Chou et al, 2009) is mediated by RNF17 and thus suggests 
induced RNF17 expression under serum-culture conditions.  This supports 
our results in Chapter 5 that maternal diets do not interact with Rnf17 and 
thus that Rnf17 is differentially regulated by another mechanism in utero 
conditions or in vitro culture (Giritharan et al, 2007).  Rhox5 is expressed in 
reproductive tissues such as those of the testis, ovary and placenta and 
plays a role in controlling the development of these organs.  Rhox5 has been 
shown to be modified in mouse embryo cultured in KSOM media 
supplemented with foetal calf serum (FCS) (Fernandez-Gonzalez et al, 
2009).  Rhox5 has also been shown to be down regulated together with 
Rnf17 and other genes involved in germ cell development and fertility 
(including Dazl and Mvh) in Dppa4-deficient embryonic stem cells (Madan et 248 
 
al, 2009).  This may support our speculation that culture conditions 
differentially regulate Rnf17. 
Early compensatory responses of the embryo to poor diet increase 
trophectoderm cell number and enhance embryo proliferation (Eckert et al, 
2012).  To be consistent with these findings, further experiments are 
required to investigate the expression of RNF17 protein in extended embryo 
growth, and whether RNF17 is related to embryo proliferation at this stage.  
However, maternal LPD has been shown to induce adaptive responses in 
the blastocyst extra-embryonic lineage (visceral yolk sac) to protect foetal 
and postnatal growth (Watkins et al, 2008a).  RT-qPCR results, in Chapter 5, 
showed a significant increase in the expression of Rnf17S in E17.5 testes.  
Induced expression of Rnf17S in male germ gonadal tissues during de novo 
DNA methylation may implicate adaptive responses induced in primordial 
germ cells by maternal LPD to protect foetal gonad differentiation and 
development.  
Immunostaining results in Chapter 3 and Chapter 4 revealed that the RNF17 
protein is expressed in the preimplantation embryo and is predominantly 
nuclear with a low intensity level in the cytoplasm.  Detected endogenous 
RNF17 in F9 cells displayed a similar pattern to that seen within the mouse 
embryo.  The nuclear expression pattern of RNF17 in early embryo 
development or in F9 cells may suggest a role of RNF17 in the spliceosome 
complexes for pre-mRNA splicing.  Proteomic analysis of nuclear complexes 
of Hela cells revealed an interaction between CDC5L and RNF17 (Lleres et 
al, 2010).  CDC5L protein is required for the second catalytic step of pre-
mRNA splicing, and its complex with PLRG1 interacts with hn-RNP-M to 
modulate both the 5’ and 3’ alternative splicing processes (Ajuh et al, 2000). 
Interaction between Tudor domain-containing proteins and PIWI proteins is 
mediated by sDMA, which is brought about by protein arginine N-249 
 
methyltransferases such as PRMT5 (Arkov and Ramos, 2010).  The nuclear 
expression of Prmt5 at early mouse embryonic stages (Tee et al, 2010) 
together with that of RNF17 raises the possibility of an interaction between 
RNF17 and PRMT5 via sDMA to promote biological activities such as 
chromatin remodelling or transposon silencing in the preimplantation embryo. 
Another possibility for the nuclear expression of RNF17 protein is the 
presence of two bipartite NLS encoded within RNF17 isoforms (AceView) 
which revealed the ability of RNF17 to shuttle between the cytoplasm and the 
nucleus.  The results showing that RNF17 exhibits a punctate distribution in 
the nucleus and in the cytoplasm is consistent with the tendency of other well 
characterised RING finger proteins to display related behaviours.  For 
example, BRCA1 RING finger-containing is a tumour suppressor protein that 
associates with BARD1 to form a RING/RING heterodimer and functions as 
an ubiquitin E3 ligase.  The Ub-conjugating enzyme UbcH5c binds only to the 
BRCA1 RING domain and not the BARD1 RING (Brzovic et al, 2003).  Using 
immunostaining and proteasome inhibitor MG132 (Chapter 3), our results in 
Cos-1 cells revealed that RNF17 is shuttled between the cytoplasm and the 
nucleus in response to proteasome inhibition.  BRCA1 also contains nuclear 
exporting (NES) and localising (NLS) signals which allow it to co-localise to 
nuclear foci following interaction with RAD51, where DNA repair occurs after 
treatment with DNA damaging reagents (Rodriguez et al, 2000; Thakur et al, 
1997). 
It is important to note here that no differences were found in the expression 
and distribution of RNF17 between the inner cell mass and the 
trophectoderm, suggesting that RNF17 is expressed in both embryonic and 
extra-embryonic tissues and may be involved in germline development and 
differentiation.  This may support the immunostaining results that the 
expression of RNF17 in foetal E17.5 testes is expressed in the nuclei of 
Sertoli cells with weak signal in those of prospermatogonia.  Previously, 250 
 
Rnf17 was detected in mouse adult testes and localised to specific 
cytoplasmic structures, termed nuage, in all germ cells including 
spermatogonia, spermatocysts and spermatids (Pan et al, 2005).  RNF17 
can be Immunoprecipitated from adult testes with MIWI- a PIWI protein that 
is expressed after birth in mouse testes (Vagin et al, 2009; Beyret et al, 
2012), although Rnf17-/- mice had no effect on the expression of Miwi (Pan 
et al, 2005).  Additionally, the differentiation of somatic cells into germ cells 
from bone marrow (Nayernia et al, 2006) or embryonic stem cells (Lavagnolli 
et al, 2009) showed that Rnf17 is expressed as PGC marker (including 
fragilis, stella, Mvh and Oct4) but not those for spermatogonia or 
spermatogonial stem cells (such as Rbm, c-Kit, Tex18, Stra8, Mili, Dazl, 
Hsp90) (Nayernia et al, 2006), which supports our results that RNF17 is 
expressed in foetal Sertoli cells.  
In male gonads, Sertoli cells are differentiated between E11.0 and E13.5 
(Adams and McLaren, 2002; reviewed in Ross and Capel, 2005; McLaren, 
2003) and coincides with proliferation of transcriptional factors such as Sox9 
localised in the nuclei of the Sertoli cells (Nel-Themaat et  al, 2009; reviewed 
in Park and Jameson, 2005).  Studies showed expression of miRNA in 
mouse and bovine foetal and adult Sertoli cells and that these are involved 
in endocrine signalling for male sex differentiation and testis development 
(Wainwright et al, 2013; Torley et al, 2011; Panneerdoss et al, 2012).  This 
suggests that Rnf17 in foetal testes may function with transcriptional factors; 
such as Sox9, and with miRNA for endocrine signalling and testis 
development. 
In Chapter 6, preliminary experiments showed Rnf17 knockdown by siRNA 
could delay preimplantation development, suggesting a role for Rnf17 in 
embryo proliferation, although more work is needed.  Microinjection of mouse 
embryos with siRNA targeting Rnf17 reduced the cellular mRNA level of 
Rnf17 and the protein signal of RNF17 in mouse embryo blastocysts.  251 
 
Knockdown of Rnf17 in 2-cell embryo, at the time of zygotic gene activation, 
has the potential to delay blastocyst development.  However embryos were 
able to reach the blastocyst stage on day 3 post-injection which indicates that 
maternal Rnf17 mRNA and protein is not a storage pool for zygotic RNF17 
involved in embryo growth.   
Using Rnf17-RNAi construct, transfected F9 cells reduced the Luciferase 
activity of target construct for Rnf17 compared to the control.  It is possible 
that higher dose of RNAi constructs is targeting endogenous Rnf17 within 
transfected F9 cells.  Further investigation using Western blot to measure 
protein levels for RNF17 and c-Myc following stable transfection may assist 
in clearing up any ambiguities.  This is may be consistent with embryo 
microinjection results that 20 µM, but not 10 µM, of siRNA oligonucleotide 
was able to knockdown Rnf17.  Another possibility is that different proteins 
have different turnover rates in which stable proteins require a longer period 
of exposure to siRNAs to be knocked down (McManus and Sharp, 2002).  
Thus incubation of injected embryos with Rnf17_siRNA for 3 days reduced 
the expression of mRNA and protein signal for Rnf17.  Further repeats of this 
experiment is recommended to identify the long-term effects on embryo 
development for Rnf17 knockdown.   
In conclusion, our results for up- and down- regulation of Rnf17 support the 
role of Rnf17 in modulating c-Myc activity and, therefore, regulating the 
Myc/Max/Mxd signalling network in preimplantation embryos.  The expected 
function of specific domains of RNF17 suggests that these domains are 
critical for cell proliferation and differentiation.  Subcellular localisation results 
indicated that RNF17 is shuttled between the nucleus and the cytoplasm by 
means of NLS domains.  In response to proteasomal activity RNF17 acts as 
a RING E3 ligase to degrade MXD via ubiquitinylation.  RNF17 is a multi-
Tudor-containing protein, which interacts via sDMA with target proteins for 
posttranscriptional activity or chromatin remodelling.     252 
 
It is possible that Rnf17 expression creates a Mxd-null phenotype by MXD 
ubiquitinylation leading to its subsequent degradation and that Rnf17 
modulates c-Myc in early development and contributes to embryo 
proliferation.  Conversely, with the loss in function of Rnf17, by siRNA 
knockdown, a delayed development and reduced cell proliferation in embryos 
was observed; however more repeats are necessary to confirm these 
findings. 
7.1 Future prospective 
More studies are needed to fully understand the molecular function of 
RNF17 in embryo growth as well as in the oocyte and the testis.  While 
structural studies of the RING and Tudor domains have greatly increased 
our knowledge of RNF17, its function is still elusive.  Further experiments for 
co-transfection of RNF17 expression plasmids with mutant interacting 
residuals for MXD1-RNF17 into MG132-treated or untreated cultured cells is 
important to investigate the effect of MXD1-RNF17 interaction on cell 
proliferation and growth.  The ability of RNF17 to shuttle between the 
nucleus and the cytoplasm could be examined in a transfection model for 
Rnf17 expression construct with mutant K/R residues to perturb NLS 
functioning.  Studying the nuclear localisation property of RNF17 is vital in 
studying the role of Rnf17 in cell cycle.  Therefore, experiments for mutation 
of cell cycle regulators (entry or exit) may point out the mechanism of 
disappearance of RNF17 during cell division. 
Further investigations are required to investigate the function of Rnf17 in 
preimplantation development and whether RNF17 interacts with PIWI 
proteins at early stages for transposable element silencing.  Using F9 cells, 
as a model for preimplantation embryo, Immunoprecipitation would be a 
useful experiment to find out the interaction between RNF17 and PIWI 
proteins, and whether this is related to transposable element silencing during 
embryo development.  It would be interesting to apply the experiments to 253 
 
examine mRNA and protein levels for Rnf17 and c-Myc expression within F9 
cells or embryo following Rnf17 knockdown.  
Further experiments are important to test whether the knockdown of 
endogenous Rnf17 may induce c-Myc activity in co-transfected F9 cells with 
Rnf17-RNAi.  This would be useful by measuring the Luciferase activity of c-
Myc reporter construct or examine the expression of c-Myc target genes by 
RT-qPCR.  Investigations for expression of Line-1 in Rnf17 knockdown in F9 
cells and embryos are required to answer the questions whether Rnf17 has 
a role in silencing transposon elements in early embryo stages and whether 
Line-1 influence embryo growth and development. 
It is important to examine the level of RNF17 and c-MYC protein to point out 
their transcriptional level for cell proliferation in the early embryo, specifically 
since no differences were seen in the expression of RNF17 protein between 
ICM and TE.  It is interesting to examine the effect of maternal LPD on the 
expression of RNF17 and c-MYC in ICM and TE and whether this is related 
to the migration and proliferation of the primordial germ cell from E9.0 to 
E13.5.    
Finally, more repeats for experiments in this thesis are recommended to give 
insight whether of Rnf17 modulates Myc in the early embryo and to explain 
the mechanism of Rnf17 in creating a MXD-null phenotype.  
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Appendices 
 
Appendix I: Media preparation for embryo 
 
H6-BSA 
 
 
Stock B (stored at 4-8°C for up to 2 weeks) 
 
dH2O  10 ml 
Sodium hydrogen carbonate (NaHCO3)  0.216 g 
   
 
Stock E (stored at 4-8°C for up to 3 months) 
 
dH2O  50 ml 
Hepes  2.9785 g 
   
 
Stock F (stored at 4-8°C for up to 3 months) 
 
Sodium chloride (NaCl)  4.720 g 
Potassium chloride (KCl)  0.110 g 
Sodiumdihydrogenorthophosphate 
(NaH2PO4.2H2O) 
0.060 g 
Magnesium chloride (MgCl2)  0.100 g 
D-glucose  1.000 g 
DL-lacticacid  3.4 ml 
dH2O  Made-up to 100 ml 
   
 
Stock G (stored at 4-8°C for up to 2 weeks) 
 
dH2O  10 ml 
Pyruvic acid  0.0 30g 
Penicillin  0.0 60g 
streptomycin  0.0 50g 
   
 
Stock H (stored at 4-8C for up to 3 months) 
 
dH2O  10 ml 
Calciumchloridedehydrate (CaCl2.2H2O)  0.260 g 
   
 
20% sodium Chloride 
 
dH2O  10 ml 
Sodiumchloride (NaCl)  1.0 g 
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To prepare 100ml of H6-BSA   
dH2O  78 ml 
Stock B  1.6 ml 
Stock E  8.4 ml 
Stock F  10 ml 
Stock G  1.0 ml 
Stock H  1.0 ml 
20% NaCl  0.6 ml 
BSA (sigma, embryo culture tested, A3311)  0.4 g 
 
PH adjusted to 7.4; osmolarilty adjusted to 270-280 mOsm; sterile 
filtered (0.22µm filter); aliquots and stored at 4°C 
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Appendix II: Reagents for western blotting 
1.  SDS/PAGE gel 
 
 
10% Amps  
(ammonium persulphate 
(200µL) 
0.02g Amps in  
200µl dH2O 
 
 
     
10% SDS  50g SDS in 50ml 
dH2O 
 
 
 
   
Reagents  Resolving gel 
buffer (3M Tris-HCl 
pH 8.85) 
Stacking gel buffer 
(0.25M Tris-HCl pH 
6.8) 
Tris  36.33g  3.028g 
dH2O  80ml  80ml 
Adjust pH with concentrated 
HCl 
to 8.85  6.8 
 
Make volume with dH2O up to 100ml 
 
 
   
Gel preparation  Resolving gel 8% 
(10 ml for 2 gels) 
Stack gel 4% 
(5 ml for 2 gels) 
dH2O  4.61ml  3.4ml 
Acrylamide (Protogel)  
(30% stock) 
2.66ml  0.625ml 
TRIS Res  2.5ml  0.835ml 
10% SDS  100µl  50µl 
10% Amps*  100µl  50µl 
Temed*  10 µl  5µl 
     
*Amps and Temed must be added last as they cause polymerisation. 
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2.  Reagent for blotting 
5X SDS PAGE running buffer (1L) (0.125M Tris, 1.25M Glycine, 0.5% 
SDS) 
Tris base    15.1g 
Glycine  94g 
10% SDS  50ml 
dH2O  Make up to 1L 
Use at 1x (0.025M Tris, 0.25M glycine, 0.1%SDS) 
   
Transfer buffer (1L)   
100% Methanol  50ml 
1x SDS running buffer  200ml 
 
3.  Reagents for gel labelling 
PBS (500ml) 
5 tablets of phosphate buffer saline (Dulbecon) in 500ml dH2O.  
Autoclave 
 
 
 
0.1% Tween-20 in PBS (0.1% PBS-
T) 
 
500µl tween-20 in 500ml PBS   
   
10% Blocking solution   
Powder dried milk  10g 
0.1% PBS-T  100ml 
5% Blocking solution   
Powder dried milk  5g 
0.1% PBS-T  100ml 
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Appendix III:  Media and reagents for cloning 
1.  Growth media  
 
 
LB media 
 
Bacto-tryptone  10g 
Bacto-yeast etract  5g 
NaCl  10g 
dH2O  950 ml 
Shake until the solutes have dissolved.  Adjust volume to 1L 
with dH2O.  Autoclave. 
 
 
 
LB agar   
Dissolve 15g Agar into 1L LB media 
 
 
 
IPTG (100mM) 
238mg dissolved in 10ml dH2O 
 
X-gal 
200mg X-gal dissolved in 10ml 
 
2.  Addition of 3' A overhang to PCR product ( total volume 50µl) 
5X GoTaq® Flexi Buffer  10µl 
25 mM MgCl2  4µl 
GoTaq® DNA Polymerase  0.5µl 
25mM dNTP  0.5µl 
PCR Product  35µl 
3.  TA cloning of 3´A overhangs PCR products(total volume 5µl) 
Taq tailed PCR product  1µl 
pGEM®-TEasy vector  0.5µl 
Ligase 2X Rapid Buffer  2.5µl 
T4 DNA Ligase  0.5µl 
dH2O  0.5 µl  
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Appendix IV 
1.  End point PCR reaction (total volume 50µl) using Phusion® Hot 
Start 
 
5X Phusion® HF Buffer 
10µl 
50mM MgCl2  2µl 
25mM dNTP  0.5µl 
Forward Primer (100ng)  1µl 
Reverse Primer (100ng)  1µl 
Template (1:100diluted)  1µl 
Phusion®  Hot Start DNA polymerase  0.5µl 
dH2O  34µl 
 
2.  End point PCR reaction using GoTaq (total volume 1µl) 
 
5X Go Taq® Flexi Buffer  10µl 
25mM MgCl2  4µl 
25mM dNTP  0.5µl 
Forward Primer (100ng)  1µl 
Reverse Primer (100ng)  1µl 
Template  1µl 
GoTaq®  DNA polymerase  0.25µl 
dH2O  32.25µl 
 
3.  Treatment of extracted RNA with DNasI (total volume 25µl) 
RNA template  10µl 
RNA inhibitor  0.5µl 
Buffer  2.5µl 
DNasI  1µl 
 
4.  cDNA synthesis (total volume20 µl) 
 
5X RT reaction Buffer 
4µl 
2mM dNTP  0.5µl 
RNAs Inhibitor  0.5µl 
Random primer  2µl 
Reverse Transcriptase (RT)  1µl 
cDNA  12µl 261 
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